Document:

Executive Employment Agreement

  
 EXHIBIT 10.48

 EXECUTIVE EMPLOYMENT AGREEMENT 
 This Executive Employment Agreement between Heckmann Corporation (“Company”) and Charles Gordon (“Executive”) is made effective on this 1st day of October 2010 (“Agreement”)
Company and Executive hereby agree to the employment of Executive by Company on the following terms and conditions: 
  

	1.	Commencement and Term of Agreement 

 Executive’s employment under this Agreement will commence on October 1, 2010, and continue for three (3) years (the “Term”), unless earlier terminated pursuant to the provisions
of this Agreement. The Term may be modified or extended by mutual agreement. 
  

	2.	Positions and Appointments 

Executive shall serve as President and Chief Operating Officer of the Company and, at the Chairman or Chief Executive Officer’s
election, its subsidiaries. Executive’s duties shall include, but not be limited to, those typical of the President and Chief Operating Officer of a New York Stock Exchange listed company, and such other duties as may be required by the
Chairman and Chief Executive Officer or Board of Directors of the Company from time to time consistent therewith. Executive will be required to travel for business purposes. 

 

	3.	Base Salary 

 Company will
pay Executive a base salary in cash at the rate of $300,000 per annum ($25,000 per month) from which tax and other withholdings will be deducted. Executive will be paid in installments in accordance with normal Company policy Executive’s base
salary may be changed by mutual agreement at any time during the Term. 
  

	4.	Bonus and Equity Incentive Holdings 

  

	4.1	Executive shall be eligible for a bonus of up to 60% of base salary, from which tax and other withholdings will be deducted, pursuant to a plan or plans developed by
you and the Chairman and approved by the Company from time to time, beginning for the calendar year 2011. 

  

	4.2	Upon your execution of this Agreement, Executive will be granted 550,000 options to purchase a share of common stock, at the fair market value thereof as defined in our
equity plan. The terms of the option will be reflected in our standard grant agreement. 

  

	4.3	Thereafter on or about each anniversary of this Agreement during which you are employed as President and Chief Operating Officer, we will grant you 100,000 options on
essentially the same terms (with fair market value measured at the applicable grant date), and 50,000 shares of restricted stock, which shall be governed by our equity plan and standard grant agreement. 

 

	5.	Expenses 

 Company shall
reimburse Executive in respect of all reasonable travelling, accommodation, marketing, entertainment, and other similar out-of-pocket business expenses necessarily incurred by Executive in the performance of his duties, provided that any expense
reimbursement claims are supported by relevant documentation and are made in accordance with Company’s expense or travel policies. 

  
 1 

  

	6.	Benefits and Vacation 

Executive shall be entitled to participate in, and receive benefits as permitted by applicable law under, any pension benefit plan,
welfare benefit plan (including, without limitation, health insurance), vacation benefit plan including 14 paid vacation days per annum or other executive benefit plan made available by Company to its senior executives. Any such plan or benefit
arrangement may be amended, modified, or terminated by Company from time to time with or without notice to Executive 
  

	7.	Termination of Employment 

  

	7.1	By Executive 

 Executive
may seek to terminate his employment by choice without any “Good Reason” by giving the Company thirty (30) days minimum notice in writing. In such case, Executive will receive only his base salary through his final day of service.

 Executive may seek to terminate his employment with “Good Reason” by giving to Company thirty (30) days notice
in writing, and Company shall have sixty (60) days after said notice to cure the problem. If uncured, Executive will receive severance compensation paid in an amount equal to his most recent twelve (12) months’ base salary, plus a
prorated bonus. Payments will be made at the same time as Company salary (or bonus) payments. Executive shall also remain covered by the Company’s health benefits plan for twelve (12) months (or the Company shall reimburse Executive for
such costs). 
 “Good Reason” shall mean: (a) a material reduction or addition in Executive’s authority,
duties, and executive responsibilities with the Company, or (b) a change in direct reporting to the Chairman and Chief Executive Officer, or (c) a material breach of this Agreement. 

 

	7.2	By Company 

 Company may
seek to terminate Executive’s employment by choice without “Cause” by giving Executive not less than thirty (30) days notice in writing. In such case, Executive will receive severance compensation equal to his most recent twelve
(12) months’ base salary, plus a prorated bonus. Payments will be made at the same time as Company salary (or bonus) payments. Executive shall also remain covered by the Company’s health benefits plan for twelve (12) months (or
the Company shall reimburse Executive for such costs). 
 Company may seek to terminate Executive’s employment with
“Cause” by giving Executive not less than thirty (30) days notice in writing, as well as providing Executive thirty (30) days to cure the problem. If uncured, Executive will receive only his base salary through his final day of
service. “Cause” shall be deemed to exist if Executive shall at any time: (a) commit a material breach of this Agreement, or (b) be guilty of gross negligence in connection with or affecting the business or affairs of the
Company, or (c) be guilty of insubordination, or (d) be convicted of, or plead no contest to, a felony criminal offense 

  
 2 

  

	7.3	Death and Disability 

Executive’s employment will automatically terminate upon his death. Further, Company reserves the right to terminate Executive’s
employment at any time during which Executive has a “Disability.” In the event of a termination of Executive’s employment due to death or Disability, Company will pay to Executive or his estate, as applicable, a severance payment
equal to his most recent twelve months’ salary, payable at the same time as Company salary payments. 
 For purposes of this
Agreement, a “Disability” means a physical or mental impairment that prevents Executive from performing the essential duties of his position, with or without reasonable accommodation, for (i) a period of sixty (60) consecutive
calendar days, or (ii) an aggregate of ninety (90) work days in any six (6) month period. A determination that Executive has incurred a Disability will be made by Company, in its sole discretion, but in consultation with a physician
selected by Company and provided that such selected physician consults with Executive’s physician in addition to any examination of Executive and/or other tests on Executive that such selected physician performs or orders to be performed.
Executive hereby agrees to submit to any such examinations and/or other tests from time to time. Notwithstanding the foregoing, any termination of employment due to a “Disability” will be made in accordance with applicable law. 

 

	8.0	Change of Control 

 In the
event that the Executive’s employment with Company is terminated by Company without Cause or by the Executive with Good Reason, in either case following a “Change of Control” (as defined below) then in lieu of any payments or benefits
under clauses 7.1 or 7 2, as applicable, the Executive shall be entitled to receive the following payments and benefits: 
  

	 	(a)	within thirty (30) days, or other mutually agreed date, a payment equal to two (2) times the Executive’s annual base salary as in effect as the time of
termination or immediately prior to the occurrence of the Change of Control; and 

  

	 	(b)	within thirty (30) days, or other mutually agreed date, a payment equal to two (2) times the Executive’s bonus for the year immediately preceding the
year in which the Change of Control occurs; and 

  

	 	(c)	two (2) years of continued coverage under the Company’s (or its successor’s) health insurance plan at the same rates and under the same terms and
conditions that are applicable to senior Executives of Company or its successor (or reimbursement therefore); and 

  

	 	(d)	immediate lapse of restrictions and immediate vesting respecting any restricted stock and outstanding equity incentive awards made to the Executive.

 For purposes of this Agreement, “Change of Control” means a material change in Executive’s
position and responsibilities combined with the earliest to occur of the following events: 
  

	 	(i)	the acquisition or ownership by any individual, entity, or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, and
any successor statute, as it may be amended from time to time (the “Exchange Act”)) (each, a “Person”) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of more than 50% the combined
voting power of the outstanding voting securities of Company entitled to vote generally in the election of directors (“Outstanding Voting Securities”) ; or 

 

	 	(ii)	individuals who, as of the commencement of the Executive’s employment with Company, constitute the Board of Directors of Company (the “Incumbent Board”)
cease for any reason to constitute at least a majority of the Board of Directors of Company; or 

  
 3 

  

	 	(iii)	consummation of a reorganization, merger or consolidation, or sale or other disposition of all or substantially all of the assets of Company (a “Corporate
Transaction”): or 

  

	 	(iv)	approval by the stockholders of Company of a complete liquidation or dissolution of Company 

 

	9.	Confidential Information 

  

	9.1	Executive acknowledges that, during the course of his employment with Company, he will have access to confidential business information and secrets. Executive agrees,
both during the term of his employment and following its termination, that he will hold the confidential business information and secrets in the strictest confidence, and that he will not use or attempt to use or disclose any confidential
information or business secrets any other person or entity without the prior written authorization of Company. 

  

	9.2	The restrictions of clause 9.1 do not apply to any Confidential Information that (a) has entered into the public domain other than by a breach of this Agreement or
other obligation of confidentiality of which Executive is aware, or (b) solely to the extent and for the duration required, is required to be disclosed under a validly-issued court order, pursuant to a request by government regulators, and
which disclosure Company is unable legally to prevent. 

  

	10.	Further Obligations of Executive 

  

	10.1	Executive shall comply with all applicable rules of law, securities laws, regulations, and codes of conduct of Company in effect from time to time in relation to
dealings in shares, notes, debentures, or other securities. 

  

	10.2	Executive represents that his employment with Company does not violate any prior agreement with a former employer or third party. 

 

	11.	Application of Section 409A 

  

	11.1	Notwithstanding anything contained in this Agreement to the contrary, no amount payable on account of Executive’s termination of employment which constitutes a
“deferral of compensation” (“Section 409A Deferred Compensation”) within the meaning of the Treasury Regulations issued pursuant to Section 409A of the Code (the “Section 409A Regulations”) shall be paid unless and
until Executive has incurred a “separation from service” within the meaning of the Section 409A Regulations. Furthermore, if Executive is a “specified employee” within the meaning of the Section 409A Regulations as of
the date of Executive’s separation from service, no amount that constitutes Section 409A Deferred Compensation which is payable on account of Executive’s separation from service shall be paid to Executive before the date (the
“Delayed Payment Date”) which is first day of the seventh month after the date of Executive’s separation from service or, if earlier, the date of Executive’s death following such separation from service. All such amounts that
would, but for this Section, become payable prior to the Delayed Payment Date will be accumulated and paid on the Delayed Payment Date. 

  

	11.2	To the extent that all or any portion of the Company’s payment of or reimbursement to Executive for the cost of health care coverage premiums pursuant to Sections
7 and 8 (the “Company-Provided Benefits”) would exceed an amount for which, or continue for a period of time in excess of which, such Company Provided Benefits would qualify for an exemption from treatment as Section 409A
Deferred Compensation, then, for the duration of the applicable period during which the Company is required to provide such benefits: (a) the amount of Company-Provided Benefits furnished in any taxable year of Executive shall not affect the
amount of Company-Provided Benefits furnished in any other taxable year of Executive; (b) any right of Executive to Company-Provided Benefits shall not be subject to liquidation or exchange for another benefit; and (c) any reimbursement
for Company-Provided Benefits to which Executive is entitled shall be paid no later than the last day of Executive’s taxable year following the taxable year in which Executive’s expense for such Company-Provided Benefits was incurred.

  
 4 

  

	11.3	Any equity award which constitutes Section 409A Deferred Compensation and which would vest and become payable upon a Change of Control in accordance with
Section 8 shall vest in full as provided by Section 8 but shall be converted automatically at the effective time of such Change of Control into a right to receive in cash on the date or dates such award would have been settled in
accordance with its then existing settlement schedule (or on such earlier date as provided by Sections 7 or 8) an amount or amounts equal in the aggregate to the intrinsic value of the equity award at the time of the Change of Control.

  

	11.4	Notwithstanding any provision of this Agreement to the contrary, to the extent that any amount constituting Section 409A Deferred Compensation would become payable
under this Agreement solely by reason of a Change of Control, such amount shall become payable only if the event constituting a Change of Control would also constitute a change in ownership or effective control of the Company or a change in the
ownership of a substantial portion of the assets of the Company within the meaning of the Section 409A Regulations 

  

	11.5	The Company intends that income provided to Executive pursuant to this Agreement will not be subject to taxation under Section 409A of the Code. The provisions of
this Agreement shall be interpreted and construed in favor of satisfying any applicable requirements of Section 409A and the Section 409A Regulations. However, the Company does not guarantee any particular tax effect for income provided to
Executive pursuant to this Agreement. In any event, except for the Company’s responsibility to withhold applicable income and employment taxes from compensation paid or provided to Executive, the Company shall not be responsible for the payment
of any applicable taxes incurred by Executive on compensation paid or provided to Executive pursuant to this Agreement. 

  

	12.	Miscellaneous 

  

	12.1	This Agreement constitutes the entire agreement and understanding between Company and Executive and supersedes any other agreements, whether oral or written, with
respect to the subject matter of this Agreement. This Agreement may only be modified or amended by a further agreement in writing signed by the parties hereto. 

 

	12.2	This Agreement is governed by and shall be construed in accordance with the laws of the State of California, and without giving effect to conflict of law principles.

  

	12.3	In the event the parties are unable to settle a dispute respecting this Agreement such dispute shall be referred to and finally settled by arbitration at a mutually
agreed local office of the American Arbitration Association within the counties of Riverside or Los Angeles, California, in accordance with its commercial and employment Arbitration Rules then in effect, administered by a three member panel of
experienced arbitrators selected by mutual agreement. The parties may offer any relevant materials in discovery under volume and timescale guidelines set by the arbitrators. 

 

	12.4	This Agreement may be executed in several counterparts, each of which shall be deemed to be an original, and all such counterparts when taken together shall constitute
one and the same original. 

  

	12.5	Except to the extent that applicable law requires that any specific action be taken or performed by Company’s Compensation Committee, or to the extent otherwise
provided in this Agreement, any action to be taken or performed, or direction to be provided, by Company under this Agreement may be taken, performed, or provided at the direction of Company’s Chairman and Chief Executive Officer.

  

	12.6	Any waiver by Company of any provision, or any breach of any provision, of this Agreement shall not operate or be construed as a waiver of any subsequent breach of such
provision or any other provision herein. 

  
 5 

  

	12.7	Due to the personal nature of the services contemplated under this Agreement, this Agreement and Executive’s rights and obligations hereunder may not be assigned
by Executive. Company may assign its rights, together with its obligations hereunder, in connection with any sale, transfer, or other disposition of all or substantially all of its business and/or assets, provided that any such assignee of Company
agrees to be bound by the provisions of this Agreement. 

  

									
	Company	 		 	
				
	By:	 	/s/ Richard J. Heckman	 		 	Date: 8/23/10
		 	Name: Richard J. Heckman	 		 	
		 	Title: Chairman of the Board and CEO	 		 	
			
	Executive	 		 	
				
	By:	 	/s/ Charles Gordon	 		 	Date: 8/28/10
		 	Name: Charles Gordon	 		 	

  
 6First Amendment to Credit Agreement

  
 Exhibit 4.1

 Execution Copy 
 FIRST AMENDMENT TO CREDIT AGREEMENT 
 THIS FIRST AMENDMENT TO CREDIT
AGREEMENT (this “Amendment”), dated as of September 1, 2010, is entered into among AMN HEALTHCARE, INC., a Nevada corporation (the “Borrower”), AMN HEALTHCARE SERVICES, INC., a Delaware
corporation (the “Parent”), the Subsidiary Guarantors identified on the signature pages hereto, the lenders identified on the signature pages hereto (the “Lenders”) and BANK OF AMERICA, N.A., as
Administrative Agent (the “Administrative Agent”). 
 W I T N E S S E T H 

WHEREAS, the Borrower, the Parent, the Subsidiary Guarantors, the Lenders party thereto, the Administrative Agent and the
Syndication Agent (as defined therein) have entered into that certain Credit Agreement dated as of December 23, 2009 (as amended, amended and restated, modified and supplemented in accordance with the terms thereof, the “Existing Credit
Agreement”); 
 WHEREAS, the Borrower has advised the Lenders that it intends to acquire NF Investors, Inc., a
Delaware corporation (the parent company of Nursefinders, Inc. (d/b/a Medfinders)) and its Subsidiaries (the “Acquisition”) pursuant to the terms of that certain Agreement and Plan of Merger by and among AMN Healthcare Services,
Inc., Nightingale Acquisition, Inc., Nightingale Acquisition, LLC, NF Investors, Inc. and GSUIG, L.L.C. (in its capacity as the representative), dated as of July 28, 2010, as it may be amended on or prior to the First Amendment Effective Date;

 WHEREAS, in connection with the Acquisition, the Borrower has requested that the Lenders amend certain provisions of
the Existing Credit Agreement in order to, (a) extend the Revolving Maturity Date from December 23, 2012 to August 31, 2014, (b) extend the Maturity Date with respect to the Tranche B Loan from December 23, 2013 to
June 23, 2015 (for Tranche B Lenders agreeing to such extension), (c) increase the Tranche B Loan by an additional $77,750,000, (d) adjust certain of the financial covenants set forth in Section 7.11 of the Existing Credit
Agreement, (e) permit the incurrence of the Second Lien Credit Agreement (as defined below) and (f) provide for such other modifications as set forth herein; 
 WHEREAS, simultaneously with this Amendment, the Borrower is entering into a Second Lien Credit Agreement in the principal amount of $40,000,000 dated as of the date hereof (as amended, amended and
restated, modified and supplemented in accordance with the terms thereof, the “Second Lien Credit Agreement”) with the Parent, each Subsidiary Guarantor party thereto, the lenders party thereto (the “Second Lien
Lenders”) and Bank of America, N.A. as administrative agent (in such capacity, the “Second Lien Administrative Agent”); 
 WHEREAS, the Requisite Lenders, each Revolving Lender, each Additional Tranche B Lender and each Extended Tranche B Lender have agreed to amend the Existing Credit Agreement in accordance with such
requests and as provided herein; and 
 NOW, THEREFORE, in consideration of the agreements hereinafter set forth, and for
other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the parties hereto agree as follows: 

  
 1 

  
 PART 1

 DEFINITIONS 
 SUBPART 1.1 Certain Definitions. Unless otherwise defined herein or the context otherwise requires, the following terms used in this Amendment, including its preamble and recitals, have the
following meanings: 
 “Amended Credit Agreement” means the Existing Credit Agreement as amended
hereby. 
 “First Amendment” has the meaning set forth in Part 3. 

SUBPART 1.2 Other Definitions. Unless otherwise defined herein or the context otherwise requires, terms used in this
Amendment, including its preamble and recitals, have the meanings provided in the Amended Credit Agreement. 
 PART 2

 AMENDMENTS TO EXISTING CREDIT AGREEMENT 
 Effective on (and subject to the occurrence of) the First Amendment Effective Date, the Existing Credit Agreement is hereby amended in accordance with this Part 2. 

SUBPART 2.1 Designation of Syndication Agents and Joint Lead Arrangers and Joint Book Managers. General Electric Capital
Corporation and SunTrust Bank are hereby designated as Co-Syndication Agents for the Lenders under the Amended Credit Agreement. ING Capital LLC is hereby designated as Documentation Agent for the Lenders under the Amended Credit Agreement. Banc of
America Securities LLC, GE Capital Markets, Inc., SunTrust Robinson Humphrey, Inc. and ING Capital LLC are hereby designated as Joint Lead Arrangers and Joint Book Managers for the Lenders under the Amended Credit Agreement. 

SUBPART 2.2 Amendments to Section 1.1. 
 (a) The definition of “Administrative Agent’s Fee Letter” is hereby amended and restated in its entirety to read as follows: 

“Administrative Agent’s Fee Letter” means that certain letter agreement, dated as of July 28,
2010, among the Administrative Agent, Banc of America Securities LLC, the Borrower and the Parent, as amended, modified, restated or supplemented from time to time. 
 (b) The definition of “Applicable Percentage” is hereby amended and restated in its entirety to read as follows: 

“Applicable Percentage” means, for purposes of calculating (a) the applicable interest rate for any
day for any Revolving Loan bearing interest at (i) the Base Rate, shall be 4.50% and (ii) the Eurodollar Rate, shall be 5.50%, (b) the applicable rate of the Unused Fee for any day for purposes of Section 3.5(a), shall be
0.75% and (c) the Letter of Credit Fee for any day for purposes of Section 3.5(b)(i), shall be 5.50%. 
 (c)
The definition of “Arrangers” is hereby amended and restated in its entirety to read as follows: 
 “Arrangers” means, collectively, Banc of America Securities LLC, GE Capital Markets, Inc., SunTrust Robinson Humphrey, Inc. and ING Capital LLC, in their capacities as joint lead
arrangers and book managers, and “Arranger” means any one of them. 

  
 2 

  
 (d) The proviso
appearing at the end of the definition of “Consolidated Cash Interest Expense” is hereby amended and restated in its entirety to read as follows: 
 provided, however, that (a) Consolidated Cash Interest Expense for the twelve month period ending as of September 30, 2010 shall be based on Consolidated Cash Interest Expense for
the one month period then ended multiplied by 12, (b) Consolidated Cash Interest Expense for the twelve month period ending as of December 31, 2010 shall be based on Consolidated Cash Interest Expense for the one fiscal-quarter
period then ended multiplied by 4, (c) Consolidated Cash Interest Expense for the twelve month period ending as of March 31, 2011 shall be based on Consolidated Cash Interest Expense for the two fiscal-quarter period then ended
multiplied by 2 and (d) Consolidated Cash Interest Expense for the twelve month period ending as of June 30, 2011 shall be based on Consolidated Cash Interest Expense for the three fiscal-quarter period then ended multiplied
by 1 1/3. 
 (e) The definition of “Consolidated EBITDA” is hereby amended and restated in its entirety to
read as follows: 
 “Consolidated EBITDA” means, as of any date for the four fiscal quarter
period ending on such date with respect to the Consolidated Parties on a consolidated basis, the sum of (i) Consolidated Net Income, plus (ii) an amount which, in the determination of Consolidated Net Income, has been deducted for,
without duplication, (A) interest expense, (B) total Federal, state, local and foreign income, value added and similar taxes, (C) depreciation and amortization expense and (D) Consolidated Non-Cash Charges, plus
(iii) with respect to each of December 31, 2009, March 31, 2010, June 30, 2010 and September 30, 2010, the Consolidated EBITDA Adjustment for such fiscal quarter plus (iv) an aggregate amount not to
exceed $7,600,000 during the term of this Agreement which, in the determination of Consolidated Net Income, has been deducted for, without duplication, costs, charges and expenses relating to, and in preparation of, the Transactions, plus
(v) expected but unrealized cost reduction synergies in connection with the Medfinders Acquisition in an amount not to exceed the amounts set forth on Schedule 1.1E for the four fiscal quarter period ending on such date plus
(vi) an amount which, in the determination of Consolidated Net Income, has been deducted for, without duplication, cash integration charges relating to reductions in the workforce, one-time incentives related to the Transactions, the
termination of leases and third-party consulting costs incurred through such period in an aggregate amount not to exceed the amounts set forth on Schedule 1.1E for the period since the First Amendment Effective Date minus
(vii) Consolidated Non-Cash Gains, all as contained within the financial statements prepared in accordance with GAAP. 

(f) The parenthetical appearing at the end of clause (b)(ii) contained in the definition of “Consolidated Fixed Charge Coverage
Ratio” is hereby amended and restated in its entirety to read as follows: 
 (other than Consolidated Scheduled Funded
Debt Payments for any period prior to the First Amendment Effective Date) 
 (g) The definition of “Consolidated Funded
Indebtedness” set forth in Section 1.1 of the Existing Credit Agreement is hereby amended by adding a new subclause (iii) to clause (a) thereof to read as follows, and by making the necessary grammatical changes thereto:

 and (iii) the Backstopped Letters of Credit, 

  
 3 

  
 (h) Clause
(iii) contained in the definition of “Consolidated Scheduled Funded Debt Payments” and the proviso appearing at the end of such definition are hereby amended and restated in their entirety to read as follows: 

(iii) shall not include any voluntary prepayments or mandatory prepayments required pursuant to Section 3.3 or
Section 3.3 of the Second Lien Credit Agreement; provided, however, that (a) Consolidated Scheduled Funded Debt Payments for the twelve month period ending as of September 30, 2010 shall be $9,250,000,
(b) Consolidated Scheduled Funded Debt Payments for the twelve month period ending as of December 31, 2010 shall be based on Consolidated Scheduled Funded Debt Payments for the one fiscal-quarter period then ended multiplied by 4,
(c) Consolidated Scheduled Funded Debt Payments for the twelve month period ending as of March 31, 2011 shall be based on Consolidated Scheduled Funded Debt Payments for the two fiscal-quarter period then ended multiplied by 2 and
(d) Consolidated Scheduled Funded Debt Payments for the twelve month period ending as of June 30, 2011 shall be based on Consolidated Scheduled Funded Debt Payments for the three fiscal-quarter period then ended multiplied by 1 1/3.

 (i) The definition of “Credit Documents” set forth in Section 1.1 of the Existing Credit Agreement is
hereby amended and restated in its entirety to read as follows: 
 “Credit Documents” means a
collective reference to this Credit Agreement, the Notes, the LOC Documents, each Joinder Agreement, the Administrative Agent’s Fee Letter, the GE Fee Letter, the ING Fee Letter, the SunTrust Fee Letter, the Collateral Documents, the
Intercreditor Agreement and all other related agreements and documents issued or delivered hereunder or thereunder or pursuant hereto or thereto (in each case as the same may be amended, modified, restated, supplemented, extended, renewed or
replaced from time to time), and “Credit Document” means any one of them. 
 (j) The definition of
“Eurodollar Rate” set forth in Section 1.1 of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows: 

“Eurodollar Rate” means for any Interest Period with respect to a Eurodollar Loan, a rate per annum
determined by the Administrative Agent pursuant to the following formula: 
  

							
		 	Eurodollar Rate =  	  	Interbank Offered Rate	  	
		 	  	1.00 – Eurodollar Reserve Requirement	  	

 Notwithstanding the foregoing, solely for purposes of Tranche B Loans, the Eurodollar Rate shall
in no event be less than (a) with respect to Non-Extended Tranche B Loans, 2.25% per annum at any time and (b) with respect to Extended Tranche B Loans, 1.75% per annum at any time. 

(k) The definition of “Excess Cash Flow” set forth in Section 1.1 of the Existing Credit Agreement is hereby
amended by adding a new subclause (iii) and a new subclause (iv) to clause (h) thereof to read as follows and by renumbering existing subclause (iii) contained in clause (h) thereof to read subclause (v). 

(iii) expected but unrealized cost reduction synergies in connection with the Medfinders Acquisition in an amount not to
exceed the amounts set forth on Schedule 1.1(E) for the four fiscal quarter period ending on such date, (iv) for the fiscal year ending December 31, 2010 only, cash on hand of the Credit Parties used on the Closing Date to consummate the
Medfinders Acquisition 

  
 4 

  
 (l) The definition of
“Excluded Taxes” set forth in Section 1.1 of the Existing Credit Agreement is hereby amended by adding a new clause (e) to the end thereof to read as follows, and by making the necessary grammatical changes thereto:

 and (e) any taxes imposed on any “withholdable payment” payable to such recipient as a result
of the failure of such recipient to satisfy the applicable requirements as set forth in FATCA after December 31, 2012. 

(m) The definition of “Maturity Date” set forth in Section 1.1 of the Existing Credit Agreement is hereby amended
and restated in its entirety to read as follows: 
 “Maturity Date” means (i) with respect
to the Revolving Loans, Swingline Loans and Letters of Credit, the Revolving Maturity Date and (ii) with respect to the Tranche B Loans, the applicable Tranche B Maturity Date. 

(n) The definition of “Permitted Acquisition” set forth in Section 1.1 of the Existing Credit Agreement is hereby
amended and restated in its entirety to read as follows: 
 “Permitted Acquisition” means
(i) the Medfinders Acquisition occurring on the First Amendment Effective Date and (ii) any other Acquisition by the Borrower or any Subsidiary of the Borrower, provided that (a) the Property acquired (or the Property of the
Person acquired) in such Acquisition (x) is used or useful in the same or a similar line of business as the Borrower and its Subsidiaries were engaged in on the Closing Date (or any reasonable extensions or expansions thereof) and (y) has
earnings before interest, taxes, depreciation and amortization for the prior four fiscal quarters in an amount greater than $0, (b) the Administrative Agent shall have received all items in respect of the Capital Stock or Property acquired in
such Acquisition required to be delivered by the terms of Section 7.12 and/or Section 7.13, (c) in the case of an Acquisition of the Capital Stock of another Person, the board of directors (or other comparable governing
body) of such other Person shall have duly approved such Acquisition, (d) the Borrower shall have delivered to the Administrative Agent a Pro Forma Compliance Certificate demonstrating that, upon giving effect to such Acquisition on a Pro Forma
Basis, no Default or Event of Default would exist as the result of a violation of Section 7.11(a) or Section 7.11(b), (e) the representations and warranties made by the Credit Parties in any Credit Document shall be true
and correct in all material respects at and as if made as of the date of such Acquisition (after giving effect thereto) except to the extent such representations and warranties expressly relate to an earlier date, (f) if such transaction
involves the purchase of an interest in a partnership between the Borrower (or a Subsidiary of the Borrower) as a general partner and entities unaffiliated with the Borrower or such Subsidiary as the other partners, such transaction shall be
effected by having such equity interest acquired by a holding company directly or indirectly wholly-owned by the Borrower newly formed for the sole purpose of effecting such transaction and (g) the total Qualifying Consideration for all such
Acquisitions occurring after the Closing Date (other than the Medfinders Acquisition) shall not exceed (x) $50,000,000 or (y) to the extent the Borrower has provided a certificate in form and substance satisfactory to the Administrative
Agent to the effect that, after giving effect to any such Acquisition on a Pro Forma Basis, the Consolidated Leverage Ratio shall be 0.50 less than the then applicable level set forth in Section 7.11(a), $125,000,000; provided, further,
however, prior to and after giving effect to all Permitted Acquisitions (other than the Medfinders Acquisition), on a pro forma basis, the Unused Revolving Committed Amount shall not be less than $10,000,000. 

(o) The definition of “Permitted Liens” set forth in Section 1.1 of the Existing Credit Agreement is hereby amended
by adding a new clause (xix) to the end thereof to read as follows, and by making the necessary grammatical changes thereto: 
  

	 	(xix) 	Liens arising under the Second Lien Collateral Documents to the extent such Liens (and related Indebtedness) are subject to the terms of the Intercreditor Agreement.

  
 5 

  
 (p) The last sentence
of the first paragraph of the definition of “Pro Forma Basis” set forth in Section 1.1 of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows: 

In connection with any calculation of the Consolidated Leverage Ratio, Consolidated First Lien Leverage Ratio and the Consolidated Fixed
Charge Coverage Ratio upon giving effect to a transaction on a Pro Forma Basis: 
 (q) Clause (a) contained in the
definition of “Pro Forma Compliance Certificate” set forth in Section 1.1 of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows: 

(a) the Consolidated Leverage Ratio, the Consolidated First Lien Leverage Ratio and the Consolidated Fixed Charge Coverage
Ratio as of the most recent fiscal quarter end preceding the date of the applicable transaction with respect to which the Administrative Agent shall have received the Required Financial Information and 

(r) The definition of “Revolving Maturity Date” set forth in Section 1.1 of the Existing Credit Agreement is hereby
amended and restated in its entirety to read as follows: 
 “Revolving Maturity Date” means
August 31, 2014. 
 (s) The definition of “SunTrust Fee Letter” set forth in Section 1.1 of the
Existing Credit Agreement is hereby amended and restated in its entirety to read as follows: 
 “SunTrust
Fee Letter” means that certain letter agreement, dated as of July 28, 2010, among SunTrust Bank, SunTrust Robinson Humphrey, Inc., the Borrower and the Parent, as amended, modified, restated or supplemented from time to time.

 (t) The definition of “Syndication Agent” set forth in Section 1.1 of the Existing Credit Agreement is
hereby amended and restated in its entirety to read as follows: 
 “Syndication Agent” means,
collectively, General Electric Capital Corporation and SunTrust Bank, in their capacities as Syndication Agents under this Agreement, and their successors and permitted assigns. 

(u) The definition of “Tranche B Loan” set forth in Section 1.1 of the Existing Credit Agreement is hereby amended
and restated in its entirety to read as follows: 
 “Tranche B Loan” shall mean the Initial
Tranche B Loan and/or the Additional Tranche B Loan, as appropriate. 
 (v) The definition of “Tranche B Loan Committed
Amount” set forth in Section 1.1 of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows: 
 “Tranche B Loan Committed Amount” shall mean the Initial Tranche B Loan Committed Amount and/or the Additional Tranche B Loan Committed Amount, as appropriate. 

  
 6 

  
 (w) The following new
definitions are hereby added to Section 1.1 of the Existing Credit Agreement in their appropriate alphabetical order: 
 “Acquired Company” means NF Investors, Inc., a Delaware corporation (the parent company of Nursefinders, Inc. (d/b/a Medfinders)) and its Subsidiaries. 

“Acquisition Agreement” means the Agreement and Plan of Merger by and among AMN Healthcare Services,
Inc., Nightingale Acquisition, Inc., Nightingale Acquisition, LLC, NF Investors, Inc. and GSUIG, L.L.C. (in its capacity as the representative), dated as of July 28, 2010, as it may be amended on or prior to the First Amendment Effective Date.

 “Additional Tranche B Lender” means those Lenders providing Additional Tranche B Loans on the
First Amendment Effective Date. 
 “Additional Tranche B Loan” shall have the meaning set forth
in Section 2.4(a). 
 “Additional Tranche B Loan Commitment Percentage” shall mean,
for any Additional Tranche B Lender, the percentage identified as its Additional Tranche B Loan Percentage on Schedule 2.1(a). 
 “Additional Tranche B Loan Committed Amount” shall have the meaning set forth in Section 2.4(a). 

“Backstopped Letters of Credit” shall mean those certain letters of credit set forth on Schedule
1.1F. 
 “Consolidated First Lien Leverage Ratio” means, as of the end of any fiscal quarter
of the Consolidated Parties for the four fiscal quarter period ending on such date with respect to the Consolidated Parties on a consolidated basis, the ratio of (a) Consolidated Funded Indebtedness of the Consolidated Parties on a consolidated
basis, other than Indebtedness attributable to the Second Lien Financing, on the last day of such period to (b) Consolidated EBITDA for such period. 
 “Existing Tranche B Loan Maturity Date” shall have the meaning set forth in the definition of Tranche B Loan Maturity Date. 

“Extended Tranche B Lender” means those Lenders with (a) Additional Tranche B Loans and/or
(b) Initial Tranche B Loans that mature on the Extended Tranche B Loan Maturity Date. 
 Extended Tranche
B Loans” means (a) the Additional Tranche B Loans and/or (b) the Initial Tranche B Loans that, as indicated on Schedule 2.1(a), mature on the Extended Tranche B Maturity Date. 

“Extended Tranche B Loan Maturity Date” shall have the meaning set forth in the definition of Tranche B
Loan Maturity Date. 
 “FATCA” means Sections 1471 through 1474 of the Code and any regulations
or official interpretations thereof. 
 “First Amendment” means that certain First Amendment to
Credit Agreement, dated as of the First Amendment Effective Date, by and among the Borrower, the Parent, the Subsidiary Guarantors, the Requisite Lenders, the Revolving Lenders, the Additional Tranche B Lenders, the Extended Tranche B Lenders and
the Administrative Agent. 

  
 7 

  

“First Amendment Effective Date” means September 1, 2010. 

“GE Fee Letter” means that certain letter agreement, dated as of July 28, 2010, among the General
Electric Capital Corporation, GE Capital Markets, Inc., the Borrower and the Parent, as amended, modified, restated or supplemented from time to time. 
 “ING Fee Letter” means that certain letter agreement, dated as of August 19, 2010, among ING Capital LLC, the Borrower and the Parent, as amended, modified, restated or supplemented
from time to time. 
 “Initial Tranche B Loan” shall have the meaning set forth in
Section 2.4(a). 
 “Initial Tranche B Loan Committed Amount” shall have the meaning
set forth in Section 2.4(a). 
 “Intercreditor Agreement” means an intercreditor
agreement in substantially the form of Exhibit A to the First Amendment, dated as of the First Amendment Effective Date by and among the Administrative Agent, the Second Lien Administrative Agent and the Borrower, as amended, modified,
restated or supplemented from time to time. 
 “Liquidity” means, as of any date of
determination, for the Consolidated Parties on a consolidated basis, the sum of all cash and Cash Equivalents of the Consolidated Parties as of such date plus the actual amount as of such date by which the Revolving Committed Amount exceeds the
aggregate amount of Revolving Loans and Letters of Credit then outstanding. 
 “Medfinders
Acquisition” means the Acquisition of the Acquired Company pursuant to the Acquisition Agreement. 

“Non-Extended Tranche B Lender” means those Lenders with Initial Tranche B Loans that mature on the
Existing Tranche B Loan Maturity Date. 
 “Non-Extended Tranche B Loans” means the Initial
Tranche B Loans that, as indicated on Schedule 2.1(a), mature on the Existing Tranche B Maturity Date. 

“Refinancing Event” means the incurrence by any Credit Party of any Indebtedness (including,
without limitation, any new or additional term loans under this Credit Agreement, whether incurred directly or by way of the conversion of Loans into a new tranche of replacement term loans under this Credit Agreement) having an effective interest
rate (to be calculated after giving effect to margins, upfront or similar fees or original issue discount shared with all lenders or holders thereof, but excluding the effect of any arrangement, structuring, syndication or other fees payable in
connection therewith that are not shared with all lenders or holders thereof) as of the date of such incurrence that is by the express terms of such Indebtedness (and not by virtue of any fluctuation in Eurodollar Rate or Base Rate), less than the
effective interest rate of (to be calculated on the same basis as above) the Extended Tranche B Loans as of the date of such incurrence. 
 “Second Lien Administrative Agent” shall mean Bank of America, N.A., in its capacity as administrative agent for the Second Lien Lenders, together with its successors and assigns.

 “Second Lien Credit Agreement” shall mean that certain Second Lien Credit Agreement dated as
of the First Amendment Effective Date among the Parent, the Borrower, each Subsidiary Guarantor party thereto, the lenders party thereto and the Second Lien Administrative Agent, as amended, amended and restated, modified or supplemented from time
to time. 

  
 8 

  

“Second Lien Collateral Documents” means a collective reference to the “Security Agreement” and
“Pledge Agreement”, each delivered pursuant to the Second Lien Credit Agreement and such other documents executed and delivered in connection with the attachment and perfection of the Second Lien Administrative Agent’s security
interests and liens arising thereunder, including, without limitation, UCC financing statements, account control agreements and patent and trademark filings. 
 “Second Lien Financing” shall mean the $40 million senior secured second lien financing incurred by the Borrower pursuant to the Second Lien Credit Agreement. 

“Second Lien Lenders” shall mean those certain banks and other financial institutions from time to time
party to the Second Lien Credit Agreement as lenders. 
 “Tranche B Loan Maturity Date” shall
mean (a) with respect to all Initial Tranche B Loans held by Non-Extended Tranche B Lenders, December 23, 2013 (the “Existing Tranche B Maturity Date”) and (b) with respect to all Extended Tranche B Loans,
June 23, 2015 (the “Extended Tranche B Maturity Date”). 
 “Transaction”
means (i) the Medfinders Acquisition, (ii) the entering into of the First Amendment by the Borrower and the Guarantors, (iii) the entering into of the Second Lien Credit Agreement by the Borrower and the Guarantors, (iv) the
entering into of the other “Credit Documents” as defined in the Second Lien Credit Agreement by the Borrower and the Guarantors, (v) the repayment, with proceeds of the Loans hereunder, of all Indebtedness of the Acquired Company and
(vi) the related financings and other transactions contemplated by this Credit Agreement, the Second Lien Credit Agreement and the Acquisition Agreement. 
 SUBPART 2.3 Amendment to Section 1.2(a). Section 1.2(a) of the Existing Credit Agreement is hereby amended in the following respects: 

(a) The reference to “the fiscal year ended December 31, 2008” in such section is hereby amended to read
“the fiscal year ended December 31, 2009.” 
 (b) The reference to “September 30, 2009”
in such section is hereby amended to read “June 30, 2010.” 
 SUBPART 2.4 Amendment to
Section 2.4(a). Section 2.4(a) of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows: 
 (a) Tranche B Loan Commitment. Subject to the terms and conditions hereof and in reliance upon the representations and warranties set forth herein each Lender with a Tranche B Loan Commitment on
the Closing Date made available to the Borrower on the Closing Date such Lender’s Commitment Percentage of a term loan in Dollars (the “Initial Tranche B Loan”) in the aggregate principal amount of ONE HUNDRED TEN MILLION
DOLLARS ($110,000,000) (the “Initial Tranche B Loan Committed Amount”). The aggregate outstanding principal amount of the Initial Tranche B Loan as of the First Amendment Effective Date is equal to ONE HUNDRED SEVEN MILLION
TWO HUNDRED FIFTY THOUSAND DOLLARS ($107,250,000). Subject to the terms and conditions hereof and in reliance upon the representations and warranties set forth herein each Additional Tranche B Lender severally agrees to make available to
the Borrower on the First Amendment Effective Date such Additional Tranche B Lender’s Additional Tranche B Loan Commitment Percentage of a term loan in Dollars (the “Additional Tranche B Loan”, together with

  
 9 

 
the Initial Tranche B Loan, the “Tranche B Loan”) in the aggregate principal amount of SEVENTY SEVEN MILLION SEVEN HUNDRED FIFTY THOUSAND DOLLARS ($77,750,000) (the
“Additional Tranche B Loan Committed Amount”, together with the Initial Tranche B Loan Committed Amount, the “Tranche B Loan Committed Amount”). The Tranche B Loan may consist of Base Rate Loans or Eurodollar Loans,
or a combination thereof, as the Borrower may request; provided, however, that no more than six (6) Eurodollar Loans which are Tranche B Loans shall be outstanding hereunder at any time (it being understood that, for purposes
hereof, Eurodollar Loans with different Interest Periods shall be considered as separate Eurodollar Loans, even if they begin on the same date, although borrowings, extensions and conversions may, in accordance with the provisions hereof, be
combined at the end of existing Interest Periods to constitute a new Eurodollar Loan with a single Interest Period). Amounts prepaid or repaid on the Tranche B Loan may not be reborrowed. 

SUBPART 2.5 Amendment to Section 2.4(b). Section 2.4(b) of the Existing Credit Agreement is hereby amended and
restated in its entirety to read as follows: 
 (b) Borrowing Procedures. The Borrower shall submit
an appropriate Notice of Borrowing to the Administrative Agent with respect to (i) the Initial Tranche B Loan not later than 12:00 Noon (Charlotte, North Carolina time) on the Closing Date and (ii) the Additional Tranche B Loan not later
than 12:00 Noon (Charlotte, North Carolina time) on the First Amendment Effective Date in the case of a Base Rate Loan or on the third Business Day prior to the First Amendment Effective Date in the case of a Eurodollar Loan; provided that
with respect to any Eurodollar Loan requested by the Borrower on the First Amendment Effective Date, the Borrower shall provide a funding indemnity letter in form and substance reasonably acceptable to the Administrative Agent contemporaneously with
the delivery of the Notice of Borrowing. Such Notices of Borrowing shall be irrevocable. Each (i) Tranche B Lender with a Tranche B Loan Commitment on the Closing Date made its Commitment Percentage of the Initial Tranche B Loan and
(ii) each Additional Tranche B Lender shall make its Additional Tranche B Commitment Percentage of the Additional Tranche B Loan available to the Administrative Agent for the account of the Borrower at the office of the Administrative Agent
specified in Schedule 2.1(a), or at such other office as the Administrative Agent may designate in writing, by 2:00 P.M. (Charlotte, North Carolina time) on (i) with respect to the Initial Tranche B Loan, the Closing Date in Dollars
and in funds immediately available to the Administrative Agent and (ii) with respect to the Additional Tranche B Loan, the First Amendment Effective Date in Dollars and in funds immediately available to the Administrative Agent;
provided, however, that the Administrative Agent shall, if requested by the Borrower and agreed to by the Administrative Agent, make the Additional Tranche B Loan available to the Borrower as provided above prior to the Administrative
Agent’s receipt of corresponding amounts from the Additional Tranche B Lenders. 
 SUBPART 2.6 Amendment to
Section 2.4(d). Section 2.4(d) of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows: 
 (d) Repayment of Tranche B Loan. 
 (i) Repayment of
Initial Tranche B Loans held by Non-Extended Tranche B Lenders. 
 [No longer applicable.] 

  
 10 

  
 (ii)
Repayment of Extended Tranche B Loans. The principal amount of Extended Tranche B Loans shall be payable in installments on the dates and in the amounts set forth in the table below, unless accelerated sooner pursuant to
Section 9.2: 
  

			
	 Payment Dates
	  	Principal Amortization
Payment
	 September 30, 2010
	  	$2,312,500
	 December 31, 2010
	  	$2,312,500
	 March 31, 2011
	  	$2,312,500
	 June 30, 2011
	  	$2,312,500
	 September 30, 2011
	  	$4,625,000
	 December 31, 2011
	  	$4,625,000
	 March 31, 2012
	  	$4,625,000
	 June 30, 2012
	  	$4,625,000
	 September 30, 2012
	  	$6,937,500
	 December 31, 2012
	  	$6,937,500
	 March 31, 2013
	  	$6,937,500
	 June 30, 2013
	  	$6,937,500
	 September 30, 2013
	  	$6,937,500
	 December 31, 2013
	  	$6,937,500
	 March 31, 2014
	  	$6,937,500
	 June 30, 2014
	  	$6,937,500
	 September 30, 2014
	  	$9,250,000
	 December 31, 2014
	  	$9,250,000
	 March 31, 2015
	  	$9,250,000
	 Extended Tranche B Loan Maturity Date
	  	$74,000,000 or the

remaining outstanding
 principal amount of the
Extended Tranche B Loans

 SUBPART 2.7 Amendment to Section 2.4(e). Section 2.4(e) of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows: 

(e) Interest. Subject to the provisions of Section 3.1, the Tranche B Loan shall bear interest at a per
annum rate equal to: 
 (i) Base Rate Loans. (A) During such periods as the Non-Extended Tranche B
Loans shall be comprised in whole or in part of Base Rate Loans, such Base Rate Loans shall bear interest on the outstanding principal amount thereof from the applicable borrowing date at a rate per annum equal to the sum of the Base Rate
plus 3.00% and (B) during such periods as the Extended Tranche B Loans shall be comprised in whole or in part of Base Rate Loans, such Base Rate Loans shall bear interest on the outstanding principal amount thereof from the applicable
borrowing date at a rate per annum equal to the sum of the Base Rate plus 4.50%. 
 (ii) Eurodollar
Loans. (A) During such periods as the Non-Extended Tranche B Loans shall be comprised in whole or in part of Eurodollar Loans, such Eurodollar Loans shall bear interest on the outstanding principal amount thereof for each Interest Period at
a rate per annum equal to the sum of the Eurodollar Rate for such Interest Period plus 4.00% and (B) during such periods as the Extended Tranche B Loans shall be comprised in whole or in part of Eurodollar Loans, such Eurodollar Loans
shall bear interest on the outstanding principal amount thereof for each Interest Period at a rate per annum equal to the sum of the Eurodollar Rate for such Interest Period plus 5.50%. 

  
 11 

  
 Interest on the Tranche
B Loan shall be payable in arrears on each applicable Interest Payment Date (or at such other times as may be specified herein). 
 SUBPART 2.8 Amendment to Section 2.5. Section 2.5 of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows: 

2.5 Reserved. 
 SUBPART 2.9 Amendments to Section 3.3. 
 (a) The
last sentence appearing at the end of clause (a) is hereby amended and restated in its entirety to read as follows 
 All prepayments under this Section 3.3(a) shall be subject to Section 3.3(c) and Section 3.12, but otherwise without premium or penalty, and shall be accompanied by
interest on the principal amount prepaid through the date of prepayment. 
 (b) A new clause (c) is hereby
added to Section 3.3 of the Existing Credit Agreement to read as follows: 
 (c) Prepayment Premiums.
In connection with any prepayment of the Extended Tranche B Loans with the proceeds of any Refinancing Event consummated prior to the first anniversary of the First Amendment Effective Date, the Borrower agrees to pay a premium in an amount equal to
1.0% of the aggregate principal amount of the Extended Tranche B Loans prepaid in connection with such Refinancing Event (it being understood that the incurrence of Indebtedness shall only be a Refinancing Event to the extent of the proceeds thereby
used to prepay the Extended Tranche B Loans and not to the extent the proceeds are generated from other sources). 
 SUBPART
2.10 Amendment to Section 3.11(e). Section 3.11(e) of the Existing Credit Agreement is hereby amended by adding a new clause (iv) to the end thereof to read as follows: 

(iv) Each Foreign Lender shall deliver to the Borrower and the Administrative Agent such documentation reasonably
requested by the Borrower and the Administrative Agent sufficient for the Administrative Agent and the Borrower to comply with their obligations under FATCA and to determine whether payments to such Lender hereunder requirements are subject to
withholding under FATCA. 
 SUBPART 2.11 Amendment to Section 3.12(a). The reference to “Closing
Date” contained in subclause (i) of Section 3.12(a) of the Existing Credit Agreement is hereby amended to read “First Amendment Effective Date.” 
 SUBPART 2.12 Amendment to Section 6.1(a). Section 6.1(a) of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows: 

6.1 Financial Condition. 
 (a) The audited consolidated balance sheets and income statements of the Consolidated Parties for the fiscal year ended December 31, 2009 (including the notes thereto) (i) have been audited
by (A) with respect to the Acquired Company, Ernst & Young and (B) with respect to the other Consolidated Parties, KPMG LLP, (ii) have been prepared in accordance with GAAP consistently applied throughout the periods covered
thereby and (iii) present fairly in all 

  
 12 

 
material respects (on the basis disclosed in the footnotes to such financial statements) the consolidated financial condition, results of operations and cash flows of each of the Consolidated
Parties referred in clauses (A) and (B) of this paragraph as of such date and for such periods, it being understood that each of the Acquired Company and the other Consolidated Parties were independent businesses and not aggregated for
purposes of preparing consolidated financial statements for periods prior to the First Amendment Effective Date. The unaudited interim balance sheets of each of the Consolidated Parties referred in clauses (A) and (B) of this paragraph as
at the end of, and the related unaudited interim statements of earnings and of cash flows for, each fiscal quarterly period ended after December 31, 2009 and prior to the First Amendment Effective Date (i) have been prepared in
accordance with GAAP consistently applied for interim financial statements throughout the periods covered thereby, and (ii) present fairly in all material respects the consolidated and consolidating financial condition, results of operations
and cash flows of the of each of the Consolidated Parties referred in clauses (A) and (B) of this paragraph as of such date and for such periods except that they do not contain the materials and disclosures to be found in notes to
financial statements prepared in accordance with GAAP nor do they reflect year-end adjustments. Other than the Medfinders Acquisition, during the period from December 31, 2009 to and including the First Amendment Effective Date, there has
been no sale, transfer or other disposition by any Consolidated Party of any material part of the business or property of the Consolidated Parties, taken as a whole, and no purchase or other acquisition by any of them of any business or property
(including any Capital Stock of any other Person) material in relation to the consolidated financial condition of the Consolidated Parties, taken as a whole, in each case, which is not reflected in the foregoing financial statements or in the notes
thereto. 
 SUBPART 2.13 Amendment to Section 6.2. Section 6.2 of the Existing Credit Agreement is
hereby amended and restated in its entirety to read as follows: 
 6.2 No Material Change. 

Since the date the Parent’s Form 10-K was filed with the SEC for the fiscal year ended December 31, 2009, there
has been no development or event relating to or affecting any Consolidated Party (other than the Acquired Company) which has had or could reasonably be expected to have a Material Adverse Effect and since the First Amendment Effective Date, there
has been no development or event relating to or affecting any Consolidated Party (including the Acquired Company) which has had or could reasonably be expected to have a Material Adverse Effect.  

SUBPART 2.14 Amendment to Section 6.7. The reference to “September 30, 2009” appearing in
Section 6.7 of the Existing Credit Agreement is hereby amended to read “June 30, 2010”. 
 SUBPART 2.15
Amendment to Section 6.13. Section 6.13 of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows: 
 6.13 Corporate Structure; Capital Stock, etc. 
 The capital
and ownership structure of the Consolidated Parties as of the First Amendment Effective Date is as described in Schedule 6.13A. Set forth on Schedule 6.13B is a complete and accurate list as of the First Amendment Effective
Date with respect to the Borrower and each of its direct and indirect Subsidiaries of (i) jurisdiction of incorporation, (ii) number of shares of each class of Capital Stock outstanding, (iii) number and percentage of outstanding
shares of each class owned (directly or indirectly) by the Consolidated Parties and (iv) number and effect, if exercised, of all outstanding options, warrants, rights of conversion or purchase and all other similar rights with respect thereto.
The outstanding Capital Stock of all such Persons is 

  
 13 

 
validly issued, fully paid and non-assessable and as of the First Amendment Effective Date is owned by the Consolidated Parties, directly or indirectly, in the manner set forth on
Schedule 6.13B, free and clear of all Liens (other than Permitted Liens). As of the First Amendment Effective Date, other than as set forth in Schedule 6.13B, neither the Borrower nor any of its Subsidiaries has outstanding
any securities convertible into or exchangeable for its Capital Stock nor does any such Person have outstanding any rights to subscribe for or to purchase any options for the purchase of, or any agreements providing for the issuance (contingent or
otherwise) of, or any calls, commitments or claims of any character relating to, its Capital Stock. 
 SUBPART 2.16
Amendment to Section 6.15. Section 6.15 of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows: 
 6.15 Purpose of Loans and Letters of Credit. 
 The Borrower
will use the proceeds of the Loans to (a) provide for working capital, capital expenditures and general corporate purposes of the Borrower and its Subsidiaries (including, without limitation, Permitted Acquisitions), (b) on the Closing
Date to refinance the Existing Credit Agreement, (c) on the Closing Date to cash collateralize certain letters of credit issued under the Existing Credit Agreement in accordance with the Cash Collateral Agreement, (d) on the First
Amendment Effective Date to consummate the Medfinders Acquisition and the other Transactions and (e) pay fees and expenses relating to any of the foregoing. The Letters of Credit shall be used only for or in connection with appeal bonds,
reimbursement obligations arising in connection with surety and reclamation bonds, reinsurance, domestic or international trade transactions and obligations not otherwise aforementioned relating to transactions entered into by the applicable account
party in the ordinary course of business. 
 SUBPART 2.17 Amendment to Section 6.19. Section 6.19 of the
Existing Credit Agreement is hereby amended and restated in its entirety to read as follows: 
 6.19 Business
Locations. 
 Set forth on Schedule 6.19(a) is a list as of the First Amendment Effective Date of
all real property located in the United States and owned or leased by any Credit Party with street address and state where located. Set forth on Schedule 6.19(b) is a list as of the First Amendment Effective Date of all locations where
any tangible personal property of a Credit Party is located, including street address and state where located. Set forth on Schedule 6.19(c) is the chief executive office and principal place of business of each Credit Party as of the
First Amendment Effective Date. 
 SUBPART 2.18 Amendment to Section 6.24. Section 6.24 of the Existing
Credit Agreement is hereby amended and restated in its entirety to read as follows: 
 6.24 Nature of
Business. 
 As of the First Amendment Effective Date, the Consolidated Parties are engaged in the business
of providing temporary healthcare staffing services, workforce management solutions, physician permanent placement services and home healthcare services. 
 SUBPART 2.19 Amendment to Section 6.25. Section 6.25 of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows: 

6.25 Solvency. 
 As of the First Amendment Effective Date, the Borrower is Solvent, and the Credit Parties are Solvent on a consolidated basis. 

  
 14 

  
 SUBPART 2.20
Amendments to Section 7.11. 
 (a) Section 7.11(a) of the Existing Credit Agreement is hereby amended and
restated in its entirety to read as follows: 
 (a) Consolidated Leverage Ratio. The Credit Parties shall
not permit the Consolidated Leverage Ratio as of the last day of any fiscal quarter of the Consolidated Parties to be greater than: 
  

									
	 Fiscal Year
	  	 March 31
	  	 June 30
	  	 September 30
	  	 December 31

	 2010
	  	N/A	  	N/A	  	4.25 to 1.0	  	4.25 to 1.0
	 2011
	  	4.25 to 1.0	  	4.25 to 1.0	  	4.00 to 1.0	  	3.75 to 1.0
	 2012
	  	3.75 to 1.0	  	3.50 to 1.0	  	3.50 to 1.0	  	2.50 to 1.0
	 2013
	  	2.50 to 1.0	  	2.50 to 1.0	  	2.50 to 1.0	  	2.25 to 1.0
	 2014 and thereafter
	  	2.25 to 1.0	  	2.25 to 1.0	  	2.25 to 1.0	  	2.25 to 1.0

 (b) A new
Section 7.11(c) is hereby added to the Existing Credit Agreement to read as follows: 
 (c) Minimum
Liquidity. The Credit Parties shall not permit Liquidity at any time following the First Amendment Effective Date to be less than $15,000,000. 
 (c) A new Section 7.11(d) is hereby added to the Existing Credit Agreement to read as follows: 
 (d) Consolidated First Lien Leverage Ratio. The Credit Parties shall not permit the Consolidated First Lien Leverage Ratio as of the last day of any fiscal quarter of the Consolidated Parties to be
greater than: 
  

									
	 Fiscal Year
	  	 March 31
	  	 June 30
	  	 September 30
	  	 December 31

	 2010
	  	N/A	  	N/A	  	3.75 to 1.0	  	3.75 to 1.0
	 2011
	  	3.75 to 1.0	  	3.75 to 1.0	  	3.50 to 1.0	  	3.00 to 1.0
	 2012
	  	3.00 to 1.0	  	2.71 to 1.0	  	2.71 to 1.0	  	2.00 to 1.0
	 2013 and thereafter
	  	2.00 to 1.0	  	2.00 to 1.0	  	2.00 to 1.0	  	2.00 to 1.0

 SUBPART
2.21 Amendment to Section 8.1. Section 8.1 of the Existing Credit Agreement is hereby amended by adding new clauses (m) and (n) to the end thereof to read as follows, and by making the necessary grammatical changes
thereto: 
 (m) Indebtedness incurred in connection with the Second Lien Financing in an aggregate amount not to
exceed $40,000,000; and 
 (n) Indebtedness with respect to the Backstopped Letters of Credit (to the extent
constituting Indebtedness). 

  
 15 

  
 SUBPART 2.22
Amendment to Section 8.7. Section 8.7 of the Existing Credit Agreement is hereby amended to (i) amend and restate clause (a) thereof in its entirety to read as follows and (ii) by adding a new clause (k) to
the end thereof to read as follows, and by making the necessary grammatical changes thereto: 
 (a) to make
dividends or other distributions payable to any Credit Party (directly or indirectly through Subsidiaries); provided that the proceeds of any dividends or distributions made to the Parent in reliance of this clause (a) are subsequently
contributed by the Parent to a Credit Party, 
 and (k) the Borrower may use a portion of the proceeds of
the Loan to make a dividend to the Parent on the Closing Date to allow the Parent to concurrently fund a portion of the Transactions. 
 SUBPART 2.23 Amendment to Section 8.8. Section 8.8 of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows: 

8.8 Other Indebtedness, etc. 

The Credit Parties will not permit any Consolidated Party to (a) if any Default or Event of Default has occurred and
is continuing or would be directly or indirectly caused as a result thereof, (i) after the issuance thereof, amend or modify any of the terms of any Indebtedness (other than the Second Lien Credit Agreement or this Agreement) of any such Person
if such amendment or modification would add or change any terms in a manner adverse to such Person, or shorten the final maturity or average life to maturity or require any payment to be made sooner than originally scheduled or increase the interest
rate applicable thereto or change any subordination provision thereof, or (ii) make (or give any notice with respect thereto) any voluntary or optional payment or prepayment or redemption or acquisition for value of (including without
limitation, by way of depositing money or securities with the trustee with respect thereto before due for the purpose of paying when due), refund, refinance or exchange of any other Indebtedness (other than the Second Lien Credit Agreement or this
Agreement) of such Person, (b) shorten the final maturity of any Subordinated Indebtedness or amend or modify any of the subordination provisions of any Subordinated Indebtedness, (c) make interest payments in respect of any Subordinated
Indebtedness in violation of the subordination provisions of the documents evidencing and/or governing such Subordinated Indebtedness or (d) except as otherwise permitted under Section 8.7, make (or give any notice with respect
thereto) any voluntary or optional payment or prepayment, redemption, acquisition for value or defeasance of (including without limitation, by way of depositing money or securities with the trustee with respect thereto before due for the purpose of
paying when due), refund, refinance or exchange of any Subordinated Indebtedness. 
 SUBPART 2.24 Amendment to
Section 8.10. Section 8.10 of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows: 
 8.10 Organizational Documents; Fiscal Year; Second Lien Credit Agreement. 
 The Credit Parties will not permit any Consolidated Party to (i) amend, modify or change its articles of incorporation (or corporate charter or other similar organizational document) or bylaws (or
other similar document) in any manner materially adverse to the Lenders, (ii) change its fiscal year or (iii) amend, modify or change any term or condition of the “Credit Documents” as defined in the Second Lien Credit Agreement
in any manner which would be adverse in any material way to the Lenders. 
 SUBPART 2.25 Amendment to
Section 8.11. Section 8.11 of the Existing Credit Agreement is hereby amended by adding the words “Except as contemplated in the Intercreditor Agreement or the Second Lien Credit Agreement,” at the beginning of such section,
and by making the necessary grammatical changes thereto. 

  
 16 

  
 SUBPART 2.26
Amendment to Section 8.12. Clause (b) contained in Section 8.12 of the Existing Credit Agreement is hereby amended and restated in its entirety to read as follows: 

(b) The Parent shall not (i) hold any material assets other than (A) the Capital Stock of the Borrower or any
Wholly-Owned Subsidiary of the Parent that is a Credit Party or an Excluded Subsidiary, (B) the Capital Stock of the Parent repurchased, redeemed or otherwise acquired or retired for value by the Parent to the extent permitted by
Section 8.7 and (C) cash to the extent permitted by Section 8.7, (ii) have any liabilities other than (A) Indebtedness permitted under Section 8.1, (B) tax liabilities in the ordinary course of
business, (C) loans, advances and payments permitted under Section 8.9, (D) corporate, administrative and operating expenses in the ordinary course of business and (E) other liabilities under (1) the Credit Documents
and the Second Lien Credit Agreement, (2) the documents evidencing and/or governing any Subordinated Indebtedness, (3) registration rights agreements, (4) stock option plans (including, without limitation, those in existence on the
Closing Date), or (5) any other agreement, document or instrument related to any of the foregoing or (iii) engage in any business other than (A) owning the Capital Stock of the Borrower or any Wholly-Owned Subsidiary of the Parent
that is a Credit Party or an Excluded Subsidiary and activities incidental or related thereto, (B) acting as a Guarantor hereunder and pledging its assets to the Administrative Agent, for the benefit of the Lenders, pursuant to the Collateral
Documents to which it is a party and the Second Lien Credit Agreement, (C) activities related to its obligations under the Securities Laws, (D) acting as a borrower or guarantor, as applicable, in respect of Indebtedness permitted under
Section 8.1, (E) in connection with the exercise of its rights under and its compliance with the obligations applicable to it under the documents listed in clause (ii)(E) above and (F) activities relating to any repurchase,
redemption or other acquisition or retirement for value of any Capital Stock or any option to acquire Capital Stock of the Parent to the extent permitted by Section 8.7. 

SUBPART 2.27 Amendment to Section 8.14. Section 8.14 of the Existing Credit Agreement is hereby amended and
restated in its entirety to read as follows: 
 8.14 Capital Expenditures. 

The Credit Parties will not permit Consolidated Capital Expenditures for any fiscal year to exceed $16,000,000 plus the
unused amount available for Consolidated Capital Expenditures under this Section 8.14 for the immediately preceding fiscal year (excluding any carry forward available from any prior fiscal year). 

SUBPART 2.28 Amendment to Section 8.15. Section 8.15 of the Existing Credit Agreement is hereby amended by adding
a new clause (e) to the end thereof to read as follows, and by making the necessary grammatical changes thereto: 
 and (e) pursuant to the Second Lien Credit Agreement and the Second Lien Collateral Documents. 
 SUBPART 2.29 Amendment to Section 10.10. Clause (b) contained in Section 10.10 of the Existing Credit Agreement is hereby amended and restated in its entirety to read as
follows: 
 (b) to subordinate any Lien on any property granted to or held by the Administrative Agent under any
Credit Document to the holder of any Lien on such property that is permitted by clause (vii), (viii) or (xix) of the definition of Permitted Liens; and 

  
 17 

  
 SUBPART 2.30
Amendment to Section 10.10. Section 10.10 of the Existing Credit Agreement is hereby amended by adding a new clause (d) to the end thereof to read as follows, and by making the necessary grammatical changes thereto:

 (d) (i) enter into the Intercreditor Agreement and (ii) to subordinate or release any Lien on any
property granted to or held by the Administrative Agent under any Credit Document in accordance with the terms of the Intercreditor Agreement. 
 SUBPART 2.31 Closing Date References. All references to “Closing Date” set forth in clause (iv) of the definition of Permitted Investments, clause (xvi) of the definition
of Permitted Liens and in Sections 6.10, 6.13. 6.19, 6.23, 7.6, 8.1 and 8.9, as such references relate to the corresponding schedules set forth in such sections, are hereby amended to read “First Amendment Effective Date”.

 SUBPART 2.32 New Schedule 1.1E. A new Schedule 1.1E is hereby added to the Existing Credit Agreement
in the form of Schedule 1.1E attached hereto. 
 SUBPART 2.33 New Schedule 1.1F. A new Schedule 1.1F
is hereby added to the Existing Credit Agreement in the form of Schedule 1.1F attached hereto. 
 SUBPART 2.34
Replacement Schedules. Schedules 1.1A, 1.1B, 1.1C, 1.1D, 2.1(a), 6.4, 6.10, 6.13A, 6.13B, 6.17, 6.19(a), 6.19(b), 6.19(c), 6.24, 7.6,
8.1, 8.9 and 11.1 of the Existing Credit Agreement are hereby deleted in their entirety and new schedules in the form of the corresponding schedules attached hereto are substituted therefor. Such schedules have been revised to
give effect to the Transactions and the joinder agreement for the Acquired Company referred to in Subpart 4.5. 
 SUBPART
2.35 Replacement of Exhibit 7.1(c). Exhibit 7.1(c) of the Existing Credit Agreement is hereby deleted in its entirety and a new exhibit in the form of Exhibit 7.1(c) attached hereto is substituted therefor. 

SUBPART 2.36 Replacement of Exhibit 11.3(b). Exhibit 11.3(b) of the Existing Credit Agreement is hereby deleted in
its entirety and a new exhibit in the form of Exhibit 11.3(b) attached hereto is substituted therefor. 
 PART 3

 LENDER JOINDER 
 From and after the First Amendment Effective Date, by execution of this Amendment, each Person identified on the signature pages hereto as an Additional Tranche B Lender hereby acknowledges, agrees and
confirms that, by its execution of this Amendment, such Person will be deemed to be a party to the Amended Credit Agreement and a “Lender” for all purposes of the Amended Credit Agreement, and shall have all of the obligations of a Lender
thereunder as if it had executed the Amended Credit Agreement. Such Person hereby ratifies, as of the date hereof, and agrees to be bound by, all of the terms, provisions and conditions applicable to the Lenders contained in the Amended Credit
Agreement. 
 PART 4 
 CONDITIONS TO EFFECTIVENESS 
 SUBPART 4.1 First Amendment
Effective Date. This Amendment shall be and become effective as of the date hereof (the “First Amendment Effective Date”) when all of the conditions set forth in this Part 4 shall have been satisfied, and thereafter this
Amendment shall be known, and may be referred to, as the “First Amendment”. 

  
 18 

  
 SUBPART 4.2
Execution of Counterparts of Amendment. The Administrative Agent shall have received counterparts of this Amendment, which collectively shall have been duly executed on behalf of each of the Borrower, the Parent, the Subsidiary
Guarantors, the Requisite Lenders, each of the Revolving Lenders, each of the Additional Tranche B Lenders, each of the Extended Tranche B Lenders and the Administrative Agent. 

SUBPART 4.3 Second Lien Financing. The Lenders shall be reasonably satisfied with the terms and conditions of the Second
Lien Financing. The Administrative Agent shall have received satisfactory evidence that simultaneously with the making of the initial Loans hereunder, the Borrower shall receive not less than $40 million in gross cash proceeds from the Second Lien
Financing. 
 SUBPART 4.4 Execution of Counterparts of Intercreditor Agreement. The Administrative Agent
shall have received counterparts of the Intercreditor Agreement, which collectively shall have been duly executed on behalf of each of the Borrower, the Administrative Agent and the Second Lien Administrative Agent and shall be in form and substance
reasonably satisfactory to the Lenders. 
 SUBPART 4.5 Collateral. All filings, recordations and searches
reasonably necessary or desirable in connection with the liens and security interests of the Borrower and its Subsidiaries forming part of the Lenders’ Collateral (including, without limitation, the Acquired Company) shall have been duly made
(including, applicable joinder agreements with respect to the Acquired Company); all filing and recording fees and taxes shall have been duly paid. The Lenders shall be satisfied with the amount and types of all insurance maintained by the Borrower
and its Subsidiaries (including, without limitation, the Acquired Company); and the Administrative Agent shall have received endorsements naming the Administrative Agent, on behalf of the Lenders, as an additional insured or loss payee, as the case
may be, under all insurance policies to be maintained with respect to the properties of the Borrower and its Subsidiaries (including, without limitation, the Acquired Company) forming part of the Lenders’ Collateral. 

SUBPART 4.6 Corporate Documents. Receipt by the Administrative Agent of the following: 

(i) Charter Documents. Copies of the articles or certificates of incorporation or other charter documents of each
Credit Party (other than Merritt, Hawkins & Associates) certified to be true and complete as of a recent date by the appropriate Governmental Authority of the state or other jurisdiction of its incorporation and certified by a secretary or
assistant secretary of such Credit Party to be true and correct as of the First Amendment Effective Date. With respect to Merritt, Hawkins & Associates, the Administrative Agent shall receive articles or certificates of incorporation or
other charter documents certified by a secretary or assistant secretary of Merritt, Hawkins & Associates to be true and correct as of the First Amendment Effective Date. 

(ii) Bylaws. A copy of the bylaws of each Credit Party certified by a secretary or assistant secretary of such
Credit Party to be true and correct as of the First Amendment Effective Date. 
 (iii) Resolutions. Copies
of resolutions of the Board of Directors or other governing body of each Credit Party approving and adopting the Credit Documents to which it is a party, the transactions contemplated therein and authorizing execution and delivery thereof, certified
by a secretary or assistant secretary of such Credit Party to be true and correct and in force and effect as of the First Amendment Effective Date. 
 (iv) Good Standing. Copies of (A) certificates of good standing, existence or its equivalent with respect to each Credit Party certified as of a recent date by the appropriate Governmental
Authorities of the state or other jurisdiction of incorporation and the state or other jurisdiction of the chief executive office or principal place of business and (B) to the extent available, a certificate indicating payment of all corporate
or comparable franchise taxes certified as of a recent date by the appropriate governmental taxing authorities. 

  
 19 

  
 (v)
Incumbency. An incumbency certificate of each Credit Party certified by a secretary or assistant secretary to be true and correct as of the First Amendment Effective Date. 

SUBPART 4.7 Opinions of Counsel. The Administrative Agent shall have received, in each case dated as of the First Amendment
Effective Date: 
 (i) a legal opinion of Paul, Weiss, Rifkind, Wharton & Garrison LLP, in form and
substance reasonably satisfactory to the Administrative Agent; 
 (ii) a legal opinion of special Nevada counsel
Lionel Sawyer & Collins, in form and substance reasonably satisfactory to the Administrative Agent; 

(iii) a legal opinion of special California counsel Cooley Godward Kronish LLP with respect to Merritt, Hawkins &
Associates, in form and substance reasonably satisfactory to the Administrative Agent; 
 (iv) a legal opinion of
special Texas counsel Locke Lord Bissell & Lidell LLP with respect to The MHA Group, Inc., AMN Healthcare Allied, Inc. and RN Demand, Inc., in form and substance reasonably satisfactory to the Administrative Agent; and 

(v) a legal opinion of special Missouri counsel Goffstein, Raskas, Pomerantz, Kraus & Sherman, L.L.C. with
respect to Linde Health Care Staffing, Inc., in form and substance reasonably satisfactory to the Administrative Agent. 

SUBPART 4.8 Officer’s Certificates. The Administrative Agent shall have received a certificate or certificates
executed by an Executive Officer of the Borrower as of the First Amendment Effective Date, in form and substance reasonably satisfactory to the Administrative Agent, stating that (i) all governmental and third party consents and approvals
(including, without limitation, the Board of Directors of the Borrower and the Parent), if any, with respect to this Amendment and the transactions contemplated thereby have been obtained, (ii) there shall not have occurred a (x) Material
Adverse Effect with respect to the Parent and its Subsidiaries taken as a whole since the date the Parent’s Form 10-K for the fiscal year ended December 31, 2009 was filed with the SEC or (y) a “Material Adverse Effect” (as
defined in the Acquisition Agreement) with respect to the Acquired Company and its Subsidiaries taken as a whole since January 3, 2010, (iii) no action, suit, investigation or proceeding is pending or, to the knowledge of the Borrower,
threatened in any court or before any arbitrator or governmental instrumentality that purports to affect any Credit Party or any transaction contemplated by the Credit Documents, if such action, suit, investigation or proceeding could reasonably be
expected to have a Material Adverse Effect, (iv) the Medfinders Acquisition has been consummated and (v) immediately after giving effect to the Transaction, (A) no Default or Event of Default exists, (B) all representations and
warranties contained in the Amended Credit Agreement and in the other Credit Documents are true and correct in all material respects as of the First Amendment Effective Date (except for those which expressly relate to an earlier date, in which case,
they were true and correct in all material respects as of such earlier date), (C) the Credit Parties, on a consolidated basis, are Solvent, and (D) (1) the Consolidated Leverage Ratio of the Consolidated Parties as of the First
Amendment Effective Date (which Consolidated Leverage Ratio shall be calculated reflecting the Medfinders Acquisition on a Pro Forma Basis as of the first day of such period as if the Medfinders Acquisition occurred as of such date) was not greater
than 3.60 to 1.0 for the twelve month period ending on June 30, 2010 and (2) the Consolidated EBITDA of the Consolidated Parties (which Consolidated EBITDA shall be calculated reflecting the Medfinders Acquisition on a Pro Forma Basis as
of the first day of such period as if the Medfinders Acquisition occurred as of such date) will be at least $65 million for the twelve months ended June 30, 2010. 

  
 20 

  
 SUBPART 4.9
Financial Statements. The Administrative Agent shall have received copies of audited consolidated financial statements for the Acquired Company and its subsidiaries for the three fiscal years most recently ended for which financial statements
are available and interim unaudited financial statements for each quarterly period ended since the end of the most recent fiscal year for which financial statements are available. 

SUBPART 4.10 Consummation of Acquisition. The Acquisition shall have been consummated in accordance with the terms of the
Acquisition Agreement and in material compliance with applicable law and regulatory approvals. The Administrative Agent shall have approved the Acquisition Agreement (it being understood that the draft of the Acquisition Agreement dated
July 28, 2010 is acceptable to the Administrative Agent) and all other material agreements, instruments and documents relating to the Medfinders Acquisition, which agreements and documents shall provide for an aggregate purchase price
(including assumption of Indebtedness) not in excess of $270 million (excluding any earn out payments). The Administrative Agent shall have received an officer’s certificate from the Parent (A) confirming that there have been no material
modifications to the Acquisition Agreement without the consent of the Administrative Agent, to the extent such modifications could reasonably be expected to materially adversely effect the Lenders, (B) attaching a certified copy of the
Acquisition Agreement, with all amendments, modifications, supplements and attachments and (C) confirming that the Medfinders Acquisition has been, or contemporaneously with the making of the initial Loans hereunder, will be consummated in
accordance with the terms of the Acquisition Agreement and in compliance with material applicable law and regulatory approvals and that the Parent and/or the Borrower shall have used not less than $33.1 million of cash-on-hand (immediately prior to
the Transaction) to fund the cash portion of the Acquisition consideration. 
 SUBPART 4.11 Repayment of Acquired
Company Indebtedness. The Administrative Agent shall have received reasonably satisfactory evidence that the repayment of all Indebtedness (other than the Backstopped Letters of Credit) of the Acquired Company shall have occurred. 

SUBPART 4.12 Ratings. The Parent shall have received (i) a current corporate family rating and a current corporate
rating, respectively, from each of Moody’s Investors Service, Inc. (“Moody’s”) and Standard & Poor’s Ratings Services, a division of The McGraw-Hill Companies, Inc. (“S&P”) and
(ii) a current facility rating with respect to the Tranche B Loan from each of Moody’s and S&P. 
 SUBPART 4.13
Fees and Expenses. The Administrative Agent shall have received from the Borrower (i) the aggregate amount of all fees and expenses payable to the Administrative Agent and the Arrangers in connection with the consummation of the
transactions contemplated hereby, (ii) for the account of each Revolving Lender approving this Amendment by 12:00 noon Eastern Time on August 20, 2010, an amendment fee in an amount equal to 25 basis points on such Lender’s Revolving
Commitment held immediately prior to the First Amendment Effective Date, (iii) for the account of each Revolving Lender agreeing to extend the maturity of its Revolving Commitment, the fees agreed upon among the Borrower, the Arrangers and the
respective Revolving Lenders, as the case may be, (iv) for the account of each Tranche B Lender approving this Amendment by 12:00 noon Eastern Time on August 20, 2010, an amendment fee in an amount equal to 25 basis points on such
Lender’s Tranche B Loans held immediately prior to the First Amendment Effective Date, (v) for the account of each Tranche B Lender agreeing to provide the Additional Tranche B Loans and/or extend the maturity of its Initial Tranche B
Loans the fees agreed upon among the Borrower, the Arrangers and the respective Tranche B Lenders, as the case may be and (vi) all reasonable and documented out-of-pocket costs and expenses of the Administrative Agent and the Joint Lead
Arrangers in connection with the preparation, execution and delivery of this Amendment, including without limitation the reasonable fees and expenses of (i) Moore & Van Allen PLLC, special counsel to the Administrative Agent and
certain Joint Lead Arrangers and (ii) Latham & Watkins LLP, special counsel to a Joint Lead Arranger. 

  
 21 

  
 PART 5

 MISCELLANEOUS 
 SUBPART 5.1 Representations and Warranties. The Borrower hereby represents and warrants to the Administrative Agent and the Lenders that, (a) no Default or Event of Default exists under
the Existing Credit Agreement, after giving effect to this Amendment and (b) the representations and warranties set forth in Section 6 of the Amended Credit Agreement are, subject to the limitations set forth therein, true and correct in
all material respects as of the date hereof (except for those which expressly relate to an earlier date, in which case, they were true and correct in all material respects as of such earlier date). 

SUBPART 5.2 Cross-References. References in this Amendment to any Part or Subpart are, unless otherwise specified, to such
Part or Subpart of this Amendment. 
 SUBPART 5.3 Instrument Pursuant to Existing Credit Agreement. This Amendment
is executed pursuant to the Existing Credit Agreement and shall (unless otherwise expressly indicated therein) be construed, administered and applied in accordance with the terms and provisions of the Existing Credit Agreement. 

SUBPART 5.4 References in Other Credit Documents. At such time as this Amendment shall become effective pursuant to the
terms of Subpart 4.1, all references to the “Credit Agreement” shall be deemed to refer to the Amended Credit Agreement. 
 SUBPART 5.5 Counterparts. This Amendment may be executed by the parties hereto in several counterparts, each of which shall be deemed to be an original and all of which shall constitute
together but one and the same agreement. Delivery of executed counterparts of the Amendment by facsimile or other electronic transmission shall be effective as an original and shall constitute a representation that an original shall be delivered
upon the request of the Administrative Agent. 
 SUBPART 5.6 Governing Law. THIS AMENDMENT SHALL BE DEEMED TO BE A
CONTRACT MADE UNDER AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK. 
 SUBPART 5.7 Acknowledgment. The
Guarantors acknowledge and consent to all of the terms and conditions of this Amendment and agree that this Amendment does not operate to reduce or discharge the Guarantors’ obligations under the Amended Credit Agreement or the other Credit
Documents. The Guarantors further acknowledge and agree that the Guarantors have no claims, counterclaims, offsets, or defenses to the Credit Documents and the performance of the Guarantors’ obligations thereunder or if the Guarantors did have
any such claims, counterclaims, offsets or defenses to the Credit Documents or any transaction related to the Credit Documents, the same are hereby waived, relinquished and released in consideration of the Lenders’ execution and delivery of
this Amendment. Each Guarantor also hereby confirms and agrees that notwithstanding the effectiveness of this Amendment, the Collateral Documents to which each of the undersigned is a party and all of the Collateral described therein do, and shall
continue to, secure the payment of all of the Credit Party Obligations. 

  
 22 

  
 SUBPART 5.8
Binding Effect. This Amendment, the Existing Credit Agreement as amended by this Amendment and the other Credit Documents embody the entire agreement between the parties and supersede all prior agreements and understandings, if any,
relating to the subject matter hereof. These Credit Documents represent the final agreement between the parties and may not be contradicted by evidence of prior, contemporaneous or subsequent oral agreements of the parties. Except as expressly
modified and amended in this Amendment, all the terms, provisions and conditions of the Credit Documents shall remain unchanged and shall continue in full force and effect. 
 SUBPART 5.9 Successors and Assigns. This Amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns. 

SUBPART 5.10 General. Except as amended hereby, the Existing Credit Agreement and all other credit documents shall continue
in full force and effect. 
 SUBPART 5.11 Severability. If any provision of this Amendment is determined to be
illegal, invalid or unenforceable, such provision shall be fully severable and the remaining provisions shall remain in full force and effect and shall be construed without giving effect to the illegal, invalid or unenforceable provisions.

 [Remainder of Page Intentionally Left Blank] 

  
 23 

  
 IN WITNESS
WHEREOF, the parties hereto have executed this Amendment as of the date first above written. 
  

									
	BORROWER:	 		 	AMN HEALTHCARE, INC.
				
		 		 	By:	 	/s/ Bary G. Bailey
		 		 		 	Name:	 	Bary G. Bailey
		 		 		 	Title:	 	Treasurer
			
	PARENT:	 		 	AMN HEALTHCARE SERVICES, INC.
				
		 		 	By:	 	/s/ Bary G. Bailey
		 		 		 	Name:	 	Bary G. Bailey
		 		 		 	Title:	 	Treasurer
			
	 SUBSIDIARY
 GUARANTORS:
	 		 	AMN SERVICES, INC.
				
		 		 	By:	 	/s/ Bary G. Bailey
		 		 		 	Name:	 	Bary G. Bailey
		 		 		 	Title:	 	Treasurer
			
		 		 	O’GRADY-PEYTON INTERNATIONAL (USA), INC.
				
		 		 	By:	 	/s/ Bary G. Bailey
		 		 		 	Name:	 	Bary G. Bailey
		 		 		 	Title:	 	Treasurer
			
		 		 	 INTERNATIONAL HEALTHCARE
 RECRUITERS, INC.

				
		 		 	By:	 	/s/ Bary G. Bailey
		 		 		 	Name:	 	Bary G. Bailey
		 		 		 	Title:	 	Treasurer

 FIRST AMENDMENT 

AMN HEALTHCARE, INC. 

  
 
			
	AMN STAFFING SERVICES, INC.
		
	By:	 	/s/ Bary G. Bailey
	Name:	 	Bary G. Bailey
	Title:	 	Treasurer
	
	THE MHA GROUP, INC.
		
	By:	 	/s/ Bary G. Bailey
	Name:	 	Bary G. Bailey
	Title:	 	Treasurer
	
	MERRITT, HAWKINS & ASSOCIATES
		
	By:	 	/s/ Bary G. Bailey
	Name:	 	Bary G. Bailey
	Title:	 	Treasurer
	
	AMN HEALTHCARE ALLIED, INC.
		
	By:	 	/s/ Bary G. Bailey
	Name:	 	Bary G. Bailey
	Title:	 	Treasurer
	
	RN DEMAND, INC.
		
	By:	 	/s/ Bary G. Bailey
	Name:	 	Bary G. Bailey
	Title:	 	Treasurer
	
	STAFF CARE, INC.
		
	By:	 	/s/ Bary G. Bailey
	Name:	 	Bary G. Bailey
	Title:	 	Treasurer
	
	MHA ALLIED CONSULTING, INC.
		
	By:	 	/s/ Bary G. Bailey
	Name:	 	Bary G. Bailey
	Title:	 	Treasurer

 FIRST AMENDMENT 

AMN HEALTHCARE, INC. 

  
 
			
	AMN ALLIED SERVICES, LLC
		
	By:	 	/s/ Bary G. Bailey
	Name:	 	Bary G. Bailey
	Title:	 	Treasurer
	
	LIFEWORK, INC.
		
	By:	 	/s/ Bary G. Bailey
	Name:	 	Bary G. Bailey
	Title:	 	Treasurer
	
	PHARMACY CHOICE, INC.
		
	By:	 	/s/ Bary G. Bailey
	Name:	 	Bary G. Bailey
	Title:	 	Treasurer
	
	RX PRO HEALTH, INC.
		
	By:	 	/s/ Bary G. Bailey
	Name:	 	Bary G. Bailey
	Title:	 	Treasurer

 FIRST AMENDMENT 

AMN HEALTHCARE, INC. 

  

									
	ADMINISTRATIVE AGENT:	 		 	BANK OF AMERICA, N. A.,
		 		 	in its capacity as Administrative Agent
				
		 		 	By:	 	/s/ Robert Rittelmeyer
		 		 		 	Name:	 	Robert Rittelmeyer
		 		 		 	Title:	 	Vice President
			
	LENDERS:	 		 	BANK OF AMERICA, N. A.,
		 		 	in its capacity as Lender, Issuing Lender and Swingline Lender
				
		 		 	By:	 	/s/ Alysa Trakas
		 		 		 	Name:	 	 Alysa Trakas

		 		 		 	Title:	 	Vice President

  
 [Signatures
Continued] 
 FIRST AMENDMENT TO CREDIT AGREEMENT 
 AMN HEALTHCARE, INC. 

  

									
	REVOLVING LENDERS:	 		 	ING CAPITAL LLC,
		 		 	as a Revolving Lender
				
		 		 	By:	 	/s/ Darren Wells
		 		 		 	Name:	 	Darren Wells
		 		 		 	Title:	 	Managing Director

 AMN Healthcare, Inc.

 First Amendment to Credit Agreement 

  

									
	REVOLVING LENDERS:	 		 	SUNTRUST BANK
		 		 	as a Revolving Lender
				
		 		 	By:	 	/s/ J. Ben Cumming
		 		 		 	Name:	 	J. Ben Cumming
		 		 		 	Title:	 	Vice President

 AMN Healthcare, Inc.

 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 APOSTLE LOOMIS SAYLES CREDIT OPPORTUNITIES FUND, 

As Lender 
 By: Loomis, Sayles & Company, L.P., Its Investment Manager 
 By: Loomis, Sayles & Company, Incorporated, Its General Partner 
 as a Tranche B Lender 
 By: /s/ Mary McCarthy

 Name: Mary McCarthy 
 Title: Vice President 
 The Lender set forth above
is agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender 
 AMN Healthcare,
Inc. First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 APOSTLE LOOMIS SAYLES SENIOR LOAN FUND, 

As Lender 
 By: Loomis, Sayles & Company, L.P., Its Investment Manager 
 By: Loomis, Sayles & Company, Incorporated, Its General Partner 
 as a Tranche B Lender 
 By: /s/ Mary McCarthy

 Name: Mary McCarthy 
 Title: Vice President 
 The Lender set forth above
is agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 
 AMN Healthcare,
Inc. First Amendment to Credit Agreement 

  

 

 

  
 Atrium IV

 By: 
 Name: Thomas Flannery 
 Title: Authorized Signatory

 *We are approving and extending our commitment.* 

AMN HEALTHCARE, INC. 

  

 

 

  
 Atrium V

 By: 
 Name: Thomas Flannery 
 Title: Authorized Signatory

 *We are approving and extending our commitment.* 

AMN HEALTHCARE, INC. 

  

 

 

  
 TRANCHE B
LENDERS: 
 BRIDGEPORT CLO II LTD. 
 By: Deerfield Capital Management LLC as 
 its
Collateral Manager, as a Tranche B Lender 
 By: /s/ Mark E. Wittnebel 

Name: Mark E. Wittnebel 
 Title: Managing Director 
 The Lender set forth
above is agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 
 AMN Healthcare,
Inc. First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 BRIDGEPORT CLO LTD. 
 By: Deerfield Capital Management LLC as 
 its
Collateral Manager, as a Tranche B Lender 
 By: /s/ Mark E. Wittnebel 

Name: Mark E. Wittnebel 
 Title: Managing Director 
 The Lender set forth
above is agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 
 AMN Healthcare,
Inc. First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 BURRRIDGE CLO Plus LTD. 
 By: Deerfield Capital Management LLC as 
 its
Collateral Manager, as a Tranche B Lender 
 By: /s/ Mark E. Wittnebel 

Name: Mark E. Wittnebel 
 Title: Managing Director 
 The Lender set forth
above is agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 
 AMN Healthcare,
Inc. First Amendment to Credit Agreement 

  

 

 

  
 California
Public Employees’ Retirement System By: Columbia Management Investment Advisers, LLC, fka RiverSource Investments, LLC. Its agent 
 By: /s/ Robin C. Stancil 
 Name: Robin C. Stancil

 Title: Assistant Vice President 
 AMN HEALTHCARE, INC. 

  

 

 

  
 Castle Garden

 By: /s/ Thomas Flannery 
 Name: Thomas Flannery 
 Title: Authorized Signatory

 *We are approving and extending our commitment.* 

AMN HEALTHCARE, INC. 

  

 

 

  
 TRANCHE B
LENDERS: 
 CCA EAGLE LOAN MASTER FUND LTD. 

By: Citigroup Alternative Investments LLC, as Investment manager for and on behalf of CCA EAGLE LOAN MASTER FUND LTD. as a
Tranche B Lender 
 By: /s/ Melanie Hanlon 

Name: Melanie Hanlon 
 Title: Director 
 The Lender set forth above is
agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 
 AMN Healthcare,
Inc. 
 First Amendment to Credit Agreement 

  

 

 

  
 Cent CDO 10
Limited 
 By: Columbia Management Investment Advisers, LLC, fka RiverSource Investments, LLC 

By: /s/ Robin C. Stancil 
 Name: Robin C. Stancil 
 Title: Director of
Operations 
 AMN HEALTHCARE, INC. 

  

 

 

  
 Cent CDO 12
Limited 
 By: Columbia Management Investment Advisers, LLC, fka RiverSource Investments, LLC 

By: /s/ Robin C. Stancil 
 Name: Robin C. Stancil 
 Title: Director of
Operations 
 AMN HEALTHCARE, INC. 

  

 

 

  
 Cent CDO 14
Limited 
 By: Columbia Management Investment Advisers, LLC, fka RiverSource Investments, LLC 

By: /s/ Robin C. Stancil 
 Name: Robin C. Stancil 
 Title: Director of
Operations 
 AMN HEALTHCARE, INC. 

  

 

 

  
 Cent CDO 15
Limited 
 By: Columbia Management Investment Advisers, LLC, fka RiverSource Investments, LLC 

By: /s/ Robin C. Stancil 
 Name: Robin C. Stancil 
 Title: Assistant Vice
President 
 AMN HEALTHCARE, INC. 

  

 

 

  
 Cent CDO XI
Limited 
 By: Columbia Management Investment Advisers, LLC, fka RiverSource Investments, LLC 

By: /s/ Robin C. Stancil 
 Name: Robin C. Stancil 
 Title: Director of
Operations 
 AMN HEALTHCARE, INC. 

  

 

 

  
 Centurion CDO 8
Limited 
 By: Columbia Management Investment Advisers, LLC, fka RiverSource Investments, LLC 

By: /s/ Robin C. Stancil 
 Name: Robin C. Stancil 
 Title: Director of
Operations 
 AMN HEALTHCARE, INC. 

  

 

 

  
 Centurion CDO 9
Limited 
 By: Columbia Management Investment Advisers, LLC, fka RiverSource Investments, LLC 

By: /s/ Robin C. Stancil 
 Name: Robin C. Stancil 
 Title: Director of
Operations 
 AMN HEALTHCARE, INC. 

  

 

 

  
 Centurion CDO
VI, Ltd. 
 By: Columbia Management Investment Advisers, LLC, fka RiverSource Investments, LLC 

By: /s/ Robin C. Stancil 
 Name: Robin C. Stancil 
 Title: Director of
Operations 
 AMN HEALTHCARE, INC. 

  

 

 

  
 Centurion CDO
VII Limited 
 By: Columbia Management Investment Advisers, LLC, 

fka RiverSource Investments, LLC 
 By: /s/ Robin C. Stancil 
 Name: Robin C. Stancil

 Title: Director of Operations 
 AMN HEALTHCARE, INC. 

  

 

 

  
 TRANCHE B
LENDERS: 
 CUMBERLAND II CLO LTD. 
 By: Deerfield Capital Management LLC as 
 its
Collateral Manager, as a Tranche B Lender 
 By: /s/ Mark E. Wittnebel 

Name: Mark E. Wittnebel 
 Title: Managing Director 
 The Lender set forth
above is agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 
 AMN Healthcare,
Inc. 
 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 DFR Middle Market CLO, LTD. 
 By: Deerfield Capital Management LLC as 
 its
Collateral Manager, as a Tranche B Lender 
 By:/s/ Mark E. Wittnebel 

Name: Mark E. Wittnebel 
 Title: Managing Director 
 The Lender set forth
above is agreeing to be: 
 An Extended Tranche B Lender and/or 

An Additional Tranche B Lender. 
 AMN Healthcare, Inc. 
 First Amendment to Credit
Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 As a Tranche B Lender 
 DWS Floating Rate Plus Fund 
 By: Deutsche
Investment Management Americas, Inc. Investment Advisor 
 By: /s/ Eric S. Meyer 

Eric S. Meyer, Managing Director 
 The Lender set forth above is agreeing to be: 
 An
Extended Tranche B Lender 
 and/or 
 An Additional Tranche B Lender. 
 By: /s/ Colleen
Cunniffe 
 Name: Colleen Cunniffe 
 Title: Managing Director 
 AMN Healthcare, Inc.

 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 As a Tranche B Lender 
 DWS Short Duration Plus Fund 
 By: Deutsche
Investment Management Americas, Inc. 
 Investment Advisor 

By: /s/ Eric S. Meyer 
 Eric S. Meyer, Managing Director 
 The Lender set
forth above is agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 
 By: /s/ Colleen
Cunniffe 
 Name: Colleen Cunniffe 
 Title: Managing Director 
 AMN Healthcare, Inc.

 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 As a Tranche B Lender 
 Flagship CLO III 
 By: Deutsche Investment
Management Americas, Inc. 
 (as successor in interest to Deutsche Asset Management, Inc.), 

As Collateral Manager 
 By: /s/ Eric S. Meyer 
 Eric S. Meyer, Managing
Director 
 The Lender set forth above is agreeing to be: 

An Extended Tranche B Lender and/or 
 An Additional Tranche B Lender. 
 By: /s/ Colleen
Cunniffe 
 Name: Colleen Cunniffe 
 Title: Managing Director 
 AMN Healthcare, Inc.

 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 As a Tranche B Lender 
 Flagship CLO IV 
 By: Deutsche Investment
Management Americas, Inc. 
 (as successor in interest to Deutsche Asset Management, Inc.), 

As Collateral Manager 
 By: Eric S. Meyer 
 Eric S. Meyer, Managing
Director 
 The Lender set forth above is agreeing to be: 

An Extended Tranche B Lender and/or 
 An Additional Tranche B Lender. 
 By: /s/ Colleen
Cunniffe 
 Name: Colleen Cunniffe 
 Title: Managing Director 
 AMN Healthcare, Inc.

 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 As a Tranche B Lender 
 Flagship CLO V 
 By: Deutsche Investment Management
Americas, Inc. 
 (as successor in interest to Deutsche Asset Management, Inc.), 

As Collateral Manager 
 By: /s/ Eric S. Meyer, Managing Director 
 The
Lender set forth above is agreeing to be: 
 An Extended Tranche B Lender and/or 

An Additional Tranche B Lender 
 By: /s/ Colleen Cunniffe 
 Name: Colleen Cunniffe

 Title: Managing Director 
 AMN Healthcare, Inc. First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 As a Tranche B Lender 
 Flagship CLO VI 
 By: Deutsche Investment
Management Americas, Inc. 
 As Collateral Manager 

By: /s/ Eric S. Meyer, Managing Director 
 The Lender set forth above is agreeing to be: 
 An
Extended Tranche B Lender and/or 
 An Additional Tranche B Lender. 

By: /s/ Colleen Cunniffe 
 Name: Colleen Cunniffe 
 Title: Managing Director

 AMN Healthcare, Inc. First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 Galaxy V CLO, Ltd. 
 By: PineBridge Investments LLC 
 Its Collateral
Manager 
 [LENDER], 
 as a Tranche B Lender 
 By: /s/ John Wesley Burgess

 Name: John Wesley Burgess 
 Title: Vice President 
 The Lender set forth above
is agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 

  

 

 

  
 TRANCHE B
LENDERS: 
 Galaxy VI CLO, Ltd. 
 By: PineBridge Investments LLC 
 Its Collateral
Manager 
 [LENDER], 
 as a Tranche B Lender 
 By: /s/ John Wesley Burgess

 Name: John Wesley Burgess 
 TitIe: Vice President 
 The Lender set forth above
is agreeing to be: 
 An Extended Tranche B Lender and/or 

An Additional Tranche B Lender. 

  

 

 

  
 TRANCHE B
LENDERS: 
 Galaxy VII CLO, Ltd. 
 By: PineBridge Investments LLC 
 Its Collateral
Manager 
 [LENDER], 
 as a Tranche B Lender 
 By: /s/ John Wesley Burgess

 Name: John Wesley Burgess 
 Title: Vice President 
 The Lender set forth above
is agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 

  

 

 

  
 TRANCHE B
LENDERS: 
 Galaxy VIII CLO, Ltd. 
 By: PineBridge Investments LLC 
 Its Collateral
Manager 
 [LENDER], 
 as a Tranche B Lender 
 By: /s/ John Wesley Burgess

 Name: John Wesley Burgess 
 Title: Vice President 
 The Lender set forth above
is agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 

  

 

 

  
 TRANCHE B
LENDERS: 
 Galaxy X CLO, Ltd. 
 By: PineBridge Investments LLC 
 Its Collateral
Manager 
 [LENDER], 
 as a Tranche B Lender 
 By: /s/ John Wesley Burgess

 Name: John Wesley Burgess 
 Title: Vice President 
 The Lender set forth above
is agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 

  

 

 

  
 TRANCHE B
LENDERS: 
 General Electric Capital Corporation, 

as a Tranche B Lender 
 By: /s/ Jason Ricketts 
 Name: Jason Ricketts

 Title: Duly Authorized Signatory 
 The Lender set forth above is agreeing to be: 
 An
Extended Tranche B Lender 
 and/or 
 An Additional Tranche B Lender. 
 AMN Healthcare,
Inc. 
 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 GULF STREAM-COMPASS CLO 2005-1, LTD 

By: Gulf Stream Asset Management LLC 
 As Collateral Manager 
 GULF STREAM-COMPASS CLO
2005-II, LTD 
 By: Gulf Stream Asset Management LLC 

As Collateral Manager 
 GULF STREAM-SEXTANT CLO 2006-1, LTD 
 By: Gulf
Stream Asset Management LLC 
 As Collateral Manager 

GULF STREAM-RASHINBAN CLO 2006-1, LTD 
 By: Gulf Stream Asset Management LLC 
 As
Collateral Manager 
 GULF STREAM-SEXTANT CLO 2007-1, LTD 

By: Gulf Stream Asset Management LLC 
 As Collateral Manager 
 GULF STREAM-COMPASS CLO
2007, LTD 
 By: Gulf Stream Asset Management LLC 

As Collateral Manager 
 NEPTUNE FINANCE CCS, LTD 
 By: Gulf Stream Asset
Management LLC 
 As Collateral Manager 
 as a Tranche B Lender 
 By: /s/ Barry K. Love

 Name: Barry K. Love 
 Title: Chief Credit Officer 
 The Lender set forth
above is agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 
 AMN Healthcare,
Inc. 
 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 HCM Pathfinder Master Fund LTD, as a Tranche B Lender 

By: /s/ Michael E. Lewitt 
 Name: Michael E. Lewitt 
 Title: Authorized
Signatory 
 The Lender set forth above is agreeing to be: 

An Extended Tranche B Lender 
 and/or 
 An Additional Tranche B Lender.

 AMN Healthcare, Inc. 
 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 Hewett’s Island CLO III, Ltd. 

By: CypressTree Investment Management Company, LLC 

as Portfolio Manager. 
 as a Tranche B Lender 
 By: /s/ Martha Hadeler

 Name: Martha Hadeler 
 Title: Sr. Portfolio Manager 
 The Lender set forth
above is agreeing to be: 
 An Extended Tranche B Lender 

AMN Healthcare, Inc. 
 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 Hewett’s Island CLO I R, Ltd. 

By: CypressTree Investment Management Company, LLC 

as Portfolio Manager 
 as a Tranche B Lender 
 By: /s/ Martha Hadeler

 Name: Martha Hadeler 
 Title: Sr. Portfolio Manager 
 The Lender set forth
above is agreeing to be: 
 An Extended Tranche B Lender 

AMN Healthcare, Inc. 
 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 Hewett’s Island CLO IV, Ltd. 

By: CypressTree Investment Management Company, LLC 

as Portfolio Manager. 
 as a Tranche B Lender 
 By: /s/ Robert Weeden

 Name: Robert Weeden 
 Title: Sr. Portfolio Manager 
 The Lender set forth
above is agreeing to be: 
 An Extended Tranche B Lender 

AMN Healthcare, Inc. 
 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 Hewett’s Island CLO V, Ltd. 

By: CypressTree Investment Management Company, LLC 

as Portfolio Manager. 
 as a Tranche B Lender 
 By: /s/ Robert Weeden

 Name: Robert Weeden 
 Title: Sr. Portfolio Manager 
 The Lender set forth
above is agreeing to be: 
 An Extended Tranche B Lender 

AMN Healthcare, Inc. 
 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 Hewette’s Island CLO VI, Ltd, 

By: CypressTree Investment Management Company, LLC 

as Portfolio Manager. 
 as a Tranche B Lender 
 By: /s/ Robert Weeden

 Name: Robert Weeden 
 Title: Sr. Portfolio Manager 
 The Lender set forth
above is agreeing to be: 
 An Extended Tranche B Lender 

AMN Healthcare, Inc. 
 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 ING CAPITAL LLC, 
 as a Tranche B Lender 
 By: /s/ Darren Wells

 Name: Darren Wells 
 Title: Managing Director 
 The Lender set forth
above is agreeing to be: 
 An Extended Tranche B Lender and/or 

An Additional Tranche B Lender. 
 AMN Healthcare, Inc. First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 LANDMARK III CDO LIMITED 
 By Aladdin Capital Management LLC, as Lender 
 By:
/s/ Thomas E. Bancroft 
 Name: Thomas E. Bancroft Title: Designated Signatory 

LANDMARK VIII CLO LTD 
 By Aladdin Capital Management LLC, as Lender 
 By:
/s/ Thomas E. Bancroft 
 Name: Thomas E. Bancroft 

Title: Designated Signatory 
 LANDMARK IX CDO LTD 
 By: Aladdin Capital
Management LLC as Lender 
 By: /s/ Thomas E. Bancroft 

Name: Thomas E. Bancroft Title: Designated Signatory 

The Lender set forth above is agreeing to be: 
 An Extended Tranche B Lender 
 and/or 

An Additional Tranche B Lender. 
 AMN Healthcare, Inc. First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 LightPoint CLO V, Ltd, 
 as a Tranche B Lender 
 By Neuberger Bernan Fixed
Income LLC as collateral manager 
 By: /s/ Colin Donlan 

Name: Colin Donlan 
 Title: Authorized Signatory 
 The Lender set forth
above is agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 
 AMN Healthcare,
Inc. First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 LightPoint CLO VIII, Ltd, 
 as a Tranche B Lender 
 By Neuberger Berman Fixed
Income LLC as collateral manager 
 By: /s/ Colin Donlan 

Name: Colin Donlan 
 Title: Authorized Signatory 
 The Lender set forth
above is agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 
 AMN Healthcare,
Inc. 
 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 LMP Corporate Loan Fund, Inc. 

By: Citi Alternative Investments LLC 
 as a Tranche B Lender 
 By: /s/ Melanie Hanlon

 Name: Melanie Hanlon 
 Title: Director 
 The Lender set forth above is
agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 
 AMN Healthcare,
Inc. 
 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 LOOMIS SAYLES 
 LEVERAGED SENIOR LOAN FUND LTD., 
 As Lender

 By: Loomis, Sayles & Company, L.P., 

Its Investment Manager 
 By: Loomis. Sayles & Company, Incorporated, 
 Its General Partner 
 as a Tranche B Lender

 By: /s/ Mary McCarthy 
 Name: Mary McCarthy 
 Title: Vice President

 The Lender set forth above is agreeing to be: 

An Extended Tranche B Lender 
 and/or 
 An Additional Tranche B Lender.

 AMN Healthcare, Inc. 
 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 THE LOOMIS SAYLES 
 SENIOR LOAN FUND, LLC, 
 As Lender 

By: Loomis, Sayles & Company, L.P., 
 Its Managing Member 
 By: Loomis, Sayles &
Company, Incorporated, 
 Its General Partner 

as a Tranche B Lender 
 By: Mary McCarthy 
 Name: Mary McCarthy 

Title: Vice President 
 The Lender set forth above is agreeing to be: 
 An
Extended Tranche B Lender 
 and/or 
 An Additional Tranche B Lender. 
 AMN Healthcare,
Inc. 
 First Amendment to Credit Agreement 

  

 

 

  
 Madison Park
III 
 By: /s/ Thomas Flannery 
 Name: Thomas Flannery 
 Title: Authorized Signatory

 *We are approving and extending our commitment.* 

AMN HEALTHCARE, INC. 

  

 

 

  
 Madison Park
Funding V 
 By: /s/ Thomas Flannery 
 Name: Thomas Flannery 
 Title: Authorized Signatory

 *We are approving and extending our commitment.* 

AMN HEALTHCARE, INC. 

  

 

 

  
 TRANCHE B
LENDERS: 
 MARQUETTE PARK CLO LTD. 
 By: Deerfield Capital Management LLC as 
 its
Collateral Manager, as a Tranche B Lender 
 By: /s/ Mark E. Wittnebel 

Name: Mark E. Wittnebel 
 Title: Managing Director 
 The Lender set forth
above is agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 
 AMN Healthcare,
Inc. 
 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 Meadows Foundation Incorporated, as a Tranche B Lender 

By: /s/ Michael E. Lewitt 
 Name: Michael E. Lewitt 
 Title: Authorized
Signatory 
 The Lender set forth above is agreeing to be: 

An Extended Tranche B Lender 
 and/or 
 An Additional Tranche B Lender.

 AMN Healthcare, Inc. 
 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 NATIXIS LOOMIS SAYLES 
 SENIOR LOAN FUND, 
 As Lender 

By: Loomis, Sayles & Company. L.P., 
 Its Investment Manager 
 By: Loomis,
Sayles & Company. Incorporated, 
 Its General Partner 

as a Tranche B Lender 
 By: /s/ Mary McCarthy 
 Name: Mary McCarthy

 Title: Vice President 
 The Lender set forth above is agreeing to be: 
 An
Extended Tranche B Lender 
 and/or 
 An Additional Trench B Lender. 
 AMN Healthcare,
Inc. 
 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 PineBridge Bank Loan Fund 
 By: PineBridge Investments LLC 
 Its Investment
Manager 
 [LENDER], 
 as a Tranche B Lender 
 By: /s/ John Wesley Burgess

 Name: John Wesley Burgess 
 Title: Vice President 
 The Lender set forth above
is agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 

  

 

 

  
 TRANCHE B
LENDERS: 
 Primus CLO I, Ltd, 
 By: Primus Asset Management, Inc., 
 as a
Collateral Manager 
 as Q Tranche B Lender 

By: /s/ Robert Weeden 
 Name: Robert Weeden 
 Title: Sr. Portfolio Manager

 The Lender set forth above is agreeing to be: 

An Extended Tranche B Lender 
 AMN Healthcare, Inc. 
 First Amendment to Credit
Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 Primus CLO II, Ltd, 
 By: Primus Asset Management, Inc., 
 as Collateral
Manager 
 as a Tranche B Lender 
 By: /s/ Martha Hadeler 
 Name: Martha Hadeler

 Title: Sr. Portfolio Manager 
 The Lender set forth above is agreeing to be: 
 An
Extended Tranche B Lender 
 AMN Healthcare, Inc. 

First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 REGATTA FUNDING LTD. 
 By: Citi Alternative Investments LLC, 

attorney-in-fact 
 as a Tranche B Lender 
 By: /s/ Melanie Hanlon

 Name: Melanie Hanlon 
 Title: Director 
 The Lender set forth above is
agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 
 AMN Healthcare,
Inc. 
 First Amendment to Credit Agreement 

  

 

 

  
 RiverSource
Bond Series, Inc. - 
 RiverSource Floating Rate Fund 

By: /s/ Robin C. Stancil 
 Name: Robin C. Stancil 
 Title: Assistant Vice
President 
 AMN HEALTHCARE, INC. 

  

 

 

  
 RiverSource
Strategic Allocation 
 Series, Inc.- RiverSource Strategic 

Income Allocation Fund 
 By: /s/ Robin C. Stancil 
 Name: Robin C. Stancil

 Title: Assistant Vice President 
 AMN HEALTHCARE, INC. 

  

 

 

  
 TRANCHE B
LENDERS: 
 Saturn CLO, Ltd. 
 By: PineBridge Investments LLC 
 Its Collateral
Manager 
 [LENDER], 
 as a Tranche B Lender 
 By: /s/ John Wesley Burgess

 Name: John Wesley Burgess 
 Title: Vice President 
 The Lender set forth above
is agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 

  

 

 

  
 TRANCHE B
LENDERS: 
 SCHILLER PARK CLO LTD. 
 By: Deerfield Capital Management LLC as 
 its
Collateral Manager, as a Tranche B Lender 
 By: /s/ Mark E. Wittnebel 

Name: Mark E. Wittnebel 
 Title: Managing Director 
 The Lender set forth
above is agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 
 AMN Healthcare,
Inc. First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 Stone Tower Credit Funding I Ltd. 

By Stone Tower Fund Management LLC 
 As Its Collateral Manager 
 as a Tranche B Lender

 By: 
 Name: Michael W DelPercio 
 Title: Authorized
Signatory 
 The Lender set forth above is agreeing to be: 

An Extended Tranche B Lender 
 and/or 
 An Additional Tranche B Lender.

 AMN Healthcare, Inc. 
 First Amendment to Credit Agreement 

  

 

 

  
 TRANCHE B
LENDERS: 
 SUNTRUST BANK 
 as a Tranche B Lender 
 By: /s/ J. Ben Cumming

 Name: J. Ben Cumming 
 Title: Vice President 
 The Lender set forth above
is agreeing to be: 
 An Extended Tranche B Lender 

and/or 
 An Additional Tranche B Lender. 
 AMN Healthcare,
Inc. 
 First Amendment to Credit Agreement 

  
 SCHEDULE 1.1A

 CONSOLIDATED EBITDA ADJUSTMENTS 
  

					
	 Fiscal Quarter Period Ending on:
	  	Amount of Consolidated
EBITDA
Adjustment	 
	 December 31, 2009
	  	$	1,300,000	  
	 March 31, 2010
	  	$	850,000	  
	 June 30, 2010
	  	$	350,000	  
	 September 30, 2010
	  	$	2,800,000	  

  

 

 

  
 SCHEDULE LIB

 CONSOLIDATED EBITDA ADJUSTMENTS RELATING TO MEDFINDERS SYNERGIES AND INTEGRATION COSTS

 For the Four Fiscal Quarter Period Ending on: Maximum Amount of Consolidated Medfinders Synergies
Adjustment(l) Maximum Amount of Consolidated Integration Cost Adjustment(2) 
 September 30, 2010 $8,162,000
$1,500,000 
 December 31, 2010 $8,162,000 $2,750,000 

March 31, 2011 $6,165,000 $3,250,000 
 June 30, 2011 $5,190,000 $3,750,000 

September 30, 2011 $3,236,000 $4,000,000 
 December 31, 2011 $1,702,000 $4,250,000 
 1)
the aggregate amount of all expected cost reduction synergies added back to EBITDA as a result of the Medfinders Acquisition shall not exceed $8,162,000 through the life of the Credit Agreement. 

2) the aggregate amount of the integration cost adjustment to EBITDA as a result of the Medfinders Acquisition shall not
exceed $4,250,000 through the life of the Credit Agreement. 

  

 

 

  
 Schedule 1.1C

 INVESTMENTS 
 1. In June 2009, Nursefinders, Inc. and Texas Health Resources, a non-profit organization operating 13 hospitals in North Texas, entered into a “Company Agreement” forming Texas
Health Single Source Staffing, LLC. The effective date of the Agreement is June 8, 2009 and it has a 5 year term. The Company’s membership is as follows: (1) Texas Health Resources (“THR”)—600 units, 60% membership; and
Nursefinders, Inc.—400 units, 40% membership. 

  

 

 

  

Schedule LID 
 EXISTING LIENS 
 Debtor Secured Party Collateral

 AMN Healthcare Services, Inc. Merritt Hawkins & Associates Staff Care, Inc. Pharmacy Choice, Inc.
Avaya Financial Services Leased Equipment 
 AMN Healthcare, Inc. IOS Capital, LLC Leased Equipment 

AMN Healthcare, Inc. Merritt Hawkins & Associates Pitney Bowes Leased Equipment 

Merritt Hawkins & Associates Staff Care, Inc. Xerox Corporation Leased Equipment 

AMN Healthcare, Inc. AMN Healthcare Services, Inc. Pharmacy Choice, Inc. Dell Financial Services Leased Equipment

 AMN Healthcare, Inc. Merritt Hawkins & Associates CIT Communications Finance Corporation Leased
Equipment (Lease No. 1005674) 
 Club Staffing, Inc. Dell Financial Services L.P. Computer equipment and
peripherals 
 Nursefinders, Inc. Imagenet Capital DFW LTD Leased Equipment 

Nursefinders, Inc. Ricoh Customer Finance Corp Leased Equipment 

  
 SCHEDULE 1.1E

 CONSOLIDATED EBITDA ADJUSTMENTS 
 RELATING TO MEDFINDERS SYNERGIES AND INTEGRATION COSTS 
  

									
	 For the Four Fiscal Quarter Period Ending on:
	  	Maximum
Amount
of
Consolidated
Medfinders
Synergies
Adjustment(1)	 	  	Maximum
Amount
of
Consolidated
Integration
Cost
Adjustment(2)	 
	 September 30, 2010
	  	$	8,162,000	  	  	$	1,500,000	  
	 December 31, 2010
	  	$	8,162,000	  	  	$	2,750,000	  
	 March 31, 2011
	  	$	6,165,000	  	  	$	3,250,000	  
	 June 30, 2011
	  	$	5,190,000	  	  	$	3,750,000	  
	 September 30, 2011
	  	$	3,236,000	  	  	$	4,000,000	  
	 December 31, 2011
	  	$	1,702,000	  	  	$	4,250,000	  

 1) the aggregate amount of all
expected cost reduction synergies added back to EBITDA as a result of the Medfinders Acquisition shall not exceed $8,162,000 through the life of the Credit Agreement. 
 2) the aggregate amount of the integration cost adjustment to EBITDA as a result of the Medfinders Acquisition shall not exceed $4,250,000 through the life of the Credit Agreement. 

  
 SCHEDULE 2.1(a)

 Lenders and Commitments 
 Revolving Lenders 
 (As of the First Amendment Effective Date)

  

									
	 Revolving Lender
	  	Revolving
Commitment	 	  	Revolving
Commitment
Percentage	 
	 BANK OF AMERICA, NA
	  	$	17,500,000	  	  	 	43.750000000	% 
	 SUNTRUST BANK
	  	$	17,500,000	  	  	 	43.750000000	% 
	 ING CAPITAL LLC
	  	$	5,000,000	  	  	 	12.5000000000	% 
	 Total:
	  	$	40,000,000	  	  	 	100.0000000000	% 

  
 Tranche B Lenders

 (As of the First Amendment Effective Date) 
 [See Attached] 

  

 

 

  

Tranche B Lenders (As of the First Amendment Effective Date) 

 

	 *
	 The Non-Extended Tranche B Loans mature on the Existing Tranche B Loan
Maturity Date 

 ** The Additional Tranche B Loans and the Extended Tranche B Loans mature on
the Extended Tranche B Loan Maturity Date 
 Tranche B Lender Non-Extended Tranche B Loans* Additional Tranche B
Loans** Additional Tranche B Loan Commitment Percentage Extended Tranche B Loans** Aggregate Tranche B Loans Tranche B Loan Commitment Percentage 
 Apostle Loomis Sayles Credit Opportunities Fund 0.000000000% $ 738,353.25 $ 738,353.25 0.399109865% 
 Apostle Loomis Sayles Senior Loan Fund 0.000000000% $ 819,493.29 $ 819,493.29 0.442969346% 
 Atrium IV 0.000000000% $ 1,462,500.00 $ 1,462,500.00 0.790540541% 
 Atrium V $ 0.000000000% $ 1,462,500.00 $ 1,462,500.00 0.790540541% 
 Bank of America, N.A. $ 76,750,000.00 98.713826367% $ 76,750,000.00 41.486486486% 
 Bridgeport CLO II Ltd. $ 0.000000000% $ 911,625.00 $ 911,625.00 0.492770270% 
 Bridgeport CLO Ltd. $ 0.000000000% $ 911,625.00 $ 911,625.00 0.492770270% 
 Burr Ridge CLO Plus Ltd. 0.000000000% $ 536,250.00 $ 536,250.00 0.289864865% 
 California Public Employees’ Retirement System 0.000000000% $ 170,625.00 $ 170,625.00 0.092229730% 
 Castle Garden Funding 0.000000000% $ 1,950,000.00 $ 1,950,000.00 1.054054054% 
 CCA Eagle Loan Master Fund Ltd. 0.000000000% $ 110,019.00 $ 110,019.00 0.059469730% 
 Cent CDO 10 Limited 0.000000000% $ 609,375.00 $ 609,375.00 0.329391892% 
 Cent CDO 12 Limited 0.000000000% $ 950,625.00 $ 950,625.00 0.513851351% 
 Cent CDO 14 Limited $ 0.000000000% $ 755,625.00 $ 755,625.00 0.408445946% 
 Cent CDO 15 Limited foe 0.000000000% $ 950,625.00 $ 950,625.00 0.513851351% 
 Cent CDO IX Limited $ 0.000000000% $ 1,121,250.00 $ 1,121,250.00 0.606081081% 
 Centurion CDO 8 Limited $ $ 0.000000000% $ 901,875.00 $ 901,875.00 0.487500000% 
 Centurion CDO 9 Limited 0.000000000% $ 1,267,500.00 $ 1,267,500.00 0.685135135% 
 Centurion CDO VI, Ltd. 0.000000000% $ 560,625.00 $ 560,625.00 0.303040541% 
 Centurion CDO VII Limited $ 0.000000000% $ 1,681,875.00 $ 1,681,875.00 0.909121622% 
 Cumberland II CLO Ltd. 0.000000000% $ 721,500.00 $ 721,500.00 0.390000000% 
 DFR Middle Market CLO, Ltd. 0.000000000% $ 536,250.00 $ 536,250.00 0.289864865% 
 DWS Floating Rate Plus Fund 0.000000000% $ 2,437,500.00 $ 2,437,500.00 1.317567568% 
 DWS Short Duration Plus Fund $ 0.000000000% $ 487,500.00 $ 487,500.00 0.263513514% 
 Flagship CLO III $ 0.000000000% $ 975,000.00 $ 975,000.00 0.527027027% 
 Flagship CLO IV $ 0.000000000% $ 975,000.00 $ 975,000.00 0.527027027% 
 Flagship CLO V 0.000000000% $ 1,950,000.00 $ 1,950,000.00 1.054054054% 
 Flagship CLO VI 0.000000000% $ 975,000.00 $ 975,000.00 0.527027027% 
 Galaxy V CLO, Ltd. $ 0.000000000% $ 487:500.00 $ 487,500.00 0.263513514% 
 The Non-Extended Tranche B Loans mature on the Existing Tranche I’ Loan Maturity Date 
 The Additional Tranche B Loans and the Extended Tranche B Loans mature on the Extended Tranche B Loan Maturity Date 

  

 

 

  
 Tranche B
Lender Non-Extended Tranche B Loans* Additional Tranche B Loans** Additional Tranche B Loan Commitment Percentage Extended Tranche B Loans** Aggregate Tranche B Loans Tranche B Loan Commitment Percentage 

Galaxy VI CLO, Ltd. $ $ 0.000000000% $ 975,000.00 $ 975,000.00 0.527027027% 

Galaxy VII CLO, Ltd. fee $ 0.000000000% $ 975,000.00 $ 975,000.00 0.527027027% 

Galaxy VIII CLO, Ltd. $ $ 0.000000000% $ 975.000.00 $ 975,000.00 0.527027027% 

Galaxy X CLO, Ltd. fee $ 0.000000000% $ 975,000.00 $ 975,000.00 0.527027027% 

General Electric Capital Corporation $ $ 0.000000000% $ 14,625,000.00 $ 14,625,000.00 7.905405405% 

Gulf Stream-Compass CLO 2005-1, Ltd. $ $ 0.000000000% $ 1,218,750.00 $ 1,218,750.00 0.658783784% 

Gulf Stream-Compass CLO 2005-11, Ltd. $ $ 0.000000000% $ 1,218,750.00 $ 1,218,750.00 0.658783784% 

Gulf Stream-Compass CLO 2007, Ltd. $ $ 0.000000000% $ 731,250.00 $ 731,250.00 0.395270270% 

Gulf Stream-Rashinban CLO 2006-1, Ltd. fee $ 0.000000000% $ 1,218,750.00 $ 1,218,750.00 0.658783784% 

Gulf Stream-Sextant CLO 2006-1, Ltd. fee $ 0.000000000% $ 1,706,250.00 $ 1,706,250.00 0.922297297% 

Gulf Stream-Sextant CLO 2007-1, Ltd. fee $ 0.000000000% $ 1,950,000.00 $ 1,950,000.00 1.054054054% 

HCM Pathfinder Master Fund Ltd. $ $ 0.000000000% $ 487,500.00 $ 487,500.00 0.263513514% 

Hewett’s Island CLO III, Ltd. $ $ 0.000000000% $ 487,500.00 $ 487,500.00 0.263513514% 

Hewett’s Island CLO I R, Ltd. $ $ 0.000000000% $ 487,500.00 $ 487,500.00 0.263513514% 

Hewett’s Island CLO IV, Ltd. $ $ 0.000000000% $ 975,000.00 $ 975,000.00 0.527027027% 

Hewett’s Island CLO V, Ltd. $ $ 0.000000000% $ 975,000.00 $ 975,000.00 0.527027027% 

Hewett’s Island CLO VI, Ltd. $ $ 0.000000000% $ 731,250.00 $ 731,250.00 0.395270270% 

ING Capital LLC $ $ 0.000000000% $ 14,625,000.00 $ 14,625,000.00 7.905405405% 

Landmark III CDO Limited $ $ 0.000000000% $ 2,925,000.00 $ 2,925,000.00 1.581081081% 

Landmark VIII CLO Ltd. $ $ 0.000000000% $ 975,000.00 $ 975,000.00 0.527027027% 

Landmark IX CDO Ltd. $ $ 0.000000000% $ 975,000.00 $ 975,000.00 0.527027027% 

LightPoint CLO V, Ltd. $ $ 0.000000000% $ 1,462,500.00 $ 1,462,500.00 0.790540541% 

LightPoint CLO VIII, Ltd. fee $ 0.000000000% $ 1,462,500.00 $ 1,462,500.00 0.790540541% 

LMP Corporate Loan Fund, Inc. $ $ 0.000000000% $ 1,303,161.60 $ 1,303,161.60 0.704411676% 

Loomis Sayles Leveraged Senior Loan Fund Ltd. $ $ 0.000000000% $ 366,604.65 $ 366,604.65 0.198164676% 

The Loomis Sayles Senior Loan Fund, LLC $ $ 0.000000000% $ 1,507,408.39 $ 1,507,408.39 0.814815346% 

Madison Park Funding III Ltd. $ $ 0.000000000% $ 1,462,500.00 $ 1,462,500.00 0.790540541% 

Madison Park Funding V Ltd. $ $ 0.000000000% $ 2,437,500.00 $ 2,437,500.00 1.317567568% 

Marquette Park CLO Ltd. $ $ 0.000000000% $ 536,250.00 $ 536,250.00 0.289864865% 

Meadows Foundation Incorporated $ $ 0.000000000% $ 487,500.00 $ 487,500.00 0.263513514% 

Natixis Loomis Sayles Senior Loan Fund $ $ 0.000000000% $ 468,140.42 $ 468,140.42 0.253048876% 

Neptune Finance CCS, Ltd. $ $ 0.000000000% $ 1,218,750.00 $ 1,218,750.00 0.658783784% 

PineBridge Bank Loan Fund $ fee 0.000000000% $ 487,500.00 $ 487.500.00 0.263513514% 

 

	 *
	 The Non-Extended Tranche B Loans mature on the Existing Tranche H Loan
Maturity Date 

 ** The Additional Tranche B Loans and the Intended Tranche B Loans mature on
the Extended Tranche B Loan Maturity Date 

  

 

 

  
 Tranche B
Lender Non-Extended Tranche B Loans* Additional Tranche B Loans** Additional Tranche B Loan Commitment Percentage Extended Tranche B Loans** Aggregate Tranche B Loans Tranche B Loan Commitment Percentage 

Primus CLO I, Ltd. 0.000000000% $ 1,218,750.00 $ 1,218,750.00 0.658783784% 

Primus CLO II, Ltd. $ $ 0.000000000% $ 487,500.00 $ 487,500.00 0.263513514% 

Regatta Funding Ltd. $ $ 0.000000000% $ 1,511,819.40 $ 1,511,819.40 0.817199676% 

RiverSource Bond Series, Inc.—RiverSource Floating Rate Fund $ $ 0.000000000% $ 706,875.00 $ 706,875.00 0.382094595%

 RiverSource Strategic Allocation Series, Inc. -RiverSource Strategic Income Allocation Fund 0.000000000% $
73,125.00 $ 73,125.00 0.039527027% 
 Saturn CLO, Ltd. $ $ 0.000000000% $ 975,000.00 $ 975,000.00 0.527027027%

 Schiller Park CLO Ltd. $ $ 0.000000000% $ 721,500.00 $ 721,500.00 0.390000000% 

Stone Tower Credit Funding I Ltd. $ $ 0.000000000% $ 10,725,000.00 $ 10,725,000.00 5.797297297% 

SunTrust Bank $ $ 1,000,000.00 1.286173633% - $ 1,000,000.00 0.540540541% 

$ 77,750,000.00 100.000000000% $ 107,250,000.00 $ 185,000,000.00 100.00000000% 

  

 

 

  
 Schedule 6.4
REQUIRED CONSENTS, AUTHORIZATIONS, NOTICES AND FILINGS 
 None. 

Doc#:USl:6534013v6 

  

 

 

  

Schedule 6.10 TAXES 
 1. Staff Care, Inc. is subject of an assessment by the California Employment 
 Development Department (“EDD”) with respect to the payment of certain payroll related taxes in connection with locum tenens and allied providers, for the period between
April 1, 2001 and June 30, 2007. Staff Care, Inc. has appealed the EDD’s assessment as does not believe the assessment has merit. However, on September 5, 2008, Staff Care, Inc. made a payment to the EDD in the amount of $2.3
million to cease the accrual of interest while the appeal is pending. Of the $2.3 million payment, $1.8 million was related to periods prior to the acquisition of MHA Group, Inc. (“MHA”), which included Staff Care, Inc., in November 2005
and $0.5 million was related to the post-acquisition period. As part of the acquisition agreement of MHA, the MHA selling shareholders indemnified with respect to the $1.8 million related to the pre-acquisition period. On August 31, 2009, a
settlement agreement with the MHA selling shareholders was entered into to release such shareholders from any further liability under the assessment in exchange for their release of claim to an additional $1.5 million in the holdback reserve. As a
result of this settlement, a benefit to pre-tax income in the third quarter of 2009 of $1.5 million we recorded, but Staff Care, Inc. will be liable for any future costs related to the EDD assessments. There is potential exposure subsequent to the
assessment period, but Staff Care, Inc. believes the exposure to be immaterial to the consolidated financial statements. 
 2. 
 The Acquired Company has identified a
potential error in the preparation of income tax returns for the periods ended 12/30/07 and 12/28/08 related to the amortization of Section 197 intangibles. However, because of the Acquired Company’s net tax loss carryforward position, no
additional tax liability is expected to result. As a result the NOL on the 2007 and 2008 tax returns would be incorrect. 
 Doc#:USl:6534013v6 
 Doc#:USl:6534013v6 

  

 

 

  
 Schedule 6.13A
CORPORATE STRUCTURE 
 See attached. 
 Unde Healthcare ‘Staffing, Inc * ^Missouri 

  

 

 

  
 AMN HEALTHCARE
SERVICES, INC. AND SUBSIDIARIES ORGANIZATIONAL STRUCTURE AS OF 8/31/10 
 Doc#:USl:6534013v6 

Legend 
 m Corporation is AMN LLC 
 A Joinl Venture

  

 

 

  

Schedule 6.13B 
 CORPORATE STRUCTURE 
 Name of Entity and State of
Incorporation Authorized Capital Stock Issued and Outstanding Capital Stock Issued and Outstanding Stock Options and Other Equity Interests % of Common Stock Owned on Undiluted Basis % of Common Stock Owned on Fully Diluted Basis 

AMN Healthcare Services, Inc. (DE)—200,000,000 shares of Common Stock—10,000,000 shares of Preferred Stock
-32,787,914 shares of Common Stock as of July 28, 2010—Agreements with the Credit Parties in respect of equity granted under stock option and equity plans: 2,656,049 shares of Common Stock as of June 30,2010 Board of Directors and
Executive Management: 0.30% Public Shareholders: 99.7% Board of Directors and Executive Management: 0.30% Public Shareholders: 99.7% 
 AMN Healthcare, Inc., (NV)—2,500,000 shares of Common Stock -34,714 shares of Common Stock held by Healthcare Services None—Healthcare Services: 100% N/A 

O’Grady-Peyton International (USA), Inc. (MA) -12,500 shares of Common Stock—5,000 shares of Common Stock held
by Healthcare None -Healthcare: 100% N/A 
 AMN Services, Inc. (NC)—100 shares of Common Stock—100
shares of Common Stock held by Healthcare None -Healthcare: 100% N/A 
 AMN Staffing Services, Inc.
(DE)—1,000 shares of Common Stock -100 shares of Common Stock held by Healthcare None -Healthcare: 100% N/A 

O’Grady-Peyton International Recruitment U.K. Limited (U.K.) -100,000 shares of Ordinary Stock -1 share of Ordinary
Stock held by O’Grady- Peyton International (USA), Inc. None—O’Grady-Peyton International (USA), Inc.: 100% N/A 
 O’Grady-Peyton International (Australia) (Proprietary) LTD (Australia) N/A -2 shares of stock held by O’Grady- Peyton International (USA), Inc. None—O’Grady-Peyton
International (USA), Inc.: 100% N/A 
 O’Grady-Peyton International (SA) (Proprietary) LTD (South Africa)
-1,000 shares of Ordinary Stock -100 shares of Ordinary Stock held by O’Grady- Peyton International (USA), Inc. None—O’Grady-Peyton International (USA), Inc.: 100% N/A 

Doc#:USl:6534013v6 

  

 

 

  
 Name of Entity
and State of Incorporation Authorized Capital Stock Issued and Outstanding Capital Stock Issued and Outstanding Stock Options and Other Equity Interests % of Common Stock Owned on Undiluted Basis % of Common Stock Owned on Fully Diluted Basis

 O’Grady-Peyton International (Europe) Limited (U.K.) -10,000 shares of Ordinary Stock—2 shares of
Ordinary Stock held by O’Grady- Peyton International (USA), Inc. None—O’Grady-Peyton International (USA), Inc.: 100% N/A 
 O’Grady-Peyton International (India) Private Limited -10,000,000 Indian rupees -497,714 Indian rupees held by O’Grady- Peyton International (USA), Inc.—10 Indian rupees held
by AMN Healthcare, Inc. None—O’Grady-Peyton International (USA), Inc.: 99.998%—AMN Healthcare, Inc.: 0.002% N/A 
 International Healthcare Recruiters, Inc. (DE) -1,000 shares of Ordinary Stock -100 shares of Common Stock held by O’Grady- Peyton International (USA), Inc.
None—O’Grady-Peyton International (USA), Inc.: 100% N/A 
 The MHA Group, Inc. (TX) -100 shares of
Common Stock—100 shares of Common Stock held by AMN Healthcare, Inc. None—Healthcare: 100% N/A 

Merritt, Hawkins & Associates (CA) -100,000 shares of Common Stock—329 shares of Common Stock held by The
MHA Group, Inc. None—The MHA Group, Inc.: 100% N/A 
 AMN Healthcare Allied, Inc. (TX) -10,000 shares of
Common Stock -100 shares of Common Stock held by RN Demand, Inc. None—RN Demand, Inc.: 100% N/A 
 RN
Demand, Inc. (TX) -10,000 shares of Common Stock -1,000 shares held by The MHA Group, Inc. None—The MHA Group, Inc.: 100% N/A 
 Staff Care, Inc. (DE) -10,000 shares of Common Stock—1,000 shares of Common Stock held by The MHA Group, Inc. None—The MHA Group, Inc.: 100% N/A 

MHA Allied Consulting, Inc. (TX)—10,000 shares of Common Stock—1,000 shares of Common Stock held by The MHA
Group, Inc. None—The MHA Group, Inc.: 100% N/A 
 Doc#:USl:6534013v6 

  

 

 

  
 Name of Entity
and State of Incorporation Authorized Capital Stock Issued and Outstanding Capital Stock Issued and Outstanding Stock Options and Other Equity Interests % of Common Stock Owned on Undiluted Basis % of Common Stock Owned on Fully Diluted Basis

 AMN Allied Services, LLC N/A N/A None—Med Travelers, Inc.; Manager and Sole Member N/A 

Lifework, Inc.—1,000 shares of Common Stock—100 shares of Common Stock held by AMN Healthcare, Inc.
None—AMN Healthcare, Inc.: 100% N/A 
 Pharmacy Choice, Inc.—5,000,000 shares of Common Stock -1885,420
shares of Common Stock held by Lifework, Inc. None -Lifework, Inc.: 100% N/A 
 Rx Pro Health,
Inc.—5,000,000 shares of Common Stock -1,000,000 shares of Common Stock held by Lifework, Inc. None—Lifework, Inc.: 100% N/A 
 Doc#:USl :6534013v6 

  

 

 

  
 Schedule 6.17
INTELLECTUAL PROPERTY 
 Trademarks U.S. Trademark and Service Mark Applications 

U.S. Trademark Registrations 
 MARK REG.# REG. DATE CLASS # TYPE HOLDER SERIAL # FILE DATE 
 AMN HEALTHCARE, INC. 
 ADVANCE YOUR PROFESSION
2839241 05/04/2004 35,41 Principal AMN 78-171786 10/07/2002 
 AMERICAN MOBILE 2735046 07/08/2003 35 Principal
AMN 75-753287 07/16/1999 
 AMERICAN MOBILE (and Design) 2716051 05/13/2003 35 Principal AMN 75-874559 12/18/1999

 AMERICAN MOBILE NURSES 2408668 11/28/2000 35 Principal AMN 75-879923 12/23/1999 

AMN 2544900 03/05/2002 35 Principal AMN 76-256857 05/14/2001 

AMN (stylized/design) 3817255 07/13/2010 35 Principal AMN 77-873187 11/16/2009 

AMN HEALTHCARE 2498874 10/16/2001 35 Principal AMN 75-753291 07/16/1999 

ANESTHESIAZONE 3452682 09/10/2007 35,44 Principal AMN 77-275735 09/10/2007 

HEALTHCARE RESOURCE MANAGEMENT CORPORATION 2760480 09/02/2003 35 Supplemental AMN 76-423244 06/19/2002 

LICENSESTAT 3221973 03/27/2007 35 Principal AMN 78-786930 01/06/2006 

MED TRAVELERS 3540365 12/2/2008 35 Principal AMN 78-789832 1/11/2006 

MEDEX 2489130 09/11/2001 35 Principal AMN 75-876165 12/21/1999 

MYMEDEX 2489132 09/11/2001 35 Principal AMN 75-876290 12/21/1999 

NURSECHOICE 3024393 12/06/2005 35 Principal AMN 78-267691 06/26/2003 

NURSEZONE 2650073 11/12/2002 35,39, 41 & 

	 42
	 Principal AMN 76-006473 03/21/2000 

NURSEZONE 2713793 05/06/2003 35 Principal AMN 75-753288 07/16/1999 

Doc#:USl:6534013v6 

  

 

 

  
 MARK REG.# REG.
DATE CLASS # TYPE HOLDER SERIAL* FILE DATE 
 NURSESRX (Stylized) 2609424 08/20/2002 35 Principal AMN 76-259124
05/18/2001 
 NURSESRX 2651490 11/19/2002 35 Principal AMN 76-277616 6/27/2001 

NURSEZONE.COM FOR WORK. FOR LIFE, (and Design) 2693088 03/04/2003 44 Principal AMN 76-412699 05/28/2002 

Preferred Globe Design 2488162 Principal 35 Principal AMN 75-568339 09/11/2001 

PREFERRED HEALTHCARE STAFFING, INC. 2301129 12/14/1999 35 Supplemental AMN 75-605359 12/09/1998 

PREFERRED HEALTHCARE STAFFING, INC.(and Design) 2801756 01/06/2004 35 Principal AMN 76-314374 09/18/2001 

RN (and Design) 2835464 04/20/2004 35,41 Principal AMN 78-171802 10/07/2002 

RN.COM 2785164 11/18/2003 35 Supplemental AMN 78-171796 10/07/2002 

RN.COM 2478710 08/14/2001 41 Supplemental AMN 75-932705 03/01/2000 

RN.COM (and Design) 2880317 08/31/2004 35,41 Principal AMN 78-171815 10/07/2002 

RN EXTEND 3304769 10/02/2007 35 Principal AMN 78-934785 07/21/2006 

THE AUTHORITY IN TRAVEL NURSING (and Design) 2970755 07/19/2005 16 Principal AMN 78-443328 06/29/2004 

THE AUTHORITY IN TRAVEL NURSING (and Design) 3005156 10/04/2005 35,41 Principal AMN 78-438880 06/21/2004 

THE LEADER IN LOCUM TENENS STAFFING 356730 1/27/09 35 Principal AMN 77-490013 6/3/2008 

THERATECH STAFFING 2856955 6/22/2004 35 Principal AMN 78-212969 02/10/2003 

THERATECH STAFFING OPPORTUNITIES ADVENTURES REWARDS and Design 3139741 09/05/2006 35 Principal AMN 78-231239 03/28/2003

 TN 2976254 07/26/2005 16 Principal AMN 78-443323 06/29/2004 

Doc#:USl:6534013v6 

  

 

 

  
 MARK REG.# REG.
DATE CLASS # TYPE HOLDER SERIAL* FILE DATE 
 TRAVELNURSING.CO M (and Design) 3081727 04/18/2006 35 Principal AMN
78-438876 06/21/2004 
 TRAVELNURSING.CO M WE MAKE IT EASY 2810478 02/03/2004 35 Principal AMN 78-157946
08/26/2002 
 “WE CARE FOR YOU, SO YOU CAN CARE FOR OTHERS” 2069933 06/10/1997 35 Principal AMN
75-145028 08/05/1996 
 WORLDVIEW HEALTHCARE 2919336 01/18/2005 35 Principal AMN 76-332822 10/31/2001 

O’GRADY PEYTON INTERNATIONAL (USA), INC. 
 O’GRADY PEYTON INTERNATIONAL 2561992 04/16/2002 35 Principal OGP 78-057380 04/09/2001 
 O’GRADY PEYTON 2543091 02/26/2002 35 Principal OGP 78-059305 04/19/2001 
 OGP 2547450 03/12/2002 35 Principal OGP 78-060543 04/26/2001 
 O’GRADY PEYTON INTERNATIONAL and Design 2615101 09/03/2002 35 Principal OGP 76-319603 09/21/2001 
 PHARMACY CHOICE, INC. 
 PHARMACY CHOICE 2772540
10/07/2003 38 Principal PC 78-010770 06/01/2000 
 RX CAREER CENTER 2785171 11/18/2003 35 Supplemental PC
78-226319 03/17/2003 
 RXSCHOOL 2945375 06/26/2005 41 Supplemental PC 78-243157 04/29/2003 

RXTECHSCHOOL 2940991 04/12/2005 41 Supplemental PC 78-293738 08/28/2003 

RN DEMAND, INC. 
 RN DEMAND 2940612 04/12/2005 35 Principal RND 76528998 07/11/2003 
 RX PRO HEALTH, INC. 
 Doc#:USl:6534013v6

  

 

 

  
 MARK REG.# REG.
DATE CLASS # TYPE HOLDER SERIAL* FILE DATE 
 RPH RECRUITER 2870728 08/03/2004 35 Supplemental RXPRO 78-247957
05/09/2003 
 RX PRO HEALTH 3442324 06/03/08 35 Principal RXPRO 78-623927 05/05/2005 

RXTEMP 2872999 08/10/2004 35 Supplemental RXPRO 78-247967 05/09/2003 

STAFF CARE, INC. 
 COUNTRY DOCTOR OF THE YEAR [and design] 2540024 2/19/2002 41 Principal SCI 76210320 2/12/2001 
 THE MHA GROUP, INC. 
 THE MHA GROUP 3025275
12/13/2005 35 Principal MHA 76-576844 02/23/2004 
 MERRITT HAWKINS & ASSOCIATES 2934515 03/22/2005 35
Principal MHA 76-576841 02/23/2004 
 STAFF CARE 2941363 04/19/2005 35 Principal MHA 76-576842 02/23/2004

 Foreign Trademark and Service Mark Applications and Registrations 

MARK REG.# REG. DATE CLASS # HOLDER SERIAL* FILE DATE JURISDICTION 

AMN HEALTHCARE, INC. 
 AMN HEALTHCARE 896147 7/15/2002 35 AMN 896147 11/26/2001 Australia 
 NURSES RX YOUR TRAVEL NURSING DESTINATION (and Design) 895692 4/19/2002 35 AMN 895692 11/21/2001 Australia 
 NURSESRX 895691 4/19/2002 35 AMN 895691 11/21/2001 Australia 
 NURSEZONE.COM FOR WORK FOR LIFE (and Design) 932189 5/19/2003 44 AMN 932189 10/29/2002 Australia 
 PREFERRED HEALTHCARE STAFFING (and Design) 895693 4/29/2002 35 AMN 895693 11/21/2001 Australia 
 AMERICAN MOBILE HEALTHCARE TMA5548 68 12/03/2001 35 AMN 1,014,709 05/07/1999 Canada 
 Doc#:USl:6534013v6 

  

 

 

  
 MARK REG.# REG.
DATE CLASS # HOLDER SERIAL* FILE DATE JURISDICTION 
 AMN HEALTHCARE TMA6283 23 12/14/2004 35 AMN 112481200
12/11/2001 Canada 
 NURSESRX TMA5942 00 11/06/2003 35 AMN 112481300 12/11/2001 Canada 

NURSESRX YOUR TRAVEL NURSING DESTINATION (and Design) TMA6057 66 03/19/2004 35 AMN 112481000 12/11/2001 Canada 

NURSEZONE.COM For Work. For Life, (and Design) TMA6253 50 11/15/2004 42 AMN 116062500 11/28/2002 Canada 

PREFERRED HEALTHCARE STAFFING (and Design) TMA6156 35 07/03/2004 35 AMN 112480900 12/11/2001 Canada 

AMN HEALTHCARE 2468619 06/10/2003 35 AMN 2468619 11/20/2001 European Community TM 

NURSESRX 2471894 04/08/2003 35 AMN 2471894 11/21/2001 European Community TM 

NURSESRX YOUR TRAVEL NURSING DESTINATION (and Design) 2472330 04/08/2003 35 AMN 2472330 11/21/2001 European Community TM

 NURSEZ0NE.COM FOR WORK. FOR LIFE, (and Design) 2948040 03/23/2004 44 AMN 2948040 11/27/2002 European Community
TM 
 PREFERRED HEALTHCARE STAFFING (and Design) 2472066 04/08/2003 35 AMN 2472066 11/21/2001 European Community
TM 
 AMERICAN MOBILE HEALTHCARE 2,196,406 10/06/2000 35 AMN 2,196,406 05/06/1999 UK 

O’GRADY PEYTON INTERNATIONAL (USA), INC. 
 O’GRADY PEYTON INTERNATIONAL (and Design) 896146 5/14/2002 35 OGP 896146 11/26/2001 Australia 
 O’GRADY PEYTON INTERNATIONAL (and Design) TMA6005 26 01/16/2004 35 OGP 112469600 12/11/2001 Canada 
 O’GRADY PEYTON INTERNATIONAL (and Design) 2472793 04/08/2003 35 OGP 2472793 11/21/2001 European Community TM 
 O’GRADY PEYTON INTERNATIONAL (and Design) 1321015 03/23/2006 35 OGP 1321015 11/18/2004 India 
 O’GRADY PEYTON INTERNATIONAL (and Design) 845166 11/17/2004 35 OGP USPTO Ref. No. A0000156 International Register 

O’GRADY PEYTON INTERNATIONAL (and Design) 721637 5/19/2005 35 OGP 721637 11/18/2004 New Zealand 

O’GRADY PEYTON INTERNATIONAL (and Design) 4-2002-03505 2/10/2005 35 OGP 4-2002-03505 4/30/2002 Philippines

 O’GRADY-PEYTON 4-2002-03504 2/10/2005 35 OGP 4-2002-03504 4/30/2002 Philippines 

Doc#:USl:6534013v6 

  

 

 

  
 MARK REG.# REG.
DATE CLASS # HOLDER SERIAL* FILE DATE JURISDICTION 
 O’GRADY-PEYTON INTERNATIONAL 4-2002-03503 2/10/2005 35
OGP 4-2002-03503 4/30/2002 Philippines 
 O’GRADY PEYTON INTERNATIONAL (and Design) 845166 04/26/2006 35 OGP
845166 06/12/2006 Romania 
 O’GRADY PEYTON INTERNATIONAL (and Design) 845166 01/31/2006 OGP 860-327088801
07/14/2005 Singapore 
 O’GRADY PEYTON INTERNATIONAL (and Design) OGP 2004/20991 11/18/2004 South Africa

 O’GRADY PEYTON INTERNATIONAL (and Design) 80053 03/01/2007 35 OGP 66865 1/30/2005 United Arab Emirates

 Acquired Company Trademarks 

Trademark Registration Number Owner 
 iApply 2,701,286 Nursefinders, Inc. 
 M Medfmders
(and Design) 3,743,848 Nursefinders, Inc. 
 Medfmders Innovative Staffing. Exceptional Care (and Design)
3,743,859 Nursefinders, Inc. 
 Nursefinders 1,669,698 Nursefinders, Inc. 

Nursefinders (Stylized) 1,222,995 Nursefinders, Inc. 

Nursefinders The Travelers’ Choice 3,240,299 Nursefinders, Inc. 

Nursefinders The Travelers’ Choice (and Design) 3,254,076 Nursefinders, Inc. 

SingleSource 2,120,812 Nursefinders, Inc. 
 The Professional Choice 1,608,455 Nursefinders, Inc. 
 Kendall & Davis 2,012,091 Jim Kendall & Associates LLC1 
 Linde Healthcare 2,892,557 Linde Health Care Staffing, Inc. 
 On Call 2,637,565 Radiologic Enterprises, Inc. 

Resources On Call 2,248,732 Radiologic Enterprises, Inc. 

Resources@Work 2,592,512 Radiologic Enterprises, Inc. 

Club Staffing 2,788,934 Club Staffing, Inc. 
 Club Staffing (and Design) 3,393,211 Club Staffing, Inc. 
 Club Staffing Inc. (and Design) 2,817,233 Club Staffing, Inc. 
 Exceptional Healthcare. Delivered. 3,299,815 Club Staffing, Inc. 
 National Healthcare Staffing 2,826,753 National Healthcare Staffing, 
 1 Note: Jim Kendall & Associates LLC merged into Linde Health Care Staffing, Inc., who is the current owner. The Company intends to register this trademark to Linde promptly
following the transaction. 
 Doc#:USl:6534013v6 

  

 

 

  
 Inc.

 National Healthcare Staffing (and Design) 2,871,580 National Healthcare Staffing, Inc. 

Doc#:US1:6534013v6 

  

 

 

  
 Copyrights U.S
Registered Copyrights 
 AMN HEALTHCARE, INC. 

Course Date of copyright Copyright number 

	 12
	 lead EKGs: ischemia, injury, infarction July 23, 2003 TX5788852

	 12
	 lead ECGs: ischemia, injury, infarction TX5802852

 A Proactive Approach to Orienting with a Preceptor February 22, 2007 TX6521444

 Abdominal Compartment Syndrome Pending Pending 

Accidental Childhood Poisoning January 9, 2008 TX 7017695 

Acute and chronic pain: assessment and management / presented by RN.com November 17, 2003 TX5941107 

Acute coronary syndrome: a spectrum of conditions and emerging therapies February 9, 2005 TX6120499 

Acute Pancreatitis January 9, 2008 TX 7017713 

Acute respiratory distress syndrome: update for the new millennium February 9, 2005 TX6120503 

Administering Chemotherapy: One Nurse’s Story November 30, 2006 TX 6483397 

Advocating for yourself and your patients February 9, 2005 TX6120500 

Advocating for Yourself and Your Patients Part 2 Dec 15, 2005 TX-6-272-667 

Age-Specific Considerations for CNAs Dec 15,2005 TX-6-272-683 

Age-specific considerations in patient care November 5, 2004 TX6065452 

Doc#:USl:6534013v6 

  

 

 

  
 Course Date of
copyright Copyright number 
 Aggie I: the mystery of Pete’s seizures [sic] monitoring drug therapy
January 30, 2004 TX5950176 
 Aggie I: the mystery of Pete’s seizures monitoring drug therapy / by
RN.com March 8, 2004 TX6006084 
 Aggie II: The mystery of John Doe and end-of-life story / presented by the
Professional Development Center October 10, 2002 TX5 872977 
 Aggie III: Childhood Asthma June 12,
2006 TX 6439946 
 American English Training for OGP Healthcare Professionals Pending Pending 

An overview of Alzheimer’s disease February 9, 2005 TX6120498 

Arrhythmia Interpretation Pending Pending 
 Arthritis Another Name for Inflammation Pending Pending 
 Autism and Other ASDs Pending Pending 
 Basic
Arrhythmia September 9, 2007 TX 6-933-145 
 An Overview of Alzheimer’s Disease for CNAs Dec 15, 2005
TX-6-272-682 
 Basic medication administration exam for RN’s October 8, 2002 TX5671558 

Basic medication administration exam for RNs March 8,2004 TX6006085 

Basic Medication Administration Exam for RNs September 11, 2006 TX6438266 

Bioterrorism for Texas nurses November 29, 2004 TX6072284 

Bipolar disorder October 8, 2002 TX5788828 
 Bipolar disorder: both sides of an illness October 12, 2004 TX6077344 
 Blast Injuries: The Wounds of War August 22, 2008 TX6838621 
 Doc#:USl:6534013v6 

  

 

 

  
 Course Date of
copyright Copyright number 
 Blood administration and transfusion reactions July 7, 2005 TX6193939

 BMAE/LPN Exam Pending Pending 
 BMAE Screening Evaluation for RNs September 11, 2006 TX6441968 
 Breastfeeding: the basics November 29, 2004 TX6072282 
 Briefing: Latex Allergy 7/11/01 TX-5413182 

Briefing: Self Determination and Advance Directive 7/11/01 TX-5413184 

Briefing: Tuberculosis 7/11/01 TX-5413183 
 Briefing: Using Physical Restraints in Acute Care 7/11/01 TX-5413185 
 Briefing: Violence in the Workplace 7/11/01 TX-5413181 
 Calculation Review Exam January 9, 2008 TX 7017619 
 Cancer 101 September 11, 2006 TX6437030 

Carbon Monoxide Poisoning September 11, 2006 TX-6-437-031 

Cardiac Interventional/Cath Lab Technologist Assessment Exam April 30, 2007 TX-6-585-505 

Case Management & the Managed Care Health System February 22, 2007 TX6521442 

Certified Occupational Therapy Assistant (COTA) Assessment Exam April 30, 2007 TX-6-585-503 

Chemotherapy Agents: General Safety for Nurses April 26, 2006 TX-6-373-974 

Chest Tube Management January 9, 2008 TX 7017721 

Child Maltreatment: Abuse & Neglect August 22, 2008 TX-6-837-634 

Childhood Asthma September 16, 2006 TX 6-439-946 

Childhood Leukemia and Lymphoma February 22, TX-6-521-439 

Doc#:USl:6534013v6 

  

 

 

  
 Course Date of
copyright Copyright number 
 2007 
 Cholesterol: the Good and the Bad March 17, 2007 TX-6-557-680 
 Chronic Heart Failure: Getting to the Heart of the Matter July 6, 2007 TX-6-601-456 
 Chronic Obstructive Pulmonary Disease September 11, 2006 TX 6-439-949 
 Claire’s communication catastrophes, and how to avoid them November 5, 2004 TX6065450 
 CNA HIPAA Overview Dec 15,2005 TX-6-272-673 

Cocaine: under the influence September 25, 2002 TX5852781 

Colorectal Cancer: Are You At Risk Pending Pending 

Colorectal Cancer: Risk Factors July 7, 2005 TX-6-193-941 

Communication With Cognitively Impaired Clients- For CNAs Dec 15,2005 TX-6-272-647 

Conquering NCLEX-RN: content specific tips June 18, 2004 TX6000174 

Conquering NCLEX-RN: general test taking tips June 18,2004 TX6000175 

Critical Care Exam Pending Pending 
 Critical thinking: addressing staffing issues / presented by the Professional Development Center July 11,2001 TX5413180 

Critical thinking: administering medications to elderly patients / presented by the Professional Development Center
June 14, 2002 TX5615623 
 Critical thinking: administering medications to elderly patients / by
NurseZone.com March 25, 2002 TX5562393 
 Critical thinking: managing stress January 10, 2002 TX5
547626 
 Critical thinking: staffing in the 21st century February 9, TX6120507 

Doc#:USl:6534013v6 

  

 

 

  
 Course Date of
copyright Copyright number 
 2005 
 Critical Thinking: Strategies to Master Floating 1/5/01 TX 5-324-344 
 Critical Thinking: Working Effectively with LPN’s and Nursing Assistive Personnel April 30, 2007 TX-6-585-023 

Critical Thinking: Working Effectively with LPNs and UAP 1/8/01 TX 5-269-814 

Cross cultural nursing December 19, 2002 TX5695187 

CT Technologist Exam April 30, 2007 TX-6-5 85-024 

Cultural Diversity for CNAs February 22, 2007 TX-6-521-381 

Deep Vein Thrombosis September 11, 2006 TX 6-439-948 

Diabetes for CNAs February 22, 2007 TX-6-521-435 

Diabetes Knowledge: Standards of Care and Diabetes Management Feb 9, 2005 TX-6-120-508 

Diabetes Pathophysiology Hypoglycemia, DKA, & HHNKS April 30, 2007 TX-6-585-017 

Dialysis Nursing Pending Pending 
 Dialysis Tech Pending Pending 
 Domestic Violence
for CNAs Dec 15, 2005 TX-6-272-676 
 Domestic violence: elder abuse, what healthcare providers need to know
November 29, 2004 TX6072287 
 Domestic violence: spouse/intimate partner abuse July 18, 2003 TX5817961

 Don’t Drink the Water. Dec 15,2005 TX-6-272-675 

Eating disorders February 9, 2005 TX6120496 
 Eating disorders: the broken mirror September 24, 2002 TX5906951 
 Doc#:USl:6534013v6 

  

 

 

  
 Course Date of
copyright Copyright number 
 ECG interpretation: learning the basics September 19, 2002 TX5677437

 ECHO Tech January 9, 2008 TX 7017636 

Ecstasy: under the influence / presented by the Professional Development Center October 10, 2002 TX5701995

 Emergency Dept. Exam Pending Pending 
 End-of-Life Care for CNAs Dec 15, 2005 TX-6-272-666 

End-stage renal disease September 18, 2002 TX5648360 

Evidence-based practice: the future of nursing May 10, 2004 TX5977683 

Fall assessment and prevention March 8, 2004 TX6006087 

Fast Facts About Premature Ovarian Failure Feb 9, 2005 TX-6-120-506 

Fire Safety in the Surgical Setting: “Just Be Smart and Do Your Part” September 11, 2006 TX 6-437-032

 Florida laws and rules: for new Florida nurses July 23, 2003 TX5802853 

Focus on advance directives November 5, 2004 TX6061663 

Focused physical examination for the acute care setting July 7, 2005 TX6193938 

Forensic Evidence Collection for Nurses Pending Pending 

Gestational Diabetes Dec 15, 2005 TX-7112648 
 Gestational Diabetes: Diagnosis and Care Dec 15,2005 TX-6-272-669 
 Heparin Induced Thrombocytopenia March 19, 2007 TX-6-557-682 
 Heroin: under the influence September 17, TX5705659 
 Doc#:USl:6534013v6 

  

 

 

  
 Course Date of
copyright Copyright number 
 2002 
 High-alert medications: questions, answers, and safety tips February 9, 2005 TX6120504 
 HIV Disease: AIDS to Zidovuidine for Florida RNs 1/8/01 TX 5-327-292 
 HIV Disease: An Epidemic In Perspective 1/4/01 TX 5-324-326 
 HIV Disease: New Research, New Treatment, New Hope 1/8/01 TX 5-327-670 
 HIV Disease: Women, Children & Injection Drug Users 1/8/01 TX 5-269-815 
 HIV disease: Women, children and Injection drug users November 12, 2002 TX5788852 
 HIV for CNAs Dec 15, 2005 TX-6-272-670 
 HIV
Infection and AIDS: An Overview October 20, 2006 TX-6-453-415 
 HIV, an epidemic of many proportions
June 18,2002 TX5588325 
 HIV: case studies / presented by RN.com November 17, 2003 TX5877717

 How to Demonstrate Your Clinical Competence with PBDS Pending Pending 

Human Papillomavirus July 6, 2007 TX-6-601-455 

Increased Intracranial Pressure and Monitoring March 19, 2007 TX-6-557-685 

Infection Control for CNAs Dec 15,2005 TX-6-272-671 

Infection control for healthcare professionals March 8, 2004 TX6006088 

Inflammatory Bowel Disease February 22, 2007 TX-6-521-445 

Influenza October 20, 2006 TX 6-448-546 
 Influenza, Pandemics and the Avian Flu Dec 15, 2005 TX-6-272-672 
 Interstitial cystitis: getting the attention it deserves / presented by the September 13, TX5852782 
 Doc#:USl:6534013v6 

  

 

 

  
 Course Date of
copyright Copyright number 
 Professional Development Center 2002 

Intraventricular Hemorrhage in the Premature Infant March 19, 2007 TX-6-557-683 

Introducing Aggie : The Mystery of Pete’s Seizure Oct 10, 2002 TX-5-705-653 

Introducing Aggie: the mystery of Pete’s seizure January 11, 2002 TX5521133 

Introduction to critical thinking September 25, 2002 TX5677436 

Introduction to Cultural Awareness and Competency Pending Pending 

Introduction to Trauma Systems: History and Timeline Pending Pending 

Interpreting ABGs: The Basics Pending Pending 
 Iowa child abuse November 18, 2003 TX5898584 

It’s on the Street: Club Drugs April 30, 2007 TX-6585016 

It’s on the Street: Inhalants April 30, 2007 TX-6-5 85-500 

It’s on the Street: Cocaine August 22, 2008 TX-6-83 7-624 

IV essentials July 7, 2005 TX6193940 
 IV Therapy Exam April 7, 2009 TX-6-933-136 

Kentucky Domestic Violence July 7, 2005 TX-6-272-551 

Kentucky HIV Infection and AIDS: An Overview August 22, 2008 TX-6-837-628 

Lab Value Interpretation for Nurses: Chemistries and Renal Studies Nov 22, 2005 TX-6-270-034 

Labor & Delivery Exam January 9, 2008 TX 70170674 

Latex Allergies for CNAs Dec 15, 2005 TX-6-290-524 

Latex allergy: more than skin deep October 8, 2002 TX5671559 

Doc#:USl:6534013v6 

  

 

 

  
 Course Date of
copyright Copyright number 
 Latex allergy: more than skin dep / presented by the Professional Development
Center January 10, 2002 TX5 547624 
 Learning to Manage Assaultive Behavior March 19, 2007
TX-6-557-681 
 Lethal Arrhythmias: Advanced Rhythm Interpretation March 21, 2006 TX-6-356-028 

LPN/LVN Brief with rn.com logo Pending 
 LPN/LVN Subacute Nursing Exam April 3, 2009 TX 6-933-183 
 Lyme Disease March 19, 2007 TX-6-557-684 

Magnet Facilities: What’s the Difference? July 6, 2007 TX-6-601-457 

Malignant hyperthermia: a crisis for your patient November 29, 2004 TX6072285 

Mammography Technologist Exam April 30, 2007 TX 6-585-501 

Managing Hypertension April 30, 2007 TX-6-585-020 

Marijuana: under the influence / presented by the Professional Development Center October 8, 2002 TX5788829

 Mechanical Ventilation in Adults July 6, 2007 TX-6-5 99-548 

Med Tech/ Med Laboratory Tech Exam January 9, 2008 TX 7017651 

Medical Error Reduction April 30, 2007 TX-6-585-018 

Medical Record Documentation and Legal Aspects Appropriate to Nursing Assistants December 15, 2005 TX-6-287-872

 Medical Surgical Exam April 3, 2009 TX 6-933-165 

Medication safety: assuring safe outcomes June 14, 2002 TX5697878 

Medication Safety: Assuring Safe Outcomes September 11, 2006 TX 6-439-945 

Medication safety: assuring safe outcomes February 19, 2003 TX5746727 

Doc#:USl:6534013v6 

  

 

 

  
 Course Date of
copyright Copyright number 
 Methamphetamine Abuse February 22, 2007 TX-6-520-398 

Migraine Head Pain April 30, 2007 TX-6-5 85-499 

Mother-Baby/Women Services Competency Test V.I01 Nov 8, 2005 TX-6-287-083 

MRI Technologist Exam April 30, 2007 TX 6585022 

MRSA: It’s Staph! April 30, 2007 TX-6-5 85-498 

Multiple Choice Test Writing Tips January 9, 2008 TX 7017669 

Narcolepsy & sleep apnea: I’ve been sleeping, but I can’t stay up! September 25, 2002 TX5677349

 Narcolepsy, sleep apnea & restless legs syndrome August 3, 2004 TX6030577 

Neonatal Intensive Care Nursing Competency Test V.lOl August 16, 2005 TX-6-230-569 

New York State child abuse and neglect July 18,2003 TX5810328 

New York State infection control for healthcare professionals July 18,2003 TX5 807793 

Nuclear Medicine Technologist Exam April 30, 2007 TX 6-585-502 

Nurse’s Role in Moderate Sedation: Are you Safe? March 21, 2006 TX-6-356-029 

Nurse’s Guide to Chemotherapy and Other Anti-Cancer Drugs October 20, 2006 TX 6-448-545 

Nursing health assessment July 28, 2004 TX6009436 

Obsessive-compulsive disorder: providing care and support March 8, 2004 TX6006086 

Occupational Therapist Exam April 30, 2007 TX 6-585-507 

OGPIRN Screening Pending Pending 
 Doc#:USl:6534013v6 

  

 

 

  
 Course Date of
copyright Copyright number 
 O’Grady Peyton International: International Nurse Orientation Binder
February 2, 2007 TX6517522 
 Ohio laws and rules July 7, 2005 TX6194756 

Oncology Exam April 3, 2009 TX 6-933-156 
 Operating Room Nurse Competency Exam V.201 April 3, 2009 TX 6-933-131 
 Ovarian Cancer February 22, 2007 TX-6-521-438 

Pain Control and Symptom Management Pending Pending 

Parkinson’s Disease March 19, 2007 TX-6-557-679 

Patient Safety: Honing in on Heparin February 22, 2007 TX-6-521-440 

Pediatric psychopharmacology November 29, 2004 TX6072276 

Pediatrics ED Exam Pending Pending 
 Pediatrics exam v.101 March 15, 2004 TX5950348 

Pediatrics Intensive Care Nursing Exam April 3, 2009 TX 6-933-173 

Performance Based Development System (PBDS) Testing Preparation September 11, 2006 TX 6-439-947 

Performance improvement: a change for the better July 18, 2003 TX5806951 

Personal Safety for CNAs Dec 15,2005 TX-6-272-668 
 Perspectives on Breast Cancer: Genetic Testing and Prophylactic Mastectomy January 9, 2008 TX 7017601 
 Physical Therapist Assistant Exam September 11, 2006 TX 6-438-265 
 Doc#:USl:6534013v6 

  

 

 

  
 Course Date of
copyright Copyright number 
 Physical Therapist Exam September 11, 2006 TX 6-441-969 

Physical Therapist Screening Evaluation September 11, 2006 TX 6-441-966 

Physical Therapy Assistant Screening Evaluation September 11, 2006 TX 6-441-967 

Pneumonia: Emerging Trends in Diagnosis & Care September 11, 2006 TX 6-439-944 

Post Anesthesia Care Nursing Exam Pending Pending 
 Postpartum Depression February 22, 2007 TX-6-521-437 
 Post Partum Nursery Pending Pending 

Polysomnographer (Sleep Tech) Pending Pending 
 Preparation for pediatric assignments March 8, 2004 TX6006083 
 Procedural Sedation: Are You Safe? January 9, 2008 TX 7019058 
 Professional communication and documentation for travelers: safe, effective, and legal / presented by RN.com November 17, 2003 TX5941106 

Professional Nursing Practice: Nurse Practice Acts, Professional Standards, & Code Ethics April 30, 2007
TX-6-585-026 
 Progressive Care Unit Exam April 3, 2009 TX 6-933-151 

Psychiatric Exam Goals Competency Test V. 101 Nov 7, 2005 TX-6-272-550 

Psychopharmacology: a guide to medications December 12, 2002 TX5788070 

Pulmonary Artery Catheter & Hemodynamic Values April 30, 2007 TX-6-585-025 

Quality Improvement February 28, 2003 TX-5-696-350 

Radiation Therapist Pending 
 Radiology Technologist Exam April 30, 2007 TX-6-585-504 
 Doc#:USl:6534013v6 

  

 

 

  
 Course Date of
copyright Copyright number 
 Recognizing and Addressing Domestic Violence in the Healthcare Setting:
Spouse/Partner Abuse 1/4/01 TX 5-324-325 
 Recognizing and Addressing Domestic Violence in the Healthcare
Setting: Child Abuse & Neglect 1/5/01 TX 5-323-001 
 Recognizing and Addressing Domestic Violence in
the Healthcare Setting: Elder Abuse December 12, 2002 TX5724976 
 Reducing medical errors: you can make a
difference! June 18, 2002 TX5619154 
 Reducing Medication Errors for CNAs December 15, 2005
TX-6-287-871 
 Rehab for CNAs February 22, 2007 TX-6-521-436 

Resident Rights for Florida CNAs Dec 15, 2005 TX-6-272-680 

Respiratory Syncytial Virus October 20, 2006 TX 6-448-548 

Respiratory Therapist Pulmonary Function Technologist Exam Pending Pending 

Restraints and Falls for CNAs Dec 15, 2005 TX-6-272-681 

Restraints in the acute care setting March 8, 2004 TX6006090 

Restraints in the acute care setting January 26, 2004 TX5944636 

RN cath lab exam October 12, 2004 TX6077340 
 RN.com’s assessment series: focused cardiovascular assessment November 29, 2004 TX6072278 
 RN.com’s assessment series: focused neurological anatomy and physiology February 9, 2005 TX6120502 
 RN.com’s assessment series: focused pulmonary assessment August 3, 2004 TX6030576 
 Doc#:USl:6534013v6 

  

 

 

  
 Course Date of
copyright Copyright number 
 RN.com’s assessment series: focused renal and urinary assessment
November 29, 2004 TX6072277 
 RN.com’s assessment series: hematological anatomy, physiology, and
assessment November 29, 2004 TX6072283 
 RN.com’s assessment series: renal and urinary anatomy and
physiology November 29, 2004 TX6072281 
 RN.com’s assessment series: skin anatomy, physiology, and
assessment November 5, 2004 TX6061662 
 RN.com’s Assessment Series: Cardiovascular anatomy &
physiology October 12, 2004 TX6077343 
 RN.com’s Assessment series: Endocrine anatomy and physiology
October 12, 2004 TX6077341 
 RN.com’s Assessment series: Focused endocrine assessment November 5,
2004 TX6065453 
 RN.com’s Assessment series: Focused gastrointestinal assessment October 12, 2004
TX6077339 
 RN.com’s Assessment series: Focused gastrointestinal assessment November 5, 2004 TX6065454

 RN.com’s Assessment series: Focused neurological assessment November 5, 2004 TX6065449 

RN.com’s Assessment series: Gastrointestinal anatomy and physiology August 23, 2004 TX-6-016-643 

Rocky Mountain Spotted fever August 22, 2008 TX-6-837-618 

Safety and Standard Manual: a national perspective for travelers 7/13/99 TX 5-026-638 

Shaken Baby Syndrome August 22, 2008 TX-6-837-625 

Sickle Cell Anemia October 20, 2006 TX 6-448-547 

Sonographer Exam April 30, 2007 TX 6-585-506 
 Doc#:USl:6534013v6 

  

 

 

  
 Course Date of
copyright Copyright number 
 Sonographer Exam April 2007 TX-6-585-506 

Speech Language Pathologist January 9, 2008 TX 7017659 

Spinal cord injuries: minimizing the damage December 12, 2002 TX5 720974 

Sports Injuries in Youth February 22, 2007 TX -6-522- 

375 
 Stem Cell Research: What It Means and Where It is Going Nov 22, 2005 TX-6-270-035 
 Stroke Care for CNAs Dec 15, 2005 TX-6-272-677 

Stroke rehabilitation November 29, 2004 TX6072279 

Substance abuse & pregnancy: a growing health concern September 24, 2002 TX5660763 

Sudden infant death syndrome November 29, 2004 TX6072286 

Suicide: assessment and prevention January 26, 2004 TX5950760 

Surgical Tech Exam Pending Pending 
 Surviving the Heat August 22, 2008 TX-6-837-408 
 Telemetry Pending Pending 
 Telemetry
Interpretation Pending Pending 
 Testicular Cancer February 22, 2007 TX-6-521-443 

The Agony of Eating Disorders January 9, 2008 TX 7017704 

The Cruise Ship Virus: Norovirus July 6, 2007 TX-6-601-171 

The Health of Minority Women August 22, 2008 TX-6-837-406 

The healthy pregnancy February 9, TX6120505 
 Doc#:USl:6534013v6 

  

 

 

  
 Course Date of
copyright Copyright number 
 2005 
 The Nurse’s Role in Hyperemesis Gravidarum February 22, 2007 TX-6-521-441 
 The patient safety revolution: implementating JCAH safety goals in the operating room August 23, 2004 TX6016642 

The Postpartum Period and the Healthy Newborn Dec 15, 2005 TX-6-272-679 

The Prevention and Detection of Elder Abuse 5/12/00 TXu-951-660 

The truth about: urinary incontinence / presented by the Professional Development Center October 8, 2002 TX5788830

 The World of Skin Care: Wound and Ulcer Prevention & Management April 30, 2007 TX-6-585-021

 Thrombolytic therapy for acute ischemic stroke: t-PA/Alteplase February 9, 2005 TX6120497 

Thyroid Disorders April 30, 2007 TX-6-585-019 

Tips for Creating An Online CE Course Pending Pending 

To sleep or not to sleep?: a primer on insomnia September 23, 2002 TX5643761 

Travel nursing: self-protection through communication & documentation June 14, 2002 TX5588326 

Traveler application August 29, 2002 TX5604361 

Traveler application August 29, 2002 TX5586835 

Tuberculosis Information for CNAs Dec 15,2005 TX-6-272-678 

Understanding the adult with Down syndrome March 8, 2004 TX6006089 

Update on stroke management and care October 12, 2004 TX6077342 

Doc#:USl:6534013v6 

  

 

 

  
 Course Date of
copyright Copyright number 
 Update on tracheostomy care February 9, 2005 TX6120501 

Vaccines: Understanding Immunity and the Principles behind Vaccination August 22, 2008 TX-6-837-630 

Vascular Interventional Radiology Tech Exam April 3 ,2009 TX 6-933-161 

Viral Hepatitis: From A to G 1/5/01 TX 5-320-183 
 West Nile virus: just the facts November 29, 2004 TX6072280 
 What’s up at the joint? November 5, 2004 TX6065451 
 Will the Last Physician in America Please Turn Out the Lights? May 15, 2006 TX6377655 
 WOCN Exam Pending Pending 
 Work Smarter Not
Harder: Critical Thinking Skills for Healthcare Professionals Pending Pending 
 Workplace safety and patient
care standards January 26, 2004 TX5943059 
 Administering Medications to Elderly Patients Part 1:
Physiology of Aging Pending Pending 
 Administering Medications to Elderly Patients Part 2: Administering and
Monitoring Medication Therapy Pending Pending 
 Administering Medications to Elderly Patients Part 3: Discharge
Planning Pending Pending 
 An Introduction to Intraventricular Hemorrhage in the Premature Infant Pending
Pending 
 An Overview of HIPAA for Healthcare Professionals Pending Pending 

Blood Pressure Management for CNA’s Pending Pending 

Breast Cancer Today: A Whole New World of Options Pending Pending 

Breastfeeding Challenges in The Early Postpartum Period Pending Pending 

Diabetes Overview Pending Pending 
 Glucose Monitoring: A Case for Improved Outcomes Pending Pending 
 H1N1: The 21st Century Pandemic Pending Pending 

High-Alert Medications: Safe Practices Pending Pending 

Doc#:USl:6534013v6 

  

 

 

  
 Course Date of
copyright Copyright number 
 Home Health Exam Pending Pending 

Infection Prevention for Healthcare Professionals Pending Pending 

Interstitial Cystitis September 13, 2002 TX-5-852-782 

Metabolic Syndrome: An Insidious Disease Pending Pending 

Narcolepsy & Sleep Apnea September 25, 2002 TX-5-677-349 

Overview of Bioterrorism Pending Pending 
 Placental Anomolies Pending Pending 
 Professional
Communication: Speak up, Speak well Pending Pending 
 Restraints: The Last Resort Pending Pending 

Staff Infections: Spothlight on MRS A Pending Pending 

Substance Abuse & Pregnancy September 24, 2002 TX-5-660-763 

Telemetry Certificate Program Pending Pending 
 The Human Genome Project Pending Pending 

Understanding Heart Failure Pending Pending 
 Work Smarter not Harder Pending Pending 
 PHARMACY
CHOICE 
 Course Date of copyright Copyright number 

PharmacyChoice.com November 3, 2000 TXu-1-043-603 

Registered Copyrights for Websites Owned by AMN Healthcare, Inc. 

Website Copyright Date Copyright Registration 
 www.preferredhealthcare.com 08/08/02 TX-5788141 

www.americanmobile.com 08/08/02 TX-5788143 
 www.medicalexpress.com 08/08/02 TX-5788142 

www.nursesrx.com 08/08/02 TX-5788144 
 www.amnhealthcare.com 04/09/01 TX-5788140 

www.ogradypeyton.com 08/28/02 TX-5595918 
 Doc#:USl:6534013v6 

  

 

 

  
 Schedule
6.19(a) 
 REAL PROPERTIES 
 (all properties leased as of 8/20/2010 unless otherwise noted) 
 12400 High Bluff Drive, Suite 100 San Diego, CA 92130 
 100 W Cypress Creek Road, Suite 1045 Fort Lauderdale, FL, 33309 (subleasing space through 2/29/12) 
 310 Interlocken Parkway, Suite 100 Broomfield, CO 80021 
 Storage Spaces CA184, CA189, BB21, BB192 & BB188 7044 Flanders Drive San Diego, CA 92121 
 Building 12—Huntersville Business Park 13620 West Reese Blvd., Suite 200 Huntersville, NC 28078 
 Unit 1,4 Mall Court Savannah, GA 31406 
 Ground
Floor, Building 2, Friars Gate 
 1011 Stratford Road, Solihull 

West Midlands, B90 4BN, UK (Birmingham) 
 Ground Floor, Building 1, Friars Gate 
 1011
Stratford Road, Solihull 
 West Midlands, B90 4BN, UK (Birmingham) 

Storage Space, Centre Court, Room G10 
 1301 Stratford Road 
 Hall Green, Birmingham B28
9HH 
 Storage Space, Unit 3033stpnr 615 Lorong, #4 Toa Payoh Singapore 0319516 

Woodlands Business Park Tower III 4021 South 700 East, Suite 300 Salt Lake City, UT 84107 

Doc#:USl:6534013v6 

  

 

 

  
 5901-A
Peachtree Dunwoody Road, N.E. Suite 300 
 Atlanta, GA 30328 

(Exercised early termination effective 12/31/09, but likely to remain in space until mid 

January. Moving into new space in mid January) 
 3500 Barranca Parkway, Suite 240 Irvine, CA 92026 

Regus Irvine Spectrum 
 8001 Irvine Center Drive, 4th Floor 
 Irvine, CA
92618 
 5001 Statesman Drive Irving, TX 75063 

3232 Royal Lane Irving, TX 75063 
 2601 Blake Street, #400 Denver, CO 80205 
 Leased
Real Property of Acquired Company 
 Abilene, 4400 Buffalo Gap Road Ste 2300, Abilene, TX 

Albany, 6 Executive Park Drive, Entrance D, Albany, NY 

Albuquerque Home Care, 4411 McLeod Suite A-l, Albuquerque, NM 

Albuquerque Staffing, 4411 McLeod Suite A-2, Albuquerque, NM 

Allentown Home Care, 1541 Alta Drive Suite 306, Whitehall, PA 

Amarillo, 3600 S. Coulter, Suite A Amarillo, TX 
 Atlanta, 2221 Peachtree Road, N.E. Suite N, Atlanta, GA 
 Baltimore, 29 W. Susquehanna Ave Ste 110, Towson, MD 
 Bartlesville, 512 C&D SE Washington Blvd, Bartlesville, OK 
 Baton Rouge, 2924 Brakley Drive Suite B-l, Baton Rouge, LA 
 Big Island Home Care, 308 Kamehameha Avenue Suite 200, Hilo, HI 
 Binghamton, 4104 Old Vestal Road, Vestal, NY 

Birmingham, 1025 Montgomery Highway Suite 213, Birmingham, AL 

Buffalo, 455 Delaware Avenue, Buffalo, NY 
 Chattanooga, 5751 Uptain Road Suite 518, Chattanooga, TN 
 Cherry Hill Home Care, 295 Marlton Pike, Route 70, Cherry Hill, NJ 
 Chevy Chase, 8701 Georgia Ave, Silver Springs, MD 

Cincinnati, 9452 & 9462A Town Square Ave, Cincinnati, OH 

Cleveland, 27600 Chagrin Blvd. Suite 400, Woodmere, OH 

Club Staffing, 5901 Broken Sound Parkway Suite 450 & 500, Boca Raton, FL 

Doc#:USl:6534013v6 

  

 

 

  
 Colorado
Springs Home Care, 545 East Pikes Peak Avenue #105, Colorado Springs, CO 
 Colorado Springs Staffing, 555 East
Pikes Peak Avenue #114, Colorado Springs, CO 
 Columbus Staffing, 6525 Busch Blvd. Suite 104, Columbus, OH

 Columbus Staffing, 6525 Busch Blvd. Suite 102, Columbus, OH 

COO—Staffing (office in Chicago), 7420 Central Ave Suite 2042, River Forest, IL 

Dallas Staffing, 1341 W. Mockingbird Lane Suite 245W, Dallas, TX 

Denver ST, 201 S. Steele St. Suite 1-D, Denver, CO 

Des Moines, 7100 University, Des Moines, LA 
 El Paso Staffing, 1605 Beach Street Suite C, El Paso, TX 
 Finger Lakes Staffing, 2525 Rochester Drive, Rt. 332 Suite 103, Canadaguia, NY 
 Fredericksburg, 2501 Fall Hill Avenue Suite C, Fredericksburg, VA 
 Fresno, 1300 E. Shaw Avenue Suite 126, Fresno, CA 

Fort Worth Staffing, 3901 West Vickery Blvd. Suites 3,5 & 7, Fort Worth, TX 

Hartford, 905 Wethersfield Ave, Hartford, CT 
 Hawaii Home Care, 615 Piikoi Street #600, Honolulu, HI 
 Hawaii Staffing, 3375 Koapaka Street Ste B235, Honolulu, HI 
 Heath, 1125 Unit C Hebron Road, Heath, OH 
 Houston
Home Care*, 3315 Burke Road Ste 105, Pasadena, TX 
 Houston Kingwood Home Care, 1521 Green Oak Place Suite 130,
Kingwood, TX 
 Houston Staffing, 1800 St. James Ste 107, Houston, TX 

Kailua-Kona Patient Care Office, 75-5737 Kuakini Highway Ste 204, Kailua Kona, HI 

Kansas City, 4350 West 107th Street, Overland Park, KS 

Kauai Home Care, 3170 Jerves Street unit B Lihue, Kauai, HI 

Lawton, 1320 NW Homestead Dr. Suite C, Lawton, OK 

Linde Health Care Staffing, 3668 S. Geyer Road Ste 100—Sunset Hills, St Louis, MO 

Los Angeles Staffing, 6167 Bristol Parkway Ste 450 & 460, Culver City, CA 

Lubbock, 3415 23rd Street, Lubbock, TX 
 Mason City, 1316-4th Street, S.W. Suite 106, Mason City, IA 
 Maui Home Care, 2200 Main Street Suite 650, Wailuku, HI 
 Memphis, 6750 Poplar Ave. Suite 206, Memphis, TN 

Minneapolis, 9001 E. Bloomington Frwy. Suite 117, Bloomington MN 

National Healthcare Staffing*, 8215 Forest Point Blvd, Charlotte, NC 

National Healthcare Staffing, 9140 Arrowpoint Blvd, Charlotte, NC 

National Healthcare Staffing*, 5775 Blue Lagoon Drive Ste 300, Miami, FL 

Medfinders Service Center, 524 E. Lamar Blvd. Ste 300, Arlington, TX 

North Texas Home Care, 7524 Mosier View Ct, Fort Worth, TX 

Northern Virginia, 11166 Main Street, Fairfax, VA 
 Oak Lawn Staffing, 9632 S. Pulaski, Oaklawn, IL 

Oakland, 411 30th Street Suite 212, Oakland, CA 
 Oklahoma City Staffing, 2601 N.W. Expressway Suite 101E, Oklahoma City, OK 
 Orange County, 2140 W. Chapman Avenue Suite 110, Orange, CA 
 Palm Desert 74-350, Alessandro Drive Suite B-l, Palm Desert ,CA 
 Phoenix, 4745 and 4747 North 7th St, Phoenix, AZ 

Portland, 5200 SW Macadam Ave. Suite 270, Portland, OR 

Pueblo, 2705 N. Elizabeth St, Pueblo, CO 
 Puna, 2937 Pahoa Village Road, Pahoa, HI 

Doc#:USl:6534013v6 

  

 

 

  
 Raleigh, 6500
Falls Neuse Road Suite 110, Raleigh, NC 
 Resources on Call, 2810 16th NE, Hickory, NC 

Rochester Staffing, 1900 S. Clinton Avenue, Rochester, NY 

Sacramento, 2233 Watt Avenue Suite 10, Sacramento, CA 

San Antonio Staffing, 7330 Louis Pasteur Dr., San Antonio, TX 

San Bernadino Home Care, 1832—B Commerce Center Circle Suite B, San Bernadino, 

CA 
 San Diego Staffing, 3838 Camino Del Rio North Suite 104, San Diego, CA 
 San Jose, 4880 Stevens Creek Blvd Suite 103, San Jose, CA 
 Scranton, 542 Spruce Street, Scranton, PA 

Springfield MA Staffing, 181 Park Ave W., Springfield, MA 

Springfield MO Staffing, 236 E. Primrose, Springfield, MO 

St. Louis Staffing, 950 Francis Place #108, St Louis, MO 

Syracuse, 7421 Oswego Road, Liverpool, NY 
 Tarzana Staffing, 18425 Burbank Blvd Suite 518, Tarzana, CA 
 Tucson Home Care, 5700 East Pima Suite C, Tucson, AZ 
 Tucson Home Care (North), 2001 W Orange Grove Rd. Suite 208, Tucson, AZ 
 Tucson Staffing, 5101 East Farness Drive Suite A, Tucson, AZ 
 Tulsa Home Care, 5063 South Yale, Tulsa, OK 
 Tulsa
Staffing, 5114 S. 95th E. Avenue, Tulsa, OK 
 Tyler, 210 S. Broadway #230, Tyler, TX 

Verona Home Care, 25 Pompton Ave Suite 201,202, 203 and 204b, Verona, NJ 

Wichita Staffing, 303 North West St. Suite 120, Wichita, KS 

Winston Salem Staffing, 1411 Plaza West Road Suite A, Winston-Salem, NC 

Worcester Staffing, 10 Austin Street, Worcester, MA 

Verona HC (Satellite), 301 60th Street, West New York, NJ 

Parking Rental 
 Maui Parking, parking (5 spaces), Wailuku, HI 

Oakland Parking ,400-29th Street, Oakland, CA 
 Storage Rental 
 Fairfield (Hartford) Storage,
Fairfield, CT 
 National Healthcare Staffing, Unit 1102, Miami, FL 

Nursefinders Service Center, Space Station Unit B4, Fort Worth, TX 

Nursefmders Service Center, Unit #1206, Arlington, TX 

Sacramento, #00129297, #00129300, Sacramento, CA 
 Tucson Home Care, Unit Gl 1 & D32, Tucson, AZ 
  

	 *
	 Subleased to Others 

Houston Home Care, 3315 Burke Road Ste 105, Pasadena, TX National Healthcare Staffing, 8215 Forest Point Blvd, Charlotte,
NC National Healthcare Staffing, 5775 Blue Lagoon Drive Ste 300, Miami, FL 
 Doc#:USl:6534013v6 

  

 

 

  
 Schedule
6.19(b) COLLATERAL LOCATIONS 
 Schedule 6.19(a) is incorporated herein by reference. 

Doc#:USl:6534013v6 

  

 

 

  

Schedule 6.19(c) 
 CHIEF EXECUTIVE OFFICES/ PRINCIPAL PLACES OF BUSINESS 
 1. The following address is the chief executive office/principal place of business for all the entities listed below: 

12400 High Bluff Drive San Diego, CA 92130 
 AMN Entities: 
 AMN Healthcare, Inc., a Nevada
corporation 
 AMN Healthcare Services, Inc., a Delaware corporation 

International Healthcare Recruiters, Inc., a Delaware corporation 

AMN Services, Inc., a North Carolina corporation 
 AMN Staffing Services, Inc. a Delaware corporation 

O’Grady Peyton International (USA), Inc. 
 LIFEWORK, INC., a Colorado Corporation 
 RX PRO
HEALTH, INC., a Colorado Corporation 
 PHARMACY CHOICE, INC., a Colorado Corporation 

 

	 2.
	 The following address is the chief executive office/principal place of
business for all the entities listed below: 

 5001 Statesman Drive Irving, TX 75063

 The MHA Group, Inc. Entities: 
 The MHA Group, Inc., a Texas corporation 
 Merritt,
Hawkins & Associates, a California corporation 
 AMN Healthcare Allied, Inc., a Texas corporation

 RN Demand, Inc., a Texas corporation 
 Staff Care, Inc., a Delaware corporation 
 MHA
Allied Consulting, Inc., a Texas corporation 
 AMN Allied Services, LLC, a Delaware limited liability company

  

	 3.
	 The following address is the chief executive office/principal place of
business for all the entities listed below: 

 524 East Lamar Blvd, Suite 300 Arlington, Texas
76011 
 Nightingale Acquisition, LLC NF Holdings Corporation 

Doc#:USl:6534013v6 

  

 

 

  
 Nursefinders,
Inc. 
 B.C.P., Inc. 
 NF Services, Inc. 
 Linde Health Care Staffing,
Inc. 
 Club Staffing, Inc. 
 National Healthcare Staffing, LLC 
 Radiologic
Enterprises, Inc. 
 Doc#:USl:6534013v6 

  

 

 

  
 Schedule 6.23

 LABOR MATTERS 
 None 

  

 

 

  
 Schedule 7.6
INSURANCE 
 Please see attached. [Certificates of Insurance to be attached.] 

Doc#:USl:6534013v6 

  

 

 

  
 Schedule 8.1
INDEBTEDNESS 
 None. 

  

 

 

  

Schedule 8.9 TRANSACTIONS WITH AFFILIATES 

 

	 1.
	 Management Termination and Release Agreement dated as of July [ ], 2010 by

 and among the AMN Healthcare Services, Inc., Nightingale Acquisition, LLC (as successor to
NF Investors, Inc.), GSUIG, LLC, Pharos Capital Partners II, L.P., Pharos Capital Partners II-A, L.P., and HWP II, L.P. An aggregate of $916,667 of accrued management fees (plus an additional $83,333 per month (pro-rated for any portion of a month)
to the extent the Closing Date occurs after August 31, 2010) will be paid pursuant to the Management Services Agreement at Closing. In addition a transaction services fee in the aggregate amount of $2.5 million will be paid to certain parties
to the Management Services Agreement at Closing. 
  

	 	 2.
	 Lease Agreement between Radiologic Enterprises, Inc. and I.Space, LLC dated
September 1, 2001. Employee Jeff Decker is a partner in the partnership that owns the building leased by Radiologic Enterprises, Inc. 

 Doc#:USl:6534013v6 

  

 

 

  

Schedule 11.1 
 NOTICES Credit Parties: 
 AMN Healthcare, Inc.

 12400 High Bluff Drive 
 Suite 100 
 San Diego, California 92130 

Attn: Bary Bailey 
 Telephone: 858.720.6257 
 With a copy to Denise L.
Jackson, General Counsel 
 Administrative Agent: 

For notices regarding borrowings, payments, conversions, fees, interest, and other administrative matters: 

Bank of America, N. A. 101 North Tryon Street Location Code: NC1-001-15-04 Charlotte, NC 28255 Attention: Wayne A. Richard
Telephone: 980.388.6484 Telecopy: 704.208.3075 
 For all other notices (including with respect to Defaults and
Events of Default, amendments, waivers and modifications of the Credit Documents, assignments): 
 Bank of
America, N. A. Agency Management 1455 Market Street, 5th Floor Location Code: CA5-701-05-19 San Francisco, California 94103 Attention: Robert J. Rittelmeyer Telephone: (415) 436-2616 Telecopy: (415)503-5099 

Bank of America, N. A. Location Code: NCI-002-28-17 100 North Tryon Charlotte, North Carolina 28255 Attention: Alysa A.
Trakas Telephone: (980) 387-2640 Telecopy: (704) 409-0936 
 Doc#:USl:6534013v6 

  

 

 

  
 Swing Line
Lender: 
 Bank of America, N. A. 101 North Tryon Street Location Code: NCI-001-15-04 Charlotte, NC 28255
Attention: Wayne A. Richard Telephone: 980.388.6484 Telecopy: 704.208.3075 
 Issuing Lender: 

Bank of America, N. A. 1000 W. Temple Street Mail Code: CA9-705-07-05 Los Angeles, CA 90012-1514 Attention: Stella Rosales
Telephone: 213.481.7828 Telecopy: 213.457.8841 
 Lenders: 

Contact information set forth on each Lender’s administrative details form on file with the Administrative Agent.

  
 EXHIBIT 7.1(C)

 FORM OF OFFICER’S COMPLIANCE CERTIFICATE 
 [See Attached] 

  

 

 

  
 OFFICER’S
CERTIFICATE TO: Bank of America, N.A., as Administrative Agent 
 RE: First Amendment dated as of
September 1, 2010 (the “Amendment”) to that 
 certain Credit Agreement dated as of
December 23, 2009 (as amended, modified, supplemented and extended from time to time, the “Credit Agreement”), by and among AMN Healthcare, Inc. (the “Borrower”), AMN Healthcare Services, Inc. (the “Parent”), each
of the Subsidiaries of the Parent party thereto (together with the Parent, the “Guarantors”), the Lenders party thereto, and Bank of America, N.A., as Administrative Agent. Capitalized terms used but not otherwise defined herein have the
meanings provided in the Credit Agreement. 
 DATE : September 1, 2010 

Pursuant to the terms of Subparts 4.3, 4.8 and 4.10 of the Amendment, the undersigned Executive Officer of the Borrower
hereby certifies, on behalf of the Borrower and not in any individual capacity that, as of the date hereof, the statements below are accurate and complete in all respects: 

 
 (a) All
governmental and third party consents and approvals (including, without limitation, the Board of Directors of the Borrower and Parent), if any, with respect to the Amendment and the transactions contemplated thereby have been obtained. 

(b) There has not occurred a Material Adverse Effect with respect to the Parent and its Subsidiaries taken as a whole
since the date the Parent’s Form 10-K for the fiscal year ended December 31, 2009 was filed with the SEC. 
 (c) There has not occurred a Material Adverse Effect (as defined in the Acquisition Agreement), with respect to the Acquired Company and its Subsidiaries taken as a whole since
January 3, 2010. 
 (d) No action, suit, investigation or proceeding is pending or, to the knowledge of the
Borrower, threatened in any court or before any arbitrator or governmental instrumentality that purports to affect any Credit Party or any transaction contemplated by the Credit Documents, if such action, suit, investigation or proceeding could
reasonably be expected to have a Material Adverse Effect. 
 (e) (i) Attached hereto as Exhibit A is a true and
correct copy of the Acquisition Agreement, with all amendments, modifications, supplements and attachments, (ii) there have been no material modifications to the Acquisition Agreement without the consent of the Administrative Agent, to the
extent such modifications could reasonably be expected to materially adversely effect the Lenders and (iii) the Medfinders Acquisition has been, or contemporaneously with the making of the initial Loans under the Credit Agreement, will be
consummated in accordance with the terms of the 
 CHARl\1177959v3 

  

 

 

  
 Acquisition
Agreement and in compliance with material applicable law and regulatory approvals, and the Parent and/or the Borrower have used not less than $33.1 million of cash-on-hand (immediately prior to the Transaction) to fund the cash portion of the
Medfinders Acquisition consideration. 

	 	 (f)
	 Immediately after giving effect to the Transaction: (i) No Default or
Event of Default exists; 

 (ii) All representations and warranties contained in the Credit
Agreement and in the other Credit Documents are true and correct in all material respects as of the date hereof (except for those which expressly relate to an earlier date, in which case they were true and correct in all material respects as of such
earlier date); 
 (iii) The Credit Parties, on a consolidated basis, are Solvent; 

(iv) (1) The Consolidated Leverage Ratio of the Consolidated Parties as of the date hereof (which Consolidated
Leverage Ratio shall be calculated reflecting the Medfinders Acquisition on a Pro Forma Basis as of the first day of such period as if the Medfinders Acquisition occurred as of such date) is not greater than 3.60 to 1.0 for the twelve month period
ending on June 30, 2010 and (2) Consolidated EBITDA of the Consolidated Parties (which Consolidated EBITDA shall be calculated reflecting the Medfinders Acquisition on a Pro Forma Basis as of the first day of such period as if the
Medfinders Acquisition occurred as of such date) has been at least $65 million for the twelve months ended June 30, 2010, in each case as demonstrated by the calculations set forth on Exhibit B attached hereto. 

(g) The Borrower has received (or simultaneously with the making of the initial Loans under the Credit Agreement shall
receive) not less than $40 million in gross cash proceeds from the Second Lien Financing. 
 This certificate
may, upon execution, be delivered by facsimile or electronic mail, which shall be deemed for all purposes to be an original signature. 
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

CHARl\1177959v3 
 CHARl\1177959v4 

  

 

 

  
 AMN HEALTHCARE,
INC., a Nevada corporation 
 By:_ 
 Name: 
 Title: 

CHARl\1177959v4 

  

 

 

  
 EXHIBIT A
Acquisition Agreement 
 CHARl\1177959v4 

  

 

 

  
 EXHIBIT B
Covenant Calculations 

  
 EXHIBIT 11.3(b)

 FORM OF ASSIGNMENT AND ASSUMPTION 
 This Assignment and Assumption (this “Assignment and Assumption”) is dated as of the Effective Date set forth below and is entered into by and between [Insert name of Assignor]
(the “Assignor”) and [Insert name of Assignee] (the “Assignee”). Capitalized terms used but not defined herein shall have the meanings given to them in the Credit Agreement identified below (the
“Credit Agreement”), receipt of a copy of which is hereby acknowledged by the Assignee. The Standard Terms and Conditions set forth in Annex 1 attached hereto are hereby agreed to and incorporated herein by reference and made a part
of this Assignment and Assumption as if set forth herein in full. 
 For an agreed consideration, the Assignor hereby
irrevocably sells and assigns to the Assignee, and the Assignee hereby irrevocably purchases and assumes from the Assignor, subject to and in accordance with the Standard Terms and Conditions and the Credit Agreement, as of the Effective Date
inserted by the Administrative Agent as contemplated below (i) all of the Assignor’s rights and obligations as a Lender under the Credit Agreement and any other documents or instruments delivered pursuant thereto to the extent related to
the amount and percentage interest identified below of all of such outstanding rights and obligations of the Assignor under the respective facilities identified below (including, without limitation, Letters of Credit and guarantees included in such
facilities) and (ii) to the extent permitted to be assigned under applicable law, all claims, suits, causes of action and any other right of the Assignor (in its capacity as a Lender) against any Person, whether known or unknown, arising under
or in connection with the Credit Agreement, any other documents or instruments delivered pursuant thereto or the loan transactions governed thereby or in any way based on or related to any of the foregoing, including, but not limited to, contract
claims, tort claims, malpractice claims, statutory claims and all other claims at law or in equity related to the rights and obligations sold and assigned pursuant to clause (i) above (the rights and obligations sold and assigned pursuant to
clauses (i) and (ii) above being referred to herein collectively as, the “Assigned Interest”). Such sale and assignment is without recourse to the Assignor and, except as expressly provided in this Assignment and
Assumption, without representation or warranty by the Assignor. 
  

					
			
	1.	  	Assignor:	  	_______________________________
			
	2.	  	Assignee:	  	_______________________________
		  		  	[and is an Affiliate/Approved Fund of                  ]
			
	3.	  	Borrower:	  	AMN Healthcare, Inc.
			
	4.	  	 Administrative

Agent:
	  	 Bank of America, N.A., as the administrative agent
 under the Credit Agreement (the “Administrative Agent”)

			
	5.	  	Credit Agreement:	  	Credit Agreement dated as of December 23, 2009 (as amended, modified, restated or supplemented from time to time) among AMN Healthcare, Inc., the Guarantors party thereto,
the Lenders party thereto, and Bank of America, N.A., as Administrative Agent

  

			
	6	  	Assigned Interest:

  

									
	 Facility Assigned
	  	 Aggregate

Amount of

Commitment/Loans
 for all Lenders1
	  	 Amount of

Commitment/Loans
 Assigned
	  	 Percentage

Assigned of

Commitment/

Loans2
	  	CUSIP
Number
	 Revolving Commitment
	  	(a)	  	(c)	  		  	
	 Non-Extended Tranche B Loans
	  	(a)	  	(c)	  		  	
	 Extended Tranche B Loans
	  	(b)	  	(d)	  		  	
		  	 Box 1
  
 ________________
 (a) + (b)
	  	 Box 2
  

 
 ______________
 (c) + (d)
	  	 _________

_________
 Box 2 divided by Box 1 times
100
	  	

  

	[7.	 Trade Date:
______________]3 

Effective Date: _____________ ___, 20___ [TO BE INSERTED BY ADMINISTRATIVE AGENT AND WHICH SHALL BE THE EFFECTIVE DATE OF RECORDATION OF TRANSFER IN THE
REGISTER THEREFOR.] 
 The terms set forth in this Assignment and Assumption are hereby agreed to: 

 

					
	ASSIGNOR
	[NAME OF ASSIGNOR]
		
	By:	 	 
		 	Title:	 	
	
	ASSIGNEER
	[NAME OF ASSIGNEER]
		
	By:	 	 
		 	Title:	 	

  

	1	 Amounts in this column and in the column immediately to the right to be adjusted by the counterparties to take into account any payments or prepayments
made between the Trade Date and the Effective Date. 

	2	 Set forth, to at least 9 decimals, as a percentage of the Commitment/Loans of all Lenders thereunder. 

	3	 To be completed if the Assignor and the Assignee intend that the minimum assignment amount is to be determined as of the Trade Date.

  
 Consented to and Accepted: 

 

					
	 BANK OF AMERICA, N.A. as
 Administrative Agent

		
	By	 	 
		 	Title:	 	

 Consented to: 
  

					
	BANK OF AMERICA, N.A., as Issuing Lender
		
	By	 	 
		 	Title:	 	

  

					
	[AMN HEALTHCARE, INC.
		
	By:	 	 
		 	Name:	 	_________________________________,
		 	Title:	 	________________________________]4

  

	4	 So long as no Event of Default has occurred or if the Assignee is not a Lender, an Affiliate of a Lender or an Approved Fund.

  
 ANNEX 1 

STANDARD TERMS AND CONDITIONS FOR 
 ASSIGNMENT AND ASSUMPTION 
 1. Representations and Warranties. 

1.1. Assignor. The Assignor (a) represents and warrants that (i) it is the legal and beneficial owner of the Assigned
Interest, (ii) the Assigned Interest is free and clear of any lien, encumbrance or other adverse claim and (iii) it has full power and authority, and has taken all action necessary, to execute and deliver this Assignment and Assumption and
to consummate the transactions contemplated hereby; and (b) assumes no responsibility with respect to (i) any statements, warranties or representations made in or in connection with the Credit Agreement or any other Credit Document,
(ii) the execution, legality, validity, enforceability, genuineness, sufficiency or value of the Credit Documents or any collateral thereunder, (iii) the financial condition of the Borrower, any of its Subsidiaries or Affiliates or any
other Person obligated in respect of any Credit Document or (iv) the performance or observance by the Borrower, any of its Subsidiaries or Affiliates or any other Person of any of their respective obligations under any Credit Document.

 1.2. Assignee. The Assignee (a) represents and warrants that (i) it has full power and authority, and has
taken all action necessary, to execute and deliver this Assignment and Assumption and to consummate the transactions contemplated hereby and to become a Lender under the Credit Agreement, (ii) it meets all requirements of an Eligible Assignee
under the Credit Agreement (subject to receipt of such consents as may be required under the Credit Agreement), (iii) from and after the Effective Date, it shall be bound by the provisions of the Credit Agreement as a Lender thereunder and, to
the extent of the Assigned Interest, shall have the obligations of a Lender thereunder, (iv) it has received a copy of the Credit Agreement, together with copies of the most recent financial statements delivered pursuant to Section 7.1
thereof, as applicable, and such other documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into this Assignment and Assumption and to purchase the Assigned Interest on the basis of which it
has made such analysis and decision independently and without reliance on the Administrative Agent or any other Lender, and (v) if it is a not a United States person under Section 7701(a)(30) of the Code, attached to the Assignment and
Assumption is any documentation required to be delivered by it pursuant to the terms of the Credit Agreement, duly completed and executed by the Assignee; and (b) agrees that (i) it will, independently and without reliance on the
Administrative Agent, the Assignor or any other Lender, and based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Credit Documents, and
(ii) it will perform in accordance with their terms all of the obligations which by the terms of the Credit Documents are required to be performed by it as a Lender. 
 2. Payments. From and after the Effective Date, the Administrative Agent shall make all payments in respect of the Assigned Interest (including payments of principal, interest, fees and other
amounts) to the Assignor for amounts which have accrued to but excluding the Effective Date and to the Assignee for amounts which have accrued from and after the Effective Date. 

3. General Provisions. This Assignment and Assumption shall be binding upon, and inure to the benefit of, the parties hereto and
their respective successors and assigns. This Assignment and Assumption may be executed in any number of counterparts, which together shall constitute one instrument. Delivery of an executed counterpart of a signature page of this Assignment and
Assumption by telecopy shall be effective as delivery of a manually executed counterpart of this Assignment and Assumption. This Assignment and Assumption shall be governed by, and construed in accordance with, the law of the State of New York.

  
 EXHIBIT A 

INTERCREDITOR AGREEMENT 
 [See Attached] 

  

 

 

  

[EXECUTION COPY] 
 INTERCREDITOR AGREEMENT 
 among 

AMN HEALTHCARE, INC., as the Company, 
 AMN HEALTHCARE SERVICES, INC. as the Parent 
 CERTAIN DOMESTIC SUBSIDIARIES OF THE PARENT 
 FROM TIME TO TIME PARTY HERETO, 
 as
Guarantors, 
 BANK OF AMERICA, N.A., as the First Lien Administrative Agent, 

BANK OF AMERICA, N.A., as the Second Lien Administrative Agent, 

and 
 BANK OF AMERICA, N.A., as the Control Agent 
 Dated
as of September 1, 2010 

  

 

 

  

TABLE OF CONTENTS 
 SECTION 1 Definitions 4 
 1.1 Defined Terms 4

 1.2 Terms Generally 12 
 SECTION 2 Lien Priorities 13 
 2.1 Relative
Priorities 13 
 2.2 Failure to Perfect 13 

2.3 Nature of First Lien Obligations 13 
 2.4 Prohibition on Contesting Liens 14 
 2.5 No New
Liens 14 
 2.6 Similar Liens and Agreements 14 

SECTION 3 Enforcement 15 
 3.1 Exercise of Remedies 15 
 3.2 Actions Upon
Breach 17 
 SECTION 4 Payments 18 
 4.1 Application of Proceeds 18 
 4.2 Payment
Turnover 18 
 4.3 Permitted Mandatory Prepayments of Second Lien Obligations 18 

SECTION 5 Other Agreements 18 
 5.1 Releases 18 
 5.2 Insurance 19 

5.3 Amendments to First Lien Loan Documents and Second Lien Loan Documents.20 

5.4 Rights As Unsecured Creditors 22 
 5.5 Control Agent for Perfection 22 
 5.6 When
Discharge of First Lien Obligations Deemed to Not Have Occurred 25 
 5.7 Option to Purchase First Lien Debt 26

 SECTION 6 Insolvency or Liquidation Proceedings 29 

6.1 Use of Cash Collateral and Financing Issues 29 

6.2 Sale Issues 29 
 6.3 Relief from the Automatic Stay 29 
 6.4
Adequate Protection 30 
 6.5 No Waiver 31 

6.6 Avoidance Issues 31 
 6.7 Separate Grants of Security and Separate Classification 31 
 6.8 Reorganization Securities 31 
 6.9
Post-Petition Claims 32 
 6.10 Waiver 32 

6.11 Expense Claims 32 
 6.12 Effectiveness in Insolvency or Liquidation Proceedings 32 
 CHARl\1175377v2 

  

 

 

  
 SECTION 7
Reliance; Waivers; Etc 32 
 7.1 Non-Reliance 32 

7.2 No Warranties or Liability 33 
 7.3 No Waiver of Lien Priorities 33 
 7.4
Obligations Unconditional 35 
 7.5 Certain Notices 36 

SECTION 8 Miscellaneous 36 
 8.1 Conflicts 36 
 8.2 Effectiveness; Continuing
Nature of this Agreement; Severability 36 
 8.3 Amendments; Waivers 37 

8.4 Information Concerning Financial Condition of Company and its Subsidiaries.37 

8.5 Subrogation 38 
 8.6 Application of Payments 38 
 8.7 SUBMISSION TO
JURISDICTION; WAIVER OF JURY TRIAL 38 
 8.8 Notices 39 

8.9 Further Assurances 39 
 8.10 APPLICABLE LAW 39 
 8.11 Binding on Successors
and Assigns 39 
 8.12 Specific Performance 40 

8.13 Headings 40 
 8.14 Counterparts 40 
 8.15 Authorization 40

 8.16 No Third Party Beneficiaries 40 
 8.17 Provisions Solely to Define Relative Rights 40 

8.18 Grantors; Additional Grantors 40 
 CHARl\1175377v2 

  

 

 

  

INTERCREDITOR AGREEMENT 
 This Intercreditor Agreement, is dated as of September 1, 2010, and entered into by and among AMN HEALTHCARE, INC., a Nevada corporation (the “Company”), AMN HEALTHCARE
SERVICES, INC., a Delaware corporation (the “Parent”), the domestic subsidiaries of the Parent as may time to time party become a party hereto (each a “Guarantor” and together with the Parent, the “Guarantors”). BANK OF
AMERICA, N.A., in its capacity as administrative agent for the First Lien Obligations (as defined below), including its successors and assigns from time to time (the “First Lien Administrative Agent”). BANK OF AMERICA, N.A., in its
capacity as administrative agent for the Second Lien Obligations (as defined below), including its successors and assigns from time to time (the “Second Lien Administrative Agent”) and BANK OF AMERICA, N.A., in its capacity as Control
Agent (defined below) for the First Lien Administrative Agent and the Second Lien Administrative Agent, including its successor and assigns from time to time. Capitalized terms used herein but not otherwise defined herein have the meanings set forth
in Section 1 below. 
 RECITALS 

WHEREAS, the Company, as borrower, the Guarantors, the lenders party thereto, Bank of America, N.A., as the swingline
lender, the issuing lender and as the administrative agent, General Electric Capital Corporation and SunTrust Bank, N.A., as co-syndication agents and ING Capital, LLC, as documentation agent, have entered into that certain Credit Agreement dated as
of December 23, 2009 providing for a revolving credit and term loan facility to the Company (as amended, restated, supplemented or modified from time to time as permitted hereunder, the “Initial First Lien Credit Agreement”);

 WHEREAS, the Company, as borrower, the Guarantors, the lenders party thereto, and Bank of America, N.A., as
administrative agent have entered into that certain Second Lien Credit Agreement dated as of the date hereof providing for a term loan to the Company (as amended, restated, supplemented or modified from time to time as permitted hereunder, the
“Initial Second Lien Credit Agreement”): 
 WHEREAS, the obligations of the Company and the Guarantors
under the Initial First Lien Credit Agreement and any Hedge Agreements and Cash Management Agreements provided by any of the First Lien Claimholders (or their affiliates) are secured by substantially all of the assets of the Company and the
Guarantors pursuant to the terms of the First Lien Collateral Documents; 
 WHEREAS, the obligations of the
Company and the Guarantors under the Initial Second Lien Credit Agreement will be secured by substantially all of the assets of the Company and the Guarantors pursuant to the terms of the Second Lien Collateral Documents; 

WHEREAS, the First Lien Loan Documents and the Second Lien Loan Documents provide, among other things, that the parties
thereto shall set forth in this Agreement their respective rights and remedies with respect to the Collateral; and 
 WHEREAS, in order to induce the First Lien Administrative Agent and the First Lien Claimholders to consent to the Grantors’ incurring the Second Lien Obligations and to induce the
First Lien Claimholders to extend credit and other financial accommodations to or for the benefit of the Company, or any other Grantor, the Second Lien Administrative Agent on behalf of the Second Lien Claimholders has agreed to the lien
subordination, intercreditor and other provisions set forth in this Agreement. 
 CHARl\1175377vl 

  

 

 

  
 NOW, THEREFORE,
in consideration of the foregoing, the mutual covenants and obligations herein set forth and for other good and valuable consideration, the sufficiency and receipt of which are hereby acknowledged, the parties hereto, intending to be legally bound,
hereby agree as follows: 
 SECTION 1 Definitions. 

1.1 Defined Terms. As used in the Agreement, the following terms shall have the following meanings: 

“Affiliate” means, with respect to any Person, any other Person (i) directly or indirectly controlling or
controlled by or under direct or indirect common control with such Person or (ii) directly or indirectly owning or holding ten percent (10%) or more of the Equity Interests in such Person. For purposes of this definition,
“control” when used with respect to any Person means the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms
“controlling” and “controlled” have meanings correlative to the foregoing. Notwithstanding the foregoing, neither the First Lien Administrative Agent, the Second Lien Administrative Agent nor any First Lien Claimholder or any
Second Lien Claimholder shall in any event be considered an Affiliate of the Company or any of its Subsidiaries. 

“Agreement” means this Intercreditor Agreement, as amended, renewed, extended, supplemented or otherwise
modified from time to time in accordance with the terms hereof. 
 “Avoidance Actions” means causes of
action arising under Sections 544, 546, 547, 548, 549 or 550 of title 11 of the United States Code. 

“Bankruptcy Code” means title 11 of the United States Code entitled “Bankruptcy,” as now and hereafter
in effect, or any successor statute. 
 “Bankruptcy Law” means the Bankruptcy Code and all other
liquidation, receivership, moratorium, conservatorship, assignment for the benefit of creditors, insolvency or similar federal, state or foreign law for the relief of debtors. 
 “Business Day” means a day other than a Saturday, Sunday or other day on which commercial banks in Charlotte, North Carolina, San Diego, California or New York, New York are
authorized or required by law to close, except that, when used in connection with a Eurodollar Loan, such day shall also be a day on which dealings between banks are carried on in Dollar deposits in London, England. 

“Capital Lease” as applied to any Person means any lease of any property (whether real, personal or mixed) by
that Person as lessee that, in conformity with GAAP, should be accounted for as a capital lease on the balance sheet of that Person. 
 “Capitalized Lease Obligations” means all obligations under Capital Leases of the Company or any of the Guarantors, without duplication, in each case taken at the amount thereof
accounted for as liabilities identified as “capital lease obligations” (or any similar words) on a consolidated balance sheet of the Company and the Guarantors prepared in accordance with GAAP. 

“Cash Management Agreement” means any agreement to provide cash management services, including treasury,
depository, overdraft, credit or debit or purchasing card, electronic funds transfer and other cash management arrangements. 
 CHARl\1175377v2 

  

 

 

  
 “Cash
Management Creditor” means any Person that, at the time it enters into a Cash Management Agreement, is a Lender or an Affiliate of a Lender, in its capacity as a party to such Cash Management Agreement. 

“Collateral” means all of the assets and property of any Grantor, whether tangible or intangible, constituting
both First Lien Collateral and Second Lien Collateral. 
 “Company” has the meaning set forth in the
introductory paragraph of this Agreement. “Control Agent” has the meaning set forth in Section 5.5(a). 
 “Control Collateral” means any Collateral consisting of any Certificated Security, Instrument, Investment Property, Deposit Accounts (each as defined in the Uniform Commercial
Code), cash and any other Collateral as to which a Lien shall or may be perfected through possession or control by the secured party or any agent therefor. 
 “Controlled Account” means those certain Deposit Accounts (as defined in the Uniform Commercial Code) of any Grantor subject to Liens under the terms of the First Lien Collateral
Documents and the Second Lien Collateral Documents. 
 “Defaulting Creditor” has the meaning set forth
in Section 5.7(d). 
 “Designated Cash Management Agreement” means any Cash Management Agreement
to which any Grantor is a party and as to which the applicable counterparty was a First Lien Lender or an Affiliate of a First Lien Lender as of the date hereof or at the time it enters into such Cash Management Agreement (even if such person ceases
to be a First Lien Lender or such Person’s Affiliate ceases to be a First Lien Lender). 
 “DIP
Financing” has the meaning set forth in Section 6.1. 
 “Discharge of First Lien Obligations”
means, except to the extent otherwise provided in Section 5.6, (i) payment in full in cash of the principal of and interest (including interest accruing on or after the commencement of any Insolvency or Liquidation Proceeding, whether or
not a claim for such interest is, or would be, allowed in such Insolvency or Liquidation Proceeding), on all Indebtedness outstanding under the First Lien Loan Documents constituting First Lien Obligations and termination of all commitments to lend
or otherwise extend credit under the First Lien Loan Documents, (ii) payment in full in cash of all other First Lien Obligations that are due and payable or otherwise accrued and owing at or prior to the time such principal and interest are
paid (including legal fees and other expenses, costs or charges accruing on or after the commencement of any Insolvency or Liquidation Proceeding, whether or not a claim for such fees, expenses, costs or charges is, or would be, allowed in such
Insolvency or Liquidation Proceeding), (iii) termination, cancellation or cash collateralization (it being understood that the cash collateralization of such letters of credit shall not be required in excess of 105% of the face amount thereof)
of, all letters of credit issued under the First Lien Loan Documents constituting First Lien Obligations and (iv) termination or cash collateralization (in an amount reasonably satisfactory to the First Lien Administrative Agent) of any Hedge
Agreements issued or entered into, as the case may be, by any First Lien Claimholder constituting First Lien Obligations. 
 “Disposition” has the meaning set forth in Section 5.1(a)(ii). “Eligible Purchaser” has the meaning set forth in Section 5.7. 

CHARl\1175377v2 

  

 

 

  

“Enforcement Action” means the exercise of any rights or remedies against any Collateral, including, without
limitation, any right to take possession or control of any Collateral under any lockbox agreement, account control agreement, landlord waiver or bailee’s letter or similar agreement or arrangement, any right of set-off or recoupment and any
enforcement, collection, execution, levy or foreclosure action or proceeding taken against the Collateral. 

“Equity Interest” means (i) in the case of a corporation, capital stock, (ii) in the case of an
association or business entity, any and all shares, interests, participations, rights or other equivalents (however designated) of capital stock, (iii) in the case of a partnership, partnership interests (whether general or limited),
(iv) in the case of a limited liability company, membership interests and (v) any other interest or participation that confers on a Person the right to receive a share of the profits and losses of, or distributions of assets of, the
issuing Person. 
 “First Lien Administrative Agent” has the meaning set forth in the preamble hereto.

 “First Lien Claimholders” means, at any relevant time, the holders of First Lien Obligations at such
time, including without limitation the First Lien Lenders, the First Lien Administrative Agent, any Issuing Lender, the Swingline Lender, any Cash Management Creditor, any Hedge Agreement Provider, the Control Agent and any other agent under the
First Lien Credit Agreement. 
 “First Lien Collateral” means all of the “Collateral”
referred to in the First Lien Collateral Documents and all of the other property that is or is intended under the terms of the First Lien Collateral Documents to be subject to Liens in favor of the First Lien Administrative Agent for the benefit of
the First Lien Claimholders. 
 “First Lien Collateral Documents” means, collectively, the Security
Agreement (as defined in the First Lien Credit Agreement as amended from time to time in accordance herewith), the Pledge Agreement (as defined in the First Lien Credit Agreement as amended from time to time in accordance herewith) and each of the
other mortgages, collateral assignments, security agreements, pledge agreements or other similar agreements delivered to the First Lien Administrative Agent pursuant to the terms of Sections 5.1(d) and 7.13 of the First Lien Credit Agreement and
each of the other agreements, instruments or documents that creates or purports to create a Lien in favor of the First Lien Administrative Agent for the benefit of the First Lien Claimholders. 

“First Lien Credit Agreement” means (i) the Initial First Lien Credit Agreement and (ii) any other
credit agreement, loan agreement, note agreement, promissory note, indenture or other agreement or instrument evidencing or governing the terms of any indebtedness or other financial accommodation that has been incurred to extend, increase,
Refinance (each subject to the limitations set forth herein) in whole or in part the indebtedness and other obligations outstanding under (x) the Initial First Lien Credit Agreement or (y) any subsequent First Lien Credit Agreement, unless
such agreement or instrument expressly provides that (1) it is not intended to be and is not a First Lien Credit Agreement hereunder or (2) all of the Indebtedness evidenced by such agreement or instrument is unsecured Indebtedness;
provided that if and to the extent that any amendment, modification, increase or Refinancing of the Initial First Lien Credit Agreement or any other agreement referred to in this clause (ii) provides for revolving credit commitments, revolving
credit loans, term loans, bonds, debentures, notes or similar instruments having a principal amount in the aggregate in excess of the Maximum First Lien Indebtedness Amount, then that portion of such principal amount in the aggregate in excess of
the Maximum First Lien Indebtedness Amount (and all interest, fees and amounts accruing thereon) shall not constitute First Lien Obligations for purposes of this Agreement. Any reference to the First Lien Credit Agreement hereunder shall be deemed a
reference to any First Lien Credit Agreement then in existence if entered into in compliance with the terms of this Agreement. 
 CHARl\1175377v2 

  

 

 

  
 “First
Lien Lenders” means the “Lenders” under and as defined in the First Lien Credit Agreement. 

“First Lien Loan Documents” means the First Lien Credit Agreement and the other Credit Documents (as defined in
the First Lien Credit Agreement as amended from time to time in accordance herewith) and any other document or instrument executed or delivered at any time in connection with the First Lien Credit Agreement, including any intercreditor or joinder
agreement among holders of First Lien Obligations, to the extent such are effective at the relevant time, as each may be modified from time to time in accordance with this Agreement. 

“First Lien Obligations” means all Obligations outstanding under (i) the First Lien Credit Agreement,
(ii) the other First Lien Loan Documents, (iii) any Hedge Agreements entered into by the Company or any other Grantor with any Hedge Agreement Provider (it being understood, for avoidance of doubt, that such obligations shall remain a
First Lien Obligation even if the counterparty (or the Affiliate of the counterparty) ceases to be a First Lien Lender), (iv) any Designated Cash Management Agreement and (v) all Guaranty Obligations, fees, expenses, indemnities and other
amounts payable from time to time pursuant to the First Lien Loan Documents, in each case whether or not allowed or allowable in an Insolvency or Liquidation Proceeding; provided that the aggregate principal amount, without duplication, of any
revolving credit commitments, revolving credit loans, letters of credit, term loans, bonds, debentures, notes or similar instruments or other obligations (excluding, in any event, Hedging Obligations and Obligations in respect of Designated Cash
Management Agreements) provided for under the First Lien Credit Agreement or any other First Lien Loan Document (or any Refinancing thereof) in excess of the Maximum First Lien Indebtedness Amount shall not constitute First Lien Obligations for
purposes of this Agreement. “First Lien Obligations” shall include (x) all interest accrued or accruing (or which would, absent commencement of an Insolvency or Liquidation Proceeding, accrue) in accordance with the rate specified in
the relevant First Lien Loan Document and (y) all fees, costs and charges incurred in connection with the First Lien Loan Documents and provided for thereunder, in the case of each of clause (x) and clause (y) whether before or after
commencement of an Insolvency or Liquidation Proceeding, and irrespective of whether any claim for such interest, fees, costs or charges is allowed as a claim in such Insolvency or Liquidation Proceeding. 

“GAAP” means generally accepted accounting principles in the United States of America as in effect from time to
time. 
 “Governmental Authority” means any nation or government, any state or other political
subdivision thereof, any agency, authority, instrumentality, regulatory body, court, global tribunal, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or global powers or functions of or pertaining to
government. 
 “Grantors” means Company, Parent and each of the Guarantors that have executed and
delivered, or may from time to time hereafter execute and deliver, a First Lien Collateral Document or a Second Lien Collateral Document. 
 “Guarantors” has the meaning set forth in the recitals hereto. 
 “Guaranty Obligations” means, as to any Person, (a) any obligation, contingent or otherwise, of such Person guaranteeing or having the economic effect of guaranteeing any
Indebtedness or other obligation payable or performable by another Person (the “primary obligor”) in any manner, whether directly or indirectly, and including any obligation of such Person, direct or indirect, (i) to purchase or pay
(or advance or supply funds for the purchase or payment of) such Indebtedness or other obligation, (ii) to 

CHARl\1175377v2 

  

 

 

  
 purchase or
lease property, securities or services for the purpose of assuring the obligee in respect of such Indebtedness or other obligation of the payment or performance of such Indebtedness or other obligation, (iii) to maintain working capital, equity
capital or any other financial statement condition or liquidity or level of income or cash flow of the primary obligor so as to enable the primary obligor to pay such Indebtedness or other obligation, or (iv) entered into for the purpose of
assuring in any other manner the obligee in respect of such Indebtedness or other obligation of the payment or performance thereof or to protect such obligee against loss in respect thereof (in whole or in part), or (b) any Lien on any assets
of such Person securing any Indebtedness or other obligation of any other Person, whether or not such Indebtedness or other obligation is assumed by such Person (or any right, contingent or otherwise, of any holder of such Indebtedness to obtain any
such Lien). The amount of any Guaranty Obligation shall be deemed to be an amount equal to the stated or determinable amount of the related primary obligation, or portion thereof, in respect of which such Guaranty Obligation is made or, if not
stated or determinable, the maximum reasonably anticipated liability in respect thereof as determined by the guaranteeing Person in good faith. 
 “Hedge Agreements” means (i) any Interest Rate Protection Agreement or (ii) any currency swap or option agreement, foreign exchange contract, forward currency purchase
agreement or similar currency management agreement, in either case, to the extent that the incurrence of the obligations in respect thereof was permitted under the First Lien Loan Documents as in effect on the date hereof at the time of the
incurrence of such obligation. 
 “Hedge Agreement Provider” shall mean any Person that enters into a
Hedge Agreement with a Grantor to the extent such Person is a First Lien Lender or an Affiliate of a First Lien Lender at the time of the incurrence of such obligation (even if such Person thereafter ceases to be a First Lien Lender or such
Person’s Affiliate ceases to be a First Lien Lender). 
 “Hedging Obligation” means, with respect
to any Person, any obligation of such Person pursuant to any Hedge Agreements. 
 “Indebtedness” means,
with respect to any Person, (a) all obligations of such Person for borrowed money, (b) all obligations of such Person evidenced by bonds, debentures, notes or similar instruments, or upon which interest payments are customarily made,
(c) all obligations of such Person under conditional sale or other title retention agreements relating to property purchased by such Person (other than customary reservations or retentions of title under agreements with suppliers entered into
in the ordinary course of business), (d) all obligations of such Person issued or assumed as the deferred purchase price of property or services purchased by such Person (other than trade debt incurred in the ordinary course of business and due
within six months of the incurrence thereof) which would appear as liabilities on a balance sheet of such Person, (e) all obligations of such Person under take or pay or similar arrangements or under commodities agreements, (f) all
Capitalized Lease Obligations of such Person, (g) the present value, determined on the basis of the implicit interest rate, of all basic rental obligations under all Synthetic Leases of such Person, (h) all net obligations of such Person
under Hedge Agreements, (i) all direct and contingent reimbursement obligations in respect of letters of credit (other than trade letters of credit), bankers’ acceptances, bank guaranties, surety bonds and similar instruments, including,
without duplication, all unreimbursed drafts drawn thereunder (less the amount of any cash collateral securing any such letters of credit or and bankers’ acceptances), (j) the principal component or liquidation preference of all Equity
Interests issued by such Person and which by the terms thereof could at any time prior to the Maturity Date (as defined in the First Lien Credit Agreement) be (at the request of the holders thereof or otherwise) subject to mandatory sinking fund
payments, mandatory redemption or other acceleration, (k) the aggregate amount of uncollected accounts receivable of such Person subject at such time to a sale or securitization of receivables (or similar transaction) (whether or not such
transaction would be reflected on the balance sheet of such Person in accordance with GAAP), (1) all Indebtedness of others secured by 
 CHARl\1175377v2 

  

 

 

  
 (or for which
the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien on, or payable out of the proceeds of production from, property owned or acquired by such Person, whether or not the obligations secured
thereby have been assumed, (m) all Guaranty Obligations of such Person with respect to Indebtedness of another Person and (n) the Indebtedness of any partnership or unincorporated joint venture in which such Person is a general partner or
a joint venturer to the extent such Indebtedness is recourse to such Person. 
 “Initial First Lien Credit
Agreement” has the meaning set forth in the recitals hereto. “Initial Second Lien Credit Agreement” has the meaning set forth in the recitals hereto. 
 “Insolvency or Liquidation Proceeding” means, with respect to any Person, (i) the commencement of a voluntary case by such Person under the Bankruptcy Code or the seeking of
relief by such Person under any bankruptcy or insolvency or analogous law in any jurisdiction outside of the United States; (ii) the commencement of an involuntary case against such Person under the Bankruptcy Code and the petition is not
timely disputed, or is not dismissed within 60 days, after commencement of the case; (iii) a custodian (as defined in the Bankruptcy Code) is appointed for, or takes charge of, all or substantially all of the property of such Person;
(iv) such Person commences (including by way of applying for or consenting to the appointment of, or the taking of possession by, a rehabilitator, receiver, custodian, trustee, conservator or liquidator of such Person or all or any substantial
portion of its property) any other proceeding under any reorganization, arrangement, adjustment of debt, relief of debtors, dissolution, insolvency, liquidation, rehabilitation, conservatorship or similar law of any jurisdiction whether now or
hereafter in effect relating to such Person; (v) any such proceeding of the type set forth in clause (iv) above is commenced against such Person to the extent such proceeding is consented to by such Person or remains undismissed for a
period of 60 days; (vi) such Person is adjudicated insolvent or bankrupt; (vii) any order of relief or other order approving any such case or proceeding is entered; (viii) such Person suffers any appointment of any conservator or the
like for it or any substantial part of its property that continues undischarged or unstayed for a period of 60 days; (ix) such Person makes a general assignment for the benefit of creditors or generally does not pay its debts as such debts
become due; or (x) any corporate (or similar organizational) action is taken by such Person for the purpose of effecting any of the foregoing. 
 “Interest Rate Protection Agreement” means any interest rate swap agreement, any interest rate cap agreement, any interest rate collar agreement or other similar interest rate
management agreement or arrangement, in each case providing for the transfer or mitigation of interest risks either generally or under specific contingencies. 
 “Issuing Lender” means any letter of credit issuer under the First Lien Credit Agreement. 
 “Lien” means any mortgage, pledge, security interest, hypothecation, encumbrance, lien or charge of any kind (including any agreement to give any of the foregoing, any
conditional sale or other title retention agreement or any lease in the nature thereof) including any right of setoff or recoupment. 
 “Maximum First Lien Indebtedness Amount” means $250,000,000 less (A) the amount of all repayments and prepayments applied to any term loans constituting First Lien
Obligations and (B) the amount of all repayments and prepayments of any revolving loans or letters of credit constituting First Lien Obligations, to the extent accompanied by a corresponding reduction in the applicable commitment amount
(excluding reductions in sub-facility commitments not accompanied by a corresponding reduction in the facility commitment amount and reductions under (A) and (B) as a result of a Refinancing). 

CHARl\lI75377v2 

  

 

 

  

“Obligations” means all advances to, and debts, indemnities and reimbursement obligations, liabilities,
obligations, covenants and duties of, any Person, whether direct or indirect (including those acquired by assumption), absolute or contingent, due or to become due, now existing or hereafter arising and including interest and fees that accrue after
the commencement by or against any Person or any Affiliate thereof of any proceeding under any Bankruptcy Law naming such Person as the debtor in such proceeding, regardless of whether such interest and fees are allowed claims in such proceeding.

 “Operating Lease” as applied to any Person means any lease of any property (whether real, personal
or mixed) by that Person as lessee that, in conformity with GAAP, is not accounted for as a Capital Lease on the balance sheet of that Person. 
 “Parent” has the meaning set forth in the recitals hereto. 
 “Permitted Refinancing Documents” shall mean any financing documentation which replaces (i) the Initial First Lien Credit Agreement and the other First Lien Loan Documents
and pursuant to which the outstanding First Lien Obligations are refinanced in their entirety, as such financing documentation may be amended, supplemented, restated, refinanced or otherwise modified from time to time in compliance with this
Agreement, but specifically excluding any such financing documentation to the extent that it contains, either initially or by amendment or other modification, any covenants or defaults other than those which (a) then exist in the Initial First
Lien Credit Agreement and the other First Lien Loan Documents or (b) could be included in the Initial First Lien Credit Agreement and the other First Lien Loan Documents by an amendment or other modification that would not be prohibited by the
terms of this Agreement or (ii) the Initial Second Lien Credit Agreement and the other Second Lien Loan Documents and pursuant to which the outstanding Second Lien Obligations are refinanced in their entirety, as such financing documentation
may be amended, supplemented, restated, refinanced or otherwise modified from time to time in compliance with this Agreement, but specifically excluding any such financing documentation to the extent that it contains, either initially or by
amendment or other modification, any covenants or defaults other than those which (a) then exist in the Initial Second Lien Credit Agreement and the other Second Lien Loan Documents or (b) could be included in the Initial Second Lien
Credit Agreement and the other Second Lien Loan Documents by an amendment or other modification that would not be prohibited by the terms of this Agreement. 
 “Permitted Second Lien Actions” means those actions that a Second Lien Claimholder may take in compliance with Section 3.1 (a). 

“Person” means any individual, partnership, joint venture, firm, corporation, limited liability company,
association, trust or other enterprise or any government or political subdivision or any agency, department or instrumentality thereof. 
 “Recovery” has the meaning set forth in Section 6.6. 
 “Refinance” means, in respect of any Indebtedness, to refinance, extend, renew, defease, restructure, replace, refund or repay, or to issue other Indebtedness, in exchange or
replacement for, such Indebtedness. “Refinanced” and “Refinancing” shall have correlative meanings, provided that (i) the Company and Guarantors shall not be permitted to Refinance the First Lien Obligations unless the
financing documentation entered into by the Company and the Guarantors in connection with any such Refinancing constitutes Permitted Refinancing Documents and (ii) the Company and Guarantors shall not be permitted to Refinance the Second Lien
Obligations unless the financing documentation entered into by the Company and the Guarantors in connection with any such Refinancing constitutes Permitted Refinancing Documents. 

CHARl\1175377v2 

  

 

 

  
 10 

“Required Lenders” means with respect to the First Lien Credit Agreement or the Second Lien Credit Agreement, as
applicable, those First Lien Claimholders or Second Lien Claimholders, as applicable, the approval of which is required to approve an amendment or modification of, termination or waiver of any provision of or consent to any departure from the First
Lien Credit Agreement or the Second Lien Credit Agreement (or would be required to effect such consent under this Agreement if such consent were treated as an amendment of the First Lien Credit Agreement or the Second Lien Credit Agreement) as
applicable. 
 “Second Lien Administrative Agent” has the meaning set forth in the preamble hereof.

 “Second Lien Claimholders” means, at any relevant time, the holders of Second Lien Obligations at
such time, including without limitation the Second Lien Lenders, the Second Lien Administrative Agent and any other agent under the Second Lien Credit Agreement. 
 “Second Lien Collateral” means all of the “Collateral” referred to in the Second Lien Collateral Documents and all of the other property that is or is intended under
the terms of the Second Lien Collateral Documents to be subject to Liens in favor of the Second Lien Administrative Agent for the benefit of the Second Lien Claimholders. 
 “Second Lien Collateral Documents” means, collectively, the Security Agreement (as defined in the Second Lien Credit Agreement as amended from time to time in accordance
herewith), the Pledge Agreement (as defined in the Second Lien Credit Agreement as amended from time to time in accordance herewith) and each of the other mortgages, collateral assignments, security agreements, pledge agreements or other similar
agreements delivered to the Second Lien Administrative Agent pursuant to the terms of Sections 5.1(d) and 7.13 of the Second Lien Credit Agreement and each of the other agreements, instruments or documents that creates or purports to create a Lien
in favor of the Second Lien Administrative Agent for the benefit of the Second Lien Claimholders. 
 “Second
Lien Credit Agreement” means (i) the Initial Second Lien Credit Agreement, (ii) any other credit agreement, loan agreement, note agreement, promissory note, indenture, or other agreement or instrument evidencing or governing the terms
of any indebtedness or other financial accommodation that has been incurred to extend, increase or Refinance in whole or in part the indebtedness and other obligations outstanding under the Initial Second Lien Credit Agreement or other agreement or
instrument referred to in this clause (ii), as the same may be amended, renewed, extended, supplemented or otherwise modified from time to time, subject to the limitations set forth herein and only to the extent permitted hereby, unless such
agreement or instrument expressly provides that (1) it is not intended to be and is not a Second Lien Credit Agreement hereunder or (2) all of the Indebtedness evidenced by such agreement or instrument is unsecured Indebtedness. Any
reference to the Second Lien Credit Agreement hereunder shall be deemed a reference to any Second Lien Credit Agreement then in existence if entered into in compliance with the terms of this Agreement. 

“Second Lien Enforcement Date” means the date which is 180 days after the occurrence of (i) an Event of
Default (under and as defined in the Second Lien Credit Agreement) and (ii) the First Lien Administrative Agent’s receipt of written notice (which notice shall reference this Agreement) from the Second Lien Administrative Agent certifying
that an Event of Default (under and as defined in the Second Lien Credit Agreement) has occurred and is continuing; provided that the Second Lien Enforcement Date shall be stayed and thereby deemed not to have occurred (1) at any time that the
First Lien Administrative Agent or the First Lien Claimholders have commenced and are then diligently pursuing any Enforcement Action with respect to all or a material portion of the Collateral, (2) at any time any Grantor is then a debtor
under or with respect to (or otherwise subject to) any Insolvency or Liquidation Proceeding or 
 CHARl\1175377v2

 11 

  

 

 

  
 (3) if the
acceleration of the Second Lien Obligations (if any) is rescinded in accordance with the terms of the Second Lien Credit Agreement. 
 “Second Lien Lenders” means the “Lenders” under and as defined in the Second Lien Credit Agreement. 

“Second Lien Loan Documents” means the Second Lien Credit Agreement and the other Credit Documents (as defined
in the Second Lien Credit Agreement as amended from time to time in accordance herewith) and any other document or instrument executed or delivered at any time in connection with the Second Lien Credit Agreement, including any intercreditor or
joinder agreement among holders of Second Lien Obligations, to the extent such are effective at the relevant time, as each may be modified from time to time in accordance with this Agreement. 

“Second Lien Obligations” means all Obligations outstanding under (i) the Second Lien Credit Agreement and
(ii) the other Second Lien Loan Documents. “Second Lien Obligations” shall include (x) all interest accrued or accruing (or which would, absent commencement of an Insolvency or Liquidation Proceeding, accrue) in accordance with
the rate specified in the relevant Second Lien Loan Document and (y) all fees, costs and charges incurred in connection with the Second Lien Loan Documents and provided for thereunder, in each case whether before or after commencement of an
Insolvency or Liquidation Proceeding and irrespective of whether any claim for such interest, fees, costs or charges is allowed as a claim in such Insolvency or Liquidation Proceeding. 

“Subsidiary” means, as to any Person at any time, (a) any corporation more than 50% of whose Equity
Interests of any class or classes having by the terms thereof ordinary voting power to elect a majority of the directors of such corporation (irrespective of whether or not at such time, any class or classes of such corporation shall have or might
have voting power by reason of the happening of any contingency) is at such time owned by such Person directly or indirectly through Subsidiaries, and (b) any partnership, association, joint venture or other entity of which such Person directly
or indirectly through Subsidiaries owns at such time more than 50% of the Capital Stock other than, in the case of each of clauses (a) and (b) above, any Excluded JV (as defined in the First Lien Credit Agreement). 

“Swing Line Lender” means Bank of America, N.A., together with its successors and permitted assigns. 

“Synthetic Lease” means any lease (i) that is accounted for by the lessee as an Operating Lease, and
(ii) under which the lessee is intended to be the “owner” of the leased property for federal income tax purposes. 
 “Uniform Commercial Code” or “UCC” means the Uniform Commercial Code as in effect from time to time. Unless otherwise specified, the UCC shall refer to the UCC as in
effect in the State of New York. 
 1.2 Terms Generally. The definitions of terms herein shall apply equally to
the singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words “include”, “includes” and “including”
shall be deemed to be followed by the phrase “without limitation.” The word “will” shall be construed to have the same meaning and effect as the word “shall.” Unless the context requires otherwise (a) any
definition of or reference to any agreement, instrument or other document herein shall be construed as referring to such agreement, instrument or other document as from time to time amended, supplemented or otherwise modified, (b) any reference
herein to any Person shall be construed to include such Person’s successors and assigns, (c) the words “herein”, “hereof and “hereunder”, and words of similar import, 

CHARl\1175377v2 

  

 

 

  
 12 

shall be construed to refer to this Agreement in its entirety and not to any particular provision hereof, (d) all
references herein to Exhibits or Sections shall be construed to refer to Exhibits or Sections of this Agreement, (e) the words “asset” and “property” shall be construed to have the same meaning and effect and to refer to any
and all tangible and intangible assets and properties, including cash, securities, accounts and contract rights, (f) reference to any law means such law as amended, modified, codified, replaced or re-enacted, in whole or in part, and in effect
on the date hereof, including rules, regulations, enforcement procedures and any interpretations promulgated thereunder, and (g) references to Sections or clauses shall refer to those portions of this Agreement and any references to a clause
shall, unless otherwise identified, refer to the appropriate clause within the same Section in which such reference occurs. 
 SECTION 2 Lien Priorities. 
 2.1 Relative
Priorities. Notwithstanding the date, manner or order of grant, attachment or perfection of any Liens securing the Second Lien Obligations granted on the Collateral or of any Liens securing the First Lien Obligations granted on the Collateral and
notwithstanding any provision of the UCC, or any applicable law or the Second Lien Loan Documents, the Second Lien Administrative Agent, on behalf of itself and the Second Lien Claimholders, hereby agrees that: (a) any Lien on the Collateral
securing any First Lien Obligations now or hereafter held by or on behalf of the First Lien Administrative Agent or any First Lien Claimholders or any agent or trustee therefor, regardless of how acquired, whether by grant, possession, statute,
operation of law, subrogation or otherwise, shall be senior in all respects and prior to any Lien on the Collateral securing any of the Second Lien Obligations; and (b) any Lien on the Collateral now or hereafter held by or on behalf of the
Second Lien Administrative Agent, any Second Lien Claimholders or any agent or trustee therefor regardless of how acquired, whether by grant, possession, statute, operation of law, subrogation or otherwise, shall be junior and subordinate in all
respects to all Liens on the Collateral securing any First Lien Obligations. 
 2.2 Failure to Perfect. All Liens
on the Collateral securing any First Lien Obligations shall be and remain senior in all respects and prior to all Liens on the Collateral securing any Second Lien Obligations for all purposes, notwithstanding any failure of the First Lien
Administrative Agent or the First Lien Claimholders to adequately perfect its security interests in the Collateral, the subordination of any Lien on the Collateral securing any First Lien Obligations to any Lien securing any other obligation of any
Grantor, or the avoidance, invalidation or lapse of any Lien on the Collateral securing any First Lien Obligations. 
 2.3 Nature of First Lien Obligations. The Second Lien Administrative Agent, for itself and on behalf of the other Second Lien Claimholders, acknowledges that (a) a portion of the
First Lien Obligations are revolving in nature, (b) subject to succeeding clause (d), the amount of such revolving First Lien Obligations that may be outstanding at any time or from time to time may be increased or reduced and subsequently
reborrowed, (c) the terms of the First Lien Obligations may be modified, extended or amended from time to time, and (d), subject to the limitations on the aggregate principal amount of First Lien Obligations set forth in the definition of
“First Lien Obligations” and Section 5.3, the aggregate amount of the First Lien Obligations may be increased or Refinanced, in either event, without notice to or consent by the Second Lien Claimholders and without affecting the
provisions hereof. Subject to the limitations on the aggregate principal amount of First Lien Obligations set forth in the definition of “First Lien Obligations” and Section 5.3. the lien priorities provided in Sections 2.1 and 2.2
shall not be altered or otherwise affected by any such amendment, modification, supplement, extension, repayment, reborrowing, increase, replacement, renewal, restatement or Refinancing of either the First Lien Obligations or the Second Lien
Obligations, or any portion thereof. 

  

 

 

  
 CHARl\1175377v2

 13 
 2.4 Prohibition on Contesting Liens. Each of the Second Lien Administrative Agent, for itself and on behalf of each Second Lien Claimholder, and the First Lien Administrative Agent, for
itself and on behalf of each First Lien Claimholder, agrees that it shall not (and hereby waives any right to) contest or support any other Person in contesting, in any proceeding (including any Insolvency or Liquidation Proceeding), the priority,
validity or enforceability of a Lien held by or on behalf of any of the First Lien Claimholders in the First Lien Collateral or by or on behalf of any of the Second Lien Claimholders in the Second Lien Collateral, as the case may be; provided that
nothing in this Agreement shall be construed to prevent or impair the rights of the First Lien Administrative Agent or any First Lien Claimholder to enforce this Agreement, including the priority of the Liens securing the First Lien Obligations as
provided in Sections 2.1 and 3.1. 
 2.5 No New Liens. 

(a) Limitation on other Collateral for First Lien Claimholders. the First Lien Administrative Agent agrees that neither
the First Lien Administrative Agent nor any First Lien Claimholder shall acquire or hold any Lien on any assets of any Grantor securing any First Lien Obligations which assets are not also subject to the Lien of the Second Lien Administrative Agent
under the Second Lien Collateral Documents, provided, however, notwithstanding the above, that the refusal of the Second Lien Administrative Agent or the Second Lien Claimholders to accept a Lien on any assets of any Grantor shall not prohibit the
taking of a Lien on such assets by the First Lien Administrative Agent or the First Lien Claimholders. If the First Lien Administrative Agent or any First Lien Claimholder shall (nonetheless and in breach hereof) acquire any Lien on any assets of
any Grantor or any of their respective Subsidiaries securing any First Lien Obligations which assets are not also subject to the Lien of the Second Lien Administrative Agent under the Second Lien Collateral Documents, then the First Lien
Administrative Agent (or the relevant First Lien Claimholder), shall, without the need for any further consent of any other Person and notwithstanding anything to the contrary in any other First Lien Document (x) hold and be deemed to have held
such Lien and security interest for the benefit of the Second Lien Administrative Agent as security for the Second Lien Obligations, or (y) release such Lien. 
 (b) Limitation on other Collateral for Second Lien Claimholders. Until the date upon which the Discharge of First Lien Obligations shall have occurred, the Second Lien Administrative Agent
agrees that, after the date hereof, neither the Second Lien Administrative Agent nor any Second Lien Claimholder shall acquire or hold any Lien on any assets of any Company, any Guarantor or any of their respective Subsidiaries securing any Second
Lien Obligations which assets are not also subject to the Lien of the First Lien Administrative Agent under the First Lien Collateral Documents. If the Second Lien Administrative Agent or any Second Lien Claimholder shall (nonetheless and in breach
hereof) acquire any Lien on any assets of any Grantor or any of their respective Subsidiaries securing any Second Lien Obligations which assets are not also subject to the Lien of the First Lien Administrative Agent under the First Lien Collateral
Documents, then the Second Lien Administrative Agent (or the relevant Second Lien Claimholder), shall, without the need for any further consent of any other Person and notwithstanding anything to the contrary in any other Second Lien Document
(x) hold and be deemed to have held such Lien and security interest for the benefit of the First Lien Administrative Agent as security for the First Lien Obligations, or (y) release such Lien. 

2.6 Similar Liens and Agreements. The parties hereto agree that it is their intention that the First Lien Collateral and
the Second Lien Collateral be identical. In furtherance of the foregoing and of Section 8.9, the parties hereto agree, subject to the other provisions of this Agreement: 
 CHARl\1175377v2 

  

 

 

  
 14 

(a) upon request by the First Lien Administrative Agent or the Second Lien Administrative Agent, to cooperate in good
faith (and to direct their counsel to cooperate in good faith) from time to time in order to determine the specific items included in the First Lien Collateral and the Second Lien Collateral and the steps taken to perfect their respective Liens
thereon and the identity of the respective parties obligated under the First Lien Loan Documents and the Second Lien Loan Documents; and 
 (b) that the documents and agreements creating or evidencing the First Lien Collateral and the Second Lien Collateral and guarantees for the First Lien Obligations and the Second Lien
Obligations shall be in all material respects the same forms of documents other than with respect to the senior and subordinate nature of the security interests in the Collateral securing the respective Obligations thereunder. 

SECTION 3 Enforcement. 
 3.1 Exercise of Remedies. 
 (a) So long as the
Discharge of First Lien Obligations has not occurred, whether or not any Insolvency or Liquidation Proceeding has been commenced by or against the Company or any other Grantor: 

 

	 (i)
	 the Second Lien Administrative Agent and the Second Lien Claimholders:

 (A) from the date hereof until the occurrence of the Second Lien Enforcement Date, will not
take any Enforcement Action with respect to any Lien held by it under the Second Lien Collateral Documents or any other Second Lien Loan Document or otherwise; 
 (B) will not contest, protest or object to, or otherwise interfere with, hinder, or delay, any Enforcement Action by the First Lien Administrative Agent or any First Lien Claimholder,
provided that the respective interests of the Second Lien Claimholders attach to the proceeds thereof, subject to the relative priorities described in Section 2 and Section 4: and 

(C) subject to the rights of the Second Lien Administrative Agent under clause (iXA) above, will not contest, protest or
object to the forbearance by the First Lien Administrative Agent or the First Lien Claimholders from bringing or pursuing any Enforcement Action; 
 (ii) subject to Section 5.1, the First Lien Administrative Agent and the First Lien Claimholders shall have the exclusive right to commence and, if applicable, maintain an Enforcement
Action and make determinations regarding the release, disposition, or restrictions with respect to the Collateral without any consultation with or the consent of the Second Lien Administrative Agent or any Second Lien Claimholder; 

provided that: 
 (A) in any Insolvency or Liquidation Proceeding commenced by or against the Company or any other Grantor, the Second Lien Administrative Agent, on behalf of itself and the Second Lien
Claimholders, may file claims or 
 CHARl\1175377v2 

15 

  

 

 

  
 statements of
interest with respect to all or any portion of the Second Lien Obligations, 
 (B) the Second Lien Administrative
Agent, on behalf of itself and the Second Lien Claimholders, agrees that it will not retain any Collateral or any proceeds of Collateral in connection with any Enforcement Action against any Collateral, and that any Collateral or proceeds taken or
received by it in connection with any Enforcement Action will be applied in accordance with Section 4.2 unless and until the Discharge of First Lien Obligations has occurred, except as expressly provided in Section 6.8; 

(C) the Second Lien Administrative Agent and Second Lien Claimholders shall be entitled to file any necessary responsive
or defensive pleadings in opposition to any motion, claim, adversary proceeding or other pleading made by any person objecting to or otherwise seeking the disallowance of the claims of the Second Lien Administrative Agent or Second Lien
Claimholders, including without limitation any claims secured by the Collateral, if any, in each case in accordance with the terms of this Agreement; 
 (D) in any Insolvency or Liquidation Proceeding, the Second Lien Administrative Agent and Second Lien Claimholders shall be entitled to file any pleadings, objections, motions or
agreements which assert rights or interests available to unsecured creditors of the Grantors arising under either Bankruptcy Law or applicable non-bankruptcy law, in each case in accordance with the terms of this Agreement; 

(E) in any Insolvency or Liquidation Proceeding, the Second Lien Administrative Agent and Second Lien Claimholders shall
be entitled to vote on any plan of reorganization, to the extent consistent with the provisions hereof; 
 (F)
the Second Lien Administrative Agent or any Second Lien Claimholder may exercise any of its rights or remedies with respect to the Collateral upon the occurrence and during the effective continuation of the Second Lien Enforcement Date; and

 (G) the Second Lien Collateral Agent may take any action (not adverse to the Liens on the Collateral securing
the First Lien Obligations, or the rights of any First Lien Collateral Agent or the First Lien Claimholders to exercise remedies in respect thereof and not otherwise inconsistent with the terms of this Agreement) in order to preserve or protect its
Lien on the Collateral. 
 In exercising rights and remedies with respect to the Collateral, the First Lien
Administrative Agent and the First Lien Claimholders may enforce the provisions of the First Lien Loan Documents and exercise remedies thereunder, all in such order and in such manner as they may determine in the exercise of their sole discretion.
Such exercise and enforcement shall include the rights of an agent appointed by the First Lien Administrative Agent and the First Lien Claimholders to sell or otherwise dispose of Collateral upon foreclosure, to incur expenses in connection with
such sale or disposition, and to exercise all the rights and remedies of a secured creditor under the Uniform Commercial Code of any applicable jurisdiction and of a secured creditor under Bankruptcy Laws of any applicable jurisdiction. 

CHARl\1175377v2 

  

 

 

  
 (b) The Second
Lien Administrative Agent, on behalf of itself and the Second Lien Claimholders, agrees that it will not take or receive any Collateral or any proceeds of Collateral in connection with the exercise of any right or remedy (including set-off or
recoupment) with respect to any Collateral, and that any Collateral or such proceeds taken or received by it will be paid over to the First Lien Administrative Agent pursuant to Section 4.2. unless and until the Discharge of First Lien
Obligations has occurred, except as expressly provided in Section 6.8. Without limiting the generality of the foregoing, unless and until the Discharge of First Lien Obligations has occurred, except as expressly provided in
Section 3.1(a)(h”). the sole right of the Second Lien Administrative Agent and the Second Lien Claimholders with respect to the Collateral is to hold a Lien on the Collateral pursuant to the Second Lien Collateral Documents for the period
and to the extent granted therein and to receive a share of the proceeds thereof, if any, after the Discharge of First Lien Obligations has occurred in accordance with the terms of the Second Lien Loan Documents and applicable law. 

(c) Subject to the proviso to clauses (i) and (ii) of Section 3.Ua), the Second Lien Administrative Agent,
for itself and on behalf of the Second Lien Claimholders, agrees that (i) the Second Lien Administrative Agent and the Second Lien Claimholders will not take any action that would hinder, delay or impede any exercise of remedies under the First
Lien Loan Documents, including any sale, lease, exchange, transfer or other disposition of the Collateral, whether by foreclosure or otherwise, and (ii) the Second Lien Administrative Agent, for itself and on behalf of the Second Lien
Claimholders, hereby waives any and all rights it or the Second Lien Claimholders may have as a junior lien creditor with respect to the First Lien Collateral to object to the manner or order in which the First Lien Administrative Agent or the First
Lien Claimholders seek to enforce or collect the First Lien Obligations or the Liens granted in any of the First Lien Collateral. 
 (d) The Second Lien Administrative Agent hereby acknowledges and agrees that no covenant, agreement or restriction contained in the Second Lien Collateral Documents or any other Second
Lien Loan Document shall be deemed to restrict in any way the rights and remedies of the First Lien Administrative Agent or the First Lien Claimholders with respect to the Collateral as set forth in this Agreement and the First Lien Loan Documents.

 (e) Notwithstanding anything to the contrary in this Section 3.1, if the First Lien Administrative Agent
or any other First Lien Lender has instituted and is diligently pursuing any Enforcement Action against any Collateral, then each of the Second Lien Administrative Agent and the Second Lien Lenders agrees that it will not institute any Enforcement
Action against any Collateral; provided that if the Second Lien Administrative Agent or any Second Lien Lender has already initiated any Enforcement Action against any Collateral, such Person shall immediately suspend such Enforcement Action.

 3.2 Actions Upon Breach. 
 (a) If any Second Lien Claimholder, contrary to this Agreement, commences or participates in any Enforcement Action against Company, any other Grantor or the Collateral, the First Lien
Administrative Agent may intervene and may interpose in the name of the First Lien Claimholders or in the name of Company or such Grantor the making of this Agreement as a defense or dilatory plea. 

(b) Should any Second Lien Claimholder, contrary to this Agreement, in any way take, or attempt or threaten to take, any
Enforcement Action with respect to the Collateral (including, without limitation, any attempt to realize upon or enforce any remedy contrary to this 
 CHARl\1175377v2 
 17 

  

 

 

  
 Agreement), or
fail to take any action required by this Agreement, the First Lien Administrative Agent (in its own name or in the name of a Grantor) may obtain relief against such Second Lien Claimholder by injunction, specific performance and/or other appropriate
equitable relief, it being understood and agreed by the Second Lien Administrative Agent on behalf of each Second Lien Claimholder that (i) the First Lien Claimholders’ damages from such actions may be difficult to ascertain and may be
irreparable, and (ii) the Second Lien Administrative Agent on behalf of each Second Lien Claimholder waives any defense that the First Lien Claimholders cannot demonstrate damage or be made whole by the awarding of damages. 

SECTION 4 Payments. 
 4.1 Application of Proceeds. So long as the Discharge of First Lien Obligations has not occurred, any proceeds of Collateral received in connection with the sale or other disposition of
such Collateral, or collection on such Collateral upon the exercise of remedies, shall be applied by the First Lien Administrative Agent to payment or cash collateralization of the First Lien Obligations in such order as specified in the relevant
First Lien Documents. Upon the Discharge of the First Lien Obligations, the First Lien Administrative Agent shall deliver any proceeds of Collateral held by it either (i) to the Second Lien Administrative Agent in the same form as received,
with any necessary endorsements, to be applied by the Second Lien Administrative Agent to the Second Lien Obligations in such order as specified in the Second Lien Collateral Documents or (ii) as a court of competent jurisdiction may otherwise
direct. 
 4.2 Payment Turnover. So long as the Discharge of First Lien Obligations has not occurred and except
as specifically permitted by Section 4.3, any Collateral or proceeds thereof (together with assets or proceeds subject to Liens referred to in the final sentence of Section 2.5(b) received by the Second Lien Administrative Agent or any
Second Lien Claimholders in connection with the exercise of any right or remedy (including set-off or recoupment) in respect of the Collateral shall be segregated and held in trust and forthwith paid over to the First Lien Administrative Agent for
the benefit of the First Lien Claimholders in the same form as received, with any necessary endorsements or as a court of competent jurisdiction may otherwise direct. The First Lien Administrative Agent is hereby authorized to make any such
endorsements as agent for the Second Lien Administrative Agent or any such Second Lien Claimholders. This authorization is coupled with an interest and is irrevocable until such time as this Agreement is terminated in accordance with its terms.

 4.3 Permitted Mandatory Prepayments of Second Lien Obligations. Notwithstanding the foregoing provisions of
this Section 4, mandatory prepayments required under Section 3.3 of the Second Lien Credit Agreement may be made and applied to the Second Lien Obligations at all times following the Discharge of the First Lien Obligations. 

SECTION 5 Other Agreements. 
 5.1 Releases. 

	 (a)
	 If, in connection with: 

	 (i)
	 an Enforcement Action by the First Lien Administrative Agent; or

 (ii) any Asset Disposition (as defined in the First Lien Credit Agreement), sale, lease,
exchange, transfer or other disposition of any Collateral permitted under the terms of the First Lien Loan Documents other than an Enforcement Action (whether or not an event of default thereunder, and as defined therein, has occurred and is
continuing) (a “Disposition”); or 
 CHARl\1175377v2 

18 

  

 

 

  
 (iii) any
release of Liens on the assets of any Grantor when the Lien on all of the Equity Interests in such Grantor is being released pursuant to any other provision of this Section 5 .Ka”); 

the First Lien Administrative Agent, for itself or on behalf of any of the First Lien Claimholders, releases any of its
Liens on any part of the Collateral, or releases any Grantor from its obligations under its guaranty of the First Lien Obligations, then the Liens, if any, of the Second Lien Administrative Agent, for itself or for the benefit of the Second Lien
Claimholders, on such Collateral, and the obligations of such Grantor under its guaranty of the Second Lien Obligations, shall be automatically, unconditionally and simultaneously released (the “Second Lien Release”) and the Second Lien
Administrative Agent, for itself or on behalf of any such Second Lien Claimholders, promptly shall execute and deliver to the First Lien Administrative Agent or such Grantor such termination statements, releases and other documents as the First Lien
Administrative Agent or such Grantor may request to effectively confirm such release; provided, however, that the Second Lien Release shall not occur without the consent of the Second Lien Administrative Agent (x) in the case of an Enforcement
Action, as to any Collateral the net proceeds of the disposition of which will not be applied to repay (and, to the extent applicable, to reduce permanently commitments with respect to) the First Lien Obligations, or (y), in the case of a
Disposition, if the Disposition is prohibited by any provision of the Second Lien Credit Agreement other than solely as the result of the existence of a default or an event of default under the Second Lien Loan Documents. 

(b) Until the Discharge of First Lien Obligations occurs, the Second Lien Administrative Agent, for itself and on behalf
of the Second Lien Claimholders, hereby irrevocably constitutes and appoints the First Lien Administrative Agent and any officer or agent of the First Lien Administrative Agent, with full power of substitution, as its true and lawful
attorney-in-fact with full irrevocable power and authority in the place and stead of the Second Lien Administrative Agent or such holder or in the First Lien Administrative Agent’s own name, from time to time in the First Lien Administrative
Agent’s discretion, for the limited purpose of carrying out the terms of this Section 5.1, to take any and all reasonable and appropriate action and to execute any and all documents and instruments which may be necessary to accomplish the
purposes of this Section 5.1, including any endorsements or other instruments of transfer or release. This authorization is coupled with an interest and is irrevocable until such time as this Agreement is terminated in accordance with its
terms. 
 (c) Until the Discharge of First Lien Obligations occurs, to the extent that the First Lien
Administrative Agent for itself and on behalf of the First Lien Claimholders (i) has released any Lien on Collateral or any Grantor from its obligation under its guaranty and any such Liens or guaranty are later reinstated or (ii) obtains
any new Liens or additional guaranties from Grantors, then the Second Lien Administrative Agent for itself and on behalf of the Second Lien Claimholders shall be granted a Lien on any such Collateral and an additional guaranty, as the case may be,
subject to the priorities set forth in Section 2. 
 5.2 Insurance. To the extent of any additional insured
and loss payee provisions contained in the First Lien Credit Agreement and the Second Lien Credit Agreement, the Control Agent shall be named as additional insured and as loss payee (on behalf of the First Lien Administrative Agent, the other First
Lien Claimholders, the Second Lien Administrative Agent and the other Second Lien Claimholders) under any insurance policies maintained from time to time by any Grantor. Until the date upon which the Discharge of First Lien Obligations shall have
occurred, as between the First Lien Administrative Agent and the First Lien Claimholders, on the one hand, and the Second Lien Administrative Agent and the 
 CHARl\1175377v2 
 19 

  

 

 

  
 Second Lien
Claimholders on the other, the First Lien Administrative Agent and the First Lien Claimholders shall have the sole and exclusive right (a) to adjust or settle any insurance policy or claim covering any Collateral in the event of any loss
thereunder and (b) to approve any award granted in any condemnation or similar proceeding affecting any Collateral, in each case to the extent such rights are granted to the First Lien Administrative Agent and the Second Lien Administrative
Agent under the First Lien Credit Agreement or the First Lien Collateral Documents and the Second Lien Credit Agreement or the Second Lien Collateral Documents, respectively. Until the date upon which the Discharge of First Lien Obligations shall
have occurred, all proceeds of any such policy and any such award in respect of any Collateral that are payable to the Control Agent for the benefit of the First Lien Administrative Agent and the Second Lien Administrative Agent shall be paid to the
First Lien Administrative Agent for the benefit of the First Lien Claimholders to the extent required under the First Lien Loan Documents and thereafter to the Second Lien Administrative Agent for the benefit of the Second Lien Claimholders to the
extent required under the applicable Second Lien Loan Documents and then to the owner of the subject property or as a court of competent jurisdiction may otherwise direct. If the Second Lien Administrative Agent or any Second Lien Claimholder shall,
at any time, receive any proceeds of any such insurance policy or any such award in contravention of this Agreement, it shall pay such proceeds over to the First Lien Administrative Agent in accordance with the terms of Section 4.2. 

5.3 Amendments to First Lien Loan Documents and Second Lien Loan Documents. 

(a) The First Lien Loan Documents may be amended, supplemented or otherwise modified in accordance with their terms and
the First Lien Credit Agreement may be Refinanced, in each case without the consent of the Second Lien Administrative Agent or the Second Lien Claimholders; provided, however, that the holders of such Refinancing debt bind themselves in writing to
the terms of this Agreement and any such amendment, supplement, modification or Refinancing shall not: (i) provide for a principal amount of, without duplication, term loans, revolving loan commitments and letters of credit, bonds, debentures,
notes or similar instruments (but excluding Hedging Obligations and Obligations in respect of Designated Cash Management Agreements) in the aggregate in excess of the Maximum First Lien Indebtedness Amount; (ii) increase the interest rate or
yield provisions applicable to the First Lien Obligations by more than 3.00% per annum in the aggregate (excluding increases (A) resulting from increases in the underlying reference rate not caused by any amendment, supplement,
modification or Refinancing of the First Lien Credit Agreement or (B) resulting from the accrual of interest at the Default Rate (as defined in the First Lien Credit Agreement as of the date hereof); or (iii) extend the scheduled final
Maturity Date (as defined in the First Lien Credit Agreement) beyond the then scheduled final maturity date of the Second Lien Credit Agreement. 
 (b) Until the Discharge of First Lien Obligations occurs, the Second Lien Loan Documents may be amended, supplemented or otherwise modified in accordance with their terms and the Second
Lien Credit Agreement may be Refinanced in each case, without the consent of the First Lien Administrative Agent or the First Lien Claimholders provided, however, that the holders of such Refinancing debt bind themselves in writing to the terms of
this Agreement and any such amendment, supplement, modification or Refinancing shall not: (i) provide for a principal amount of the Second Lien Obligations in excess of the amount permitted under the First Lien Credit Agreement (as in effect on
the date hereof); (ii) increase the interest rate or yield provisions applicable to the Second Lien Obligations by more than 3.00% per annum in the aggregate (excluding increases (A) resulting from increases in the underlying
reference rate not caused by any amendment, supplement, modification or Refinancing of the Second Lien Credit Agreement or (B) resulting from the accrual of interest at the Default Rate (as defined in the Second Lien Credit Agreement as of the
date hereof); (iii) change to earlier dates the dates upon which payments of principal or interest on the Second Lien Obligations are due; (iv) change any 
 CHARl\1175377v2 
 20 

  

 

 

  
 covenants,
defaults or events of default (including the addition of defaults or events of default not contained in the Second Lien Loan Documents as of the date hereof) in any manner that makes them more restrictive, in any material respect, as to any Grantor
except to make conforming changes to match changes made to the First Lien Loan Documents so as to preserve, in connection with any amendments to the First Lien Loan Documents, on substantially similar economic terms, the differential (if any) that
exists on the date hereof between such covenants, defaults or events of defaults in the First Lien Loan Documents and such covenants, defaults or events of default in the Second Lien Loan Documents; (v) change any mandatory or voluntary
prepayment provisions of the Second Lien Obligations if the effect of such change is to require any new payment or accelerate the payment date of any existing payment obligation (other than as a result of a change in the Maturity Date (as defined in
the Second Lien Credit Agreement) or other dates as permitted by part (iii) of this clause (b)); or (vi) change or amend any other term of the Second Lien Loan Documents if such change or amendment would result in a default under the First
Lien Credit Agreement, increase the obligations of any Grantor or confer additional material rights on any Second Lien Claimholder in a manner adverse in any material respect to any of the First Lien Claimholders. 

(c) Notwithstanding the foregoing clauses (a) and (b) of this Section 5.3, (i) until the date upon
which the Discharge of First Lien Obligations shall have occurred, without the prior written consent of the First Lien Administrative Agent, no Second Lien Collateral Document may be amended, supplemented or otherwise modified or entered into to the
extent such amendment, supplement or modification, or the terms of any new Second Lien Credit Agreement or Second Lien Collateral Document, would contravene any of the terms of this Agreement and (ii) without the prior written consent of the
Second Lien Administrative Agent, no First Lien Collateral Document may be amended, supplemented or otherwise modified or entered into to the extent such amendment, supplement or modification, or the terms of any new First Lien Credit Agreement or
First Lien Collateral Document, would contravene any of the terms of this Agreement. 
 (d) The Second Lien
Administrative Agent agrees that each Second Lien Collateral Document shall include the following language: 

“Notwithstanding anything herein to the contrary, the lien and security interest granted to the administrative agent
pursuant to this Agreement and the exercise of any right or remedy by the administrative agent hereunder are subject to the provisions of the Intercreditor Agreement, dated as of September 1, 2010 as the same may be amended, supplemented,
modified or replaced from time to time (the “Intercreditor Agreement”) among Bank of America, N.A., as First Lien Administrative Agent, Bank of America, N.A., as Second Lien Administrative Agent, Bank of America, N.A., as Control Agent and
the Grantors (as defined therein) from time to time a party thereto. In the event of any conflict between the terms of the Intercreditor Agreement and this Agreement, the terms of the Intercreditor Agreement shall govern.” 

In addition, the Second Lien Administrative Agent agrees that each Second Lien Collateral Document under which any Lien on
real property owned by any Grantor is granted to secure the Second Lien Obligations covering any Collateral shall contain such other language as the First Lien Administrative Agent may reasonably request to reflect the priority of the First Lien
Collateral Document covering such Collateral over such Second Lien Collateral Document. 
 (e) Notwithstanding
the foregoing clauses (a) and (b) of this Section 5.3. until the date upon which the Discharge of First Lien Obligations shall have occurred, in the event the 
 CHARl\1175377v2 
 21 

  

 

 

  
 First Lien
Administrative Agent or the First Lien Claimholders enter into any amendment, waiver or consent in respect of any of the First Lien Collateral Documents for the purpose of adding to, or deleting from, or waiving or consenting to any departures from
any provisions of any First Lien Collateral Document or changing in any manner the rights of the First Lien Administrative Agent, the First Lien Claimholders, the Grantors thereunder, then such amendment, waiver or consent shall automatically apply
in a comparable manner to any comparable provision of the Second Lien Collateral Documents without the consent of the Second Lien Administrative Agent or the Second Lien Claimholders and without any action by the Second Lien Administrative Agent or
any Grantor; provided, however, (A) that no such amendment, waiver or consent shall be effective to (i) release any Lien of the Second Lien Collateral Documents, (ii) remove assets subject to the Lien of the Second Lien Collateral
Documents, (iii) adversely affect the perfection or priority of any such Lien, (iv) reduce the principal of, or interest or other amounts payable on, any amount payable under the Second Lien Credit Agreement or any Second Lien Loan
Document, (v) postpone any date fixed for any payment of principal of, or interest or other amounts payable on, any amounts payable under the Second Lien Credit Agreement or any Second Lien Loan Document, (vi) permit any Liens on the
Collateral not permitted under the Second Lien Loan Documents or Section 6. or (vii) impose duties on the Second Lien Administrative Agent without its consent, except, in the cases of clauses (i), (ii) and (iii), to the extent that a
release of, or adverse effect on the perfection or priority of, such Lien is permitted by Section 5.1 or Section 6, and (B) notice of such amendment, waiver or consent shall have been given to the Second Lien Administrative Agent no
later than 10 days after its effectiveness; provided that the failure to give such notice shall not affect the effectiveness or validity thereof; and provided further that this paragraph is intended solely to set forth provisions by which the Second
Lien Collateral Documents shall be automatically affected by amendments, waivers and consents given by the First Lien Administrative Agent and First Lien Claimholders under the First Lien Credit Agreement and the First Lien Collateral Documents and
is not intended to impose any liability on the First Lien Administrative Agent or First Lien Claimholders. 
 5.4
Rights As Unsecured Creditors. Except as otherwise expressly set forth in Section 2.4, Section 3.1 or Section 6, the Second Lien Administrative Agent and the Second Lien Claimholders may exercise rights and remedies as unsecured
creditors against any Grantor in accordance with the terms of the Second Lien Loan Documents and applicable law. Except as otherwise set forth in Section 2.1 and Section 4, nothing in this Agreement shall prohibit the receipt by the Second
Lien Administrative Agent or any Second Lien Claimholders of the required payments of interest and principal so long as such receipt is not the direct or indirect result of the exercise by the Second Lien Administrative Agent or any Second Lien
Claimholders of rights or remedies as a secured creditor (including set-off or recoupment) or enforcement of any Lien held by any of them. Nothing in this Agreement impairs or otherwise adversely affects any rights or remedies the First Lien
Administrative Agent or the First Lien Claimholders may have with respect to the Collateral. In the event that any Second Lien Claimholder becomes a judgment Lien creditor as a result of its enforcement of its rights as an unsecured creditor, such
judgment Lien shall be subject to the terms of this Agreement for all purposes to the same extent as all other Liens securing the Second Lien Obligations subject to this Agreement. 

5.5 Control Agent for Perfection. 
 (a) The First Lien Administrative Agent, on behalf of itself and the First Lien Claimholders, and the Second Lien Administrative Agent, on behalf of itself and the Second Lien
Claimholders, each hereby appoints Bank of America, N.A. as its collateral agent (in such capacity, together with any successor in such capacity appointed by the First Lien Administrative Agent and the Second Lien Administrative Agent, the
“Control Agent”) for the limited purpose of acting as the agent on behalf of the First Lien Administrative Agent (on behalf of itself and the 
 CHARl\1175377v2 
 22 

  

 

 

  
 First Lien
Claimholders) and the Second Lien Administrative Agent (on behalf of itself and the Second Lien Claimholders) with respect to the Control Collateral for purposes perfecting the Liens of such parties on the Control Collateral. The Control Agent
accepts such appointment and agrees to hold the Control Collateral in its possession or control (or in the possession or control of its agents or bailees) as Control Agent for the benefit of the First Lien Administrative Agent (on behalf of itself
and the First Lien Claimholders) and the Second Lien Administrative Agent (on behalf of itself and the Second Lien Claimholders) and any permitted assignee of any thereof solely for the purpose of perfecting the security interest granted to such
parties in such Control Collateral, subject to the terms and conditions of this Section 5.5. The First Lien Administrative Agent and the Second Lien Administrative Agent hereby acknowledge that the Control Agent will obtain “control”
under the UCC over each Controlled Account to the extent required by the First Lien Collateral Documents and the Second Lien Collateral Documents for the benefit of both the First Lien Administrative Agent (on behalf of itself and the First Lien
Claimholders) and the Second Lien Administrative Agent (on behalf of itself and the Second Lien Claimholders) pursuant to the control agreements relating to each respective Controlled Account. The First Lien Administrative Agent and the Second Lien
Administrative Agent hereby also acknowledge and agree that the Control Agent will obtain landlord lien waivers as contemplated by the First Lien Collateral Documents and the Second Lien Collateral Documents for the benefit of (i) the First
Lien Administrative Agent for the benefit of the First Lien Claimholders and (ii) the Second Lien Administrative Agent for the benefit of Second Lien Claimholders. 
 (b) The Control Agent, the First Lien Administrative Agent, on behalf of itself and the First Lien Claimholders, and the Second Lien Administrative Agent, on behalf of itself and the
Second Lien Claimholders, each hereby agrees that the First Lien Administrative Agent shall have the sole and exclusive right and authority to give instructions to, and otherwise direct, the Control Agent in respect of the Control Collateral or any
control agreement with respect to any Control Collateral until the earlier of (i) the date upon which the Discharge of First Lien Obligations shall have occurred and (ii) the Second Lien Enforcement Date and neither the Second Lien
Administrative Agent nor any Second Lien Claimholder will impede, hinder, delay or interfere with the exercise of such rights by the First Lien Administrative Agent in any respect, other than by taking Permitted Second Lien Actions. The Grantors
hereby jointly and severally agree to pay, reimburse, indemnify and hold harmless the Control Agent to the same extent and on the same terms that the Grantors are required to do so for the First Lien Administrative Agent in accordance with the First
Lien Credit Agreement as in effect on the date hereof. The First Lien Claimholders and the Second Lien Claimholders hereby jointly and severally agree to pay, reimburse, indemnify and hold harmless the Control Agent to the same extent and on the
same terms that the First Lien Claimholders are required to do so for the First Lien Administrative Agent in accordance with the First Lien Credit Agreement and the Second Lien Claimholders are required to do so for the Second Lien Administrative
Agent in accordance with the Second Lien Credit Agreement. 
 (c) The provisions of Section 10 of the First
Lien Credit Agreement and Section 10 of the Second Lien Credit Agreement shall inure to the benefit of the Control Agent (as if the Control Agent were the agent named therein) in respect of this Agreement, the First Lien Collateral Documents
and the Second Lien Collateral Documents and shall be binding upon all Grantors, all First Lien Claimholders and all Second Lien Claimholders and upon the parties hereto in such respect. In furtherance and not in derogation of the rights, privileges
and immunities of the Control Agent therein set forth: 
 (i) The Control Agent is authorized to take all such
actions as are provided to be taken by it as Control Agent hereunder, under any First Lien Collateral Document, 

CHAR1M 175377v2 
 23 

  

 

 

  
 under any
Second Lien Collateral Document or as instructed by the First Lien Administrative Agent or the Second Lien Administrative Agent as provided herein, in each case together with all other actions reasonably incidental thereto. As to any matters not
expressly provided for herein (including, without limitation, the timing and methods of realization upon the Collateral) or in one or more of the First Lien Collateral Documents or Second Lien Collateral Documents, the Control Agent shall act or
refrain from acting in accordance with written instructions from the First Lien Administrative Agent or the Second Lien Administrative Agent, as applicable, or, in the absence of such instructions or provisions, in accordance with its reasonable
discretion. 
 (ii) The Control Agent shall not be responsible for the existence, genuineness or value of any of
the Collateral or for the validity, perfection, priority or enforceability of any Lien created under and First Lien Collateral Document or Second Lien Collateral Document in any of the Collateral, whether impaired by operation of Law or by reason of
any action or omission to act on its part hereunder unless such action or omission constitutes gross negligence or willful misconduct. The Control Agent shall not have a duty to ascertain or inquire as to the performance or observance of any of the
terms of this Agreement, and First Lien Collateral Document or any Second Lien Collateral Document by any Grantor. This Agreement shall not subject the Control Agent to any obligation or liability except as expressly set forth herein. In particular,
the Control Agent shall have no duty to investigate whether the obligations of any Grantor to the First Lien Administrative Agent or the Second Lien Administrative Agent or any other First Lien Claimholder or Second Lien Claimholder are in default
or whether the First Lien Administrative Agent or the Second Lien Administrative Agent is entitled under the First Lien Collateral Documents or the Second Lien Collateral Documents, as applicable, or otherwise to give any instructions or notice of
exclusive control. The Control Agent is fully entitled to rely upon such instructions as it believes in good faith to have originated from the First Lien Administrative Agent or the Second Lien Administrative Agent, as applicable. 

(iii) Except as set forth in clause (iv) below, the Control Agent shall have no obligation whatsoever to the First
Lien Administrative Agent, the Second Lien Administrative Agent, any First Lien Claimholder or any Second Lien Claimholder including, without limitation, any obligation to assure that the Control Collateral is owned by any Grantor or one of their
respective Subsidiaries or to preserve rights or benefits of any Person except as expressly set forth in this Section 5.5. 
 (iv) In acting on behalf of the Second Lien Administrative Agent and the Second Lien Claimholders and the First Lien Administrative Agent and the First Lien Claimholders, the duties or
responsibilities of the Control Agent under this Section 5.5 shall be limited solely to: 
 (A) physically
holding the Control Collateral delivered to the Control Agent by any Grantor as agent for the First Lien Administrative Agent (on behalf of itself and the First Lien Claimholders) and the Second Lien Administrative Agent (on behalf of itself and the
Second Lien Claimholders) for purposes of perfecting the Lien held by the First Lien Administrative Agent and the Second Lien Administrative Agent; 
 (B) delivering such collateral as set forth in Section 5.5ff) and £g); 
 CHARl\1175377v2 
 24 

  

 

 

  
 (C) to the
extent required by the First Lien Collateral Documents and the Second Lien Collateral Documents, entering into one or more control agreements in form and substance satisfactory to the Control Agent, the First Lien Administrative Agent and the Second
Lien Administrative Agent with respect to Control Collateral consisting of deposit accounts, securities accounts, uncertificated securities or letter-of-credit rights and exercising the rights of the secured party thereunder in accordance with the
instructions of, and on behalf of, the First Lien Administrative Agent and/or the Second Lien Administrative Agent, as applicable; and 
 (D) delivering any notices received by it with respect to any item of Control Collateral in its possession or control to each of the First Lien Administrative Agent and the Second Lien
Administrative Agent. 
 (d) The rights of the Second Lien Administrative Agent shall at all times be subject to
the terms of this Agreement and to the First Lien Administrative Agent’s rights under the First Lien Loan Documents. 
 (e) Neither the Control Agent nor the First Lien Administrative Agent shall have by reason of the Second Lien Loan Documents or this Agreement or any other document a fiduciary
relationship in respect of any Second Lien Claimholder or any Grantor. The Control Agent shall not have by reason of the First Lien Loan Documents, the Second Lien Loan Documents or this Agreement or any other document a fiduciary relationship to
any First Lien Claimholder, any Second Lien Claimholder or any Grantor. 
 (f) Upon the Discharge of First Lien
Obligations (other than in connection with a Refinancing of the First Lien Obligations), the Control Agent shall deliver the Control Collateral together with the necessary endorsements to either (i) the Second Lien Administrative Agent (or
otherwise allow the Second Lien Administrative Agent to obtain control of such Control Collateral) and the Second Lien Administrative Agent shall accept and succeed to the role of the Control Agent as the agent for perfection on the Control
Collateral or (ii) as a court of competent jurisdiction may otherwise direct. 
 (g) The Control Agent shall
have an unfettered right to resign as Control Agent upon 30 days notice to the First Lien Administrative Agent and the Second Lien Administrative Agent. If upon the effective date of such resignation no successor to the Control Agent has been
appointed by the First Lien Administrative Agent and the Second Lien Administrative Agent, the Control Agent shall deliver to either (i) the First Lien Administrative Agent the Control Collateral together with any necessary endorsements (or
otherwise allow the First Lien Administrative Agent to obtain control of such Control Collateral) and the First Lien Administrative Agent shall accept and succeed to the role of the Control Agent as the agent for perfection on the Control
Collateral, or (ii) as a court of competent jurisdiction may otherwise direct. 
 5.6 When Discharge of
First Lien Obligations Deemed to Not Have Occurred. If in connection with the Discharge of First Lien Obligations, the Company enters into any Refinancing of any First Lien Loan Document evidencing a First Lien Obligation which Refinancing is
permitted hereby and by the terms of the Second Lien Loan Documents, then such Discharge of First Lien Obligations shall automatically be deemed not to have occurred for all purposes of this Agreement (other than with respect to any actions taken
prior to the date of such designation as a result of the occurrence of such first Discharge of First Lien Obligations), and the obligations under such Refinancing (and related documents) shall automatically be treated as First Lien Obligations for
all purposes of this Agreement, including for 
 CHARl\1175377v2 

25 

  

 

 

  
 purposes of the
Lien priorities and rights in respect of Collateral set forth herein, and the First Lien Administrative Agent under such First Lien Loan Documents shall be a First Lien Administrative Agent for all purposes of this Agreement. Upon receipt of a
notice stating that the Company has entered into a new First Lien Loan Document (which notice shall include the identity of the new collateral agent, such agent, the “New Agent”), the Second Lien Administrative Agent shall promptly enter
into such documents and agreements (including amendments or supplements to this Agreement) as the Company or such New Agent shall reasonably request in order to provide to the New Agent the rights contemplated hereby, in each case consistent in all
material respects with the terms of this Agreement. If the new First Lien Obligations under the new First Lien Loan Documents are secured by assets of the Grantors of the type constituting Collateral that do not also secure the Second Lien
Obligations, then the Second Lien Obligations shall be secured at such time by a second priority Lien on such assets to the same extent provided in the Second Lien Collateral Documents provided, however, notwithstanding the above, that the refusal
of the Second Lien Administrative Agent or the Second Lien Claimholders to accept a Lien on any assets of any Grantor shall not prohibit the taking of a Lien on such assets by the First Lien Administrative Agent or the First Lien Claimholders.

 5.7 Option to Purchase First Lien Debt, (a) Without prejudice to the enforcement of remedies by the First
Lien Claimholders, any Person or Persons (in each case who must meet all eligibility standards contained in all relevant First Lien Loan Documents (not to be more restrictive than those in effect on the date hereof) at any time or from time to time
designated by the holders of more than 50% in aggregate outstanding principal amount of the Second Lien Obligations as being entitled to exercise all default purchase options as to the Second Lien Obligations then outstanding (an “Eligible
Purchaser”) shall have the right to purchase by way of assignment (and shall thereby also assume all commitments and duties of the First Lien Claimholders), at any time during the exercise period described in clause (c) below of this
Section 5.7, all, but not less than all, of the First Lien Obligations (other than the First Lien Obligations of a Defaulting Creditor), including all principal of and accrued and unpaid interest and fees on and all prepayment or acceleration
penalties and premiums in respect of all First Lien Obligations outstanding at the time of purchase. Upon receipt of a notice in accordance with Section 5.7(b) from an Eligible Purchaser, the First Lien Claimholders shall have no further
obligation under this Section 5.7 to sell the First Lien Obligations to any other Eligible Purchaser thereafter providing notice under Section 5.7(b). Any purchase pursuant to this Section 5.7(a) shall be made as follows: 

(1) for (x) a purchase price equal to the sum of (A) in the case of all loans, advances or other similar
extensions of credit that constitute First Lien Obligations (including unreimbursed amounts drawn in respect of letters of credit, but excluding the undrawn amount of then outstanding letters of credit), 100% of the principal amount thereof and all
accrued and unpaid interest thereon through the date of purchase (including any acceleration prepayment penalties or premiums), (B) in the case of any Hedge Agreement constituting a First Lien Loan Document, the net aggregate amount then owing
to each Hedge Agreement Provider thereunder pursuant to the terms of the respective Hedge Agreement, including without limitation all amounts owing to such Hedge Agreement Provider as a result of the termination (or early termination) thereof
(C) in the case of any Designated Cash Management Agreement constituting a First Lien Loan Document, the net aggregate amount then owing to each Cash Management Creditor thereunder pursuant to the terms of the respective Designated Cash
Management Agreement, including without limitation all amounts owing to such Cash Management Creditor as a result of the termination (or early termination) thereof, plus (D) all accrued and unpaid fees, expenses, indemnities and other amounts
through the date of purchase; and (y) an obligation on the part of the respective Eligible Purchasers (which shall be expressly provided in the assignment documentation described below) to reimburse each issuing lender (or any First Lien
Claimholder required to pay same) for all amounts thereafter drawn with respect to any letters of credit constituting First Lien Obligations which remain outstanding after the date of any purchase 

CHARl\1175377v2 
 26 

  

 

 

  
 pursuant to
this Section 5.7, together with all facing fees and other amounts which may at any future time be owing to the respective issuing lender with respect to such letters of credit; 

(2) with the purchase price described in preceding clause (a)(l)(x) payable in cash on the date of purchase against
transfer to the respective Eligible Purchaser or Eligible Purchasers (without recourse and without any representation or warranty whatsoever, whether as to the enforceability of any First Lien Obligation or the validity, enforceability, perfection,
priority or sufficiency of any Lien securing, or guarantee or other supporting obligation for, any First Lien Obligation or as to any other matter whatsoever, except the representation and warranty that the transferor owns free and clear of all
Liens and encumbrances (other than participation interests not prohibited by the First Lien Credit Agreement, in which case the purchase price described in preceding clause (a)(l)(x) shall be appropriately adjusted so that the Eligible Purchaser or
Eligible Purchasers do not pay amounts represented by any participation interest which remains in effect), and has the right to convey, whatever claims and interests it may have in respect of the First Lien Obligations); provided that the purchase
price in respect of any outstanding letter of credit that remains undrawn on the date of purchase shall be payable in cash as and when such letter of credit is drawn upon (i) first, from the cash collateral account described in clause (a)(3)
below, until the amounts contained therein have been exhausted, and (ii) thereafter, directly by the respective Eligible Purchaser or Eligible Purchasers; 
 (3) with such purchase accompanied by a deposit of cash collateral under the sole dominion and control of the First Lien Administrative Agent or its designee in an amount equal to 105% of
the sum of the aggregate undrawn amount of all then outstanding letters of credit pursuant to the First Lien Loan Documents and the aggregate facing and similar fees which will accrue thereon through the stated maturity of the letters of credit
(assuming no drawings thereon before stated maturity), as security for the respective Eligible Purchaser’s or Eligible Purchasers’ obligation to pay amounts as provided in preceding clause (a)(l)(v), it being understood and agreed that
(x) at the time any facing or similar fees are owing to an issuer with respect to any letter of credit, the First Lien Administrative Agent may apply amounts deposited with it as described above to pay same and (y) upon any drawing under
any letter of credit, the First Lien Administrative Agent shall apply amounts deposited with it as described above to repay the respective unpaid drawing and any customary fees charged by the issuer in connection with such draws. After giving effect
to any payment made as described above in this clause (3), those amounts (if any) then on deposit with the First Lien Administrative Agent as described in this clause (3) which exceed 105% of the sum of the aggregate undrawn amount of all then
outstanding letters of credit and the aggregate facing and similar fees (to the respective issuers) which will accrue thereon through the stated maturity of the then outstanding letters of credit (assuming no drawings thereon before stated
maturity), shall be returned to the respective Eligible Purchaser or Eligible Purchasers (as their interests appear). Furthermore, at such time as all letters of credit have been cancelled, expired or been fully drawn, as the case may be, and after
all applications described above have been made, any excess cash collateral deposited as described above in this clause (3) (and not previously applied or released as provided above) shall be returned to the respective Eligible Purchaser or
Eligible Purchasers, as their interests appear; 
 (4) with the purchase price described in preceding clause
(a)(l)(x) accompanied by a waiver by the Second Lien Administrative Agent (on behalf of itself and the other Second Lien Claimholders) of all claims arising out of this Agreement and the transactions contemplated hereby as a result of exercising the
purchase option contemplated by this Section 5.7; 
 CHARl\1175377v2 

27 

  

 

 

  
 (5) with all
amounts payable to the various First Lien Claimholders in respect of the assignments described above to be distributed to them by the First Lien Administrative Agent in accordance with their respective holdings of the various First Lien Obligations;
and 
 (6) with such purchase to be made pursuant to assignment documentation in form and substance reasonably
satisfactory to, and prepared by counsel for, the First Lien Administrative Agent (with the cost of such counsel to be paid by the respective Eligible Purchaser or Eligible Purchasers); it being understood and agreed that the First Lien
Administrative Agent and each other First Lien Claimholder shall retain all rights to indemnification as provided in the relevant First Lien Loan Documents for all periods prior to any assignment by them pursuant to the provisions of this
Section 5.7. The relevant assignment documentation shall also provide that, if for any reason (other than the gross negligence or willful misconduct of the First Lien Administrative Agent), the amount of cash collateral held by the First Lien
Administrative Agent or its designee pursuant to preceding clause (a)(3) is at any time less than the full amounts owing with respect to any letter of credit described above (including facing and similar fees) then the respective Eligible Purchaser
or Eligible Purchasers shall promptly reimburse the First Lien Administrative Agent (who shall pay the respective issuing bank) the amount of deficiency. 
 (b) The right to exercise the purchase option described in Section 5.7(a) above shall be exercisable and legally enforceable upon at least seven Business Days’ prior written
notice of exercise (which notice, once given, shall be irrevocable and fully binding on the respective Eligible Purchaser or Eligible Purchasers) given to the First Lien Administrative Agent by an Eligible Purchaser. Neither the First Lien
Administrative Agent nor any other First Lien Claimholder shall have any disclosure obligation to any Eligible Purchaser, the Second Lien Administrative Agent or any other Second Lien Claimholder in connection with any exercise of such purchase
option. 
 (c) The right to purchase the First Lien Obligations as described in this Section 5.7 may be
exercised (by giving the irrevocable written notice described in preceding clause (b)) during each of the periods that (1) begins on the date occurring three (3) Business Days after the first to occur of (x) the date of the
acceleration of the final maturity of the loans under the First Lien Credit Agreement, (y) the occurrence of the final maturity of the loans under the First Lien Credit Agreement or (z) the occurrence of an Insolvency or Liquidation
Proceeding with respect to the Company or any Grantor that constitutes an event of default under the First Lien Credit Agreement (in the case of preceding clauses (x) and (y), so long as the acceleration or failure to pay amounts due at final
maturity has not been rescinded or cured, as the case may be, within such three (3) Business Day Period, and so long as any unpaid amounts constituting First Lien Obligations remain owing) and (2) ends on the 60th day after the start of
the applicable period described above. 
 (d) The obligations of the First Lien Claimholders to sell their
respective First Lien Obligations under this Section 5.7 are several and not joint and several. To the extent any First Lien Claimholder (a “Defaulting Creditor”) breaches its obligation to sell its First Lien Obligations under this
Section 5.7, nothing in this Section 5.7 shall be deemed to require the First Lien Administrative Agent or any other First Lien Claimholder to purchase such Defaulting Creditor’s First Lien Obligations for resale to the holders of
Second Lien Obligations and in all cases, the First Lien Administrative Agent and each First Lien Claimholder complying with the terms of this Section 5.7 shall not be deemed to be in default of this Agreement or otherwise be deemed liable for
any action or inaction of any Defaulting Creditor; provided that nothing in this clause (d) shall require any Eligible Purchaser to purchase less than all of the First Lien Obligations. 

CHARl\1175377v2 
 28 

  

 

 

  
 (e) Each
Grantor irrevocably consents to any assignment effected to one or more Eligible Purchasers pursuant to this Section 5.7 for purposes of all First Lien Loan Documents and hereby agrees that no further consent from such Grantor shall be required.

 SECTION 6 Insolvency or Liquidation Proceedings. 

6.1 Use of Cash Collateral and Financing Issues. Until the Discharge of First Lien Obligations has occurred, if Company or
any other Grantor shall be subject to any Insolvency or Liquidation Proceeding and the First Lien Administrative Agent shall desire to permit the use of cash collateral on which the First Lien Administrative Agent or any other creditor has a Lien or
to permit Company or any other Grantor to obtain financing, from one of more of the First Lien Claimholders or any other Person approved by the First Lien Administrative Agent under Section 363 or Section 364 of the Bankruptcy Code or any
similar Bankruptcy Law (each, a “DIP Financing”), then, so long as the maximum principal amount of Indebtedness that may be outstanding from time to time in connection with such DIP Financing, together with the principal amount of First
Lien Obligations (but excluding Hedging Obligations and Obligations in respect of Designated Cash Management Agreements) outstanding at such time (after giving effect to the application of the proceeds of any DIP Financing to refinance all or any
portion of the First Lien Obligations) shall not exceed the Maximum First Lien Indebtedness Amount then the Second Lien Administrative Agent, on behalf of itself and the Second Lien Claimholders, (A) agrees that it will raise no objection to,
or otherwise contest or interfere with, such use of cash collateral or DIP Financing on the grounds of adequate protection or otherwise nor support any other Person objecting to, or otherwise contest or interfere with, such sale, use, or lease of
cash collateral or DIP Financing and will not request any form of adequate protection or any other relief in connection therewith (except as agreed by the First Lien Administrative Agent or to the extent expressly permitted by Section 6.4) and,
to the extent the Liens securing the First Lien Obligations are subordinated to or pari passu with such DIP Financing, the Second Lien Administrative Agent will subordinate its Liens in the Collateral to (x) the Liens securing such DIP
Financing (and all Obligations relating thereto), (y) any adequate protection Liens provided to the First Lien Claimholders and (z) any “carve-out” for professional and United States Trustee fees agreed to by the First Lien
Administrative Agent; and (B) agrees that notice received two (2) calendar days prior to the entry of an order approving such usage of cash collateral or approving such DIP Financing shall be adequate notice provided that the foregoing
shall not prohibit the Second Lien Administrative Agent or the Second Lien Claimholders from objecting solely to any provisions in any DIP Financing relating to, describing or requiring any provision or content of a plan of reorganization other than
any provisions requiring that the DIP Financing be paid in full in cash. Nothing set forth in this Agreement shall restrict the Second Lien Claimholders from proposing debtor-in-possession financing, or the First Lien Claimholders from objecting
thereto on any grounds. 
 6.2 Sale Issues. The Second Lien Agent, on behalf of itself and the Second Lien
Claimholders, agrees that it will raise no objection to or otherwise contest or oppose a sale or other disposition of any Collateral (and any post-petition assets subject to adequate protection Liens in favor of the First Lien Administrative Agent)
free and clear of its Liens or other claims under Section 363 of the Bankruptcy Code if the Required Lenders under the First Lien Credit Agreement have consented to such sale or disposition of such assets so long as the interests of the Second
Lien Claimholders in the Collateral (and any post-petition assets subject to adequate protection liens, if any, in favor of the Second Lien Administrative Agent) attach to the proceeds thereof, subject to the terms of this Agreement. If requested by
the First Lien Administrative Agent in connection therewith, the Second Lien Administrative Agent shall affirmatively consent to the release of its lien in connection with such a sale or disposition. 

6.3 Relief from the Automatic Stay. Until the Discharge of First Lien Obligations has occurred, the Second Lien
Administrative Agent, on behalf of itself and the Second Lien Claimholders, agrees that none of them shall (i) seek relief from the automatic stay or any other stay in any Insolvency 

CHARl\1175377v2 
 29 

  

 

 

  
 or Liquidation
Proceeding in respect of the Collateral, without the prior written consent of the First Lien Administrative Agent, or (ii) oppose any request by the First Lien Administrative Agent or any First Lien Claimholder to seek relief from the automatic
stay or any other stay in any Insolvency or Liquidation Proceeding in respect of the Collateral. 
 6.4 Adequate
Protection, (a) The Second Lien Administrative Agent, on behalf of itself and the Second Lien Claimholders, agrees that none of them shall contest or object to, (or support any other person contesting or objecting to) (i) any request by
the First Lien Administrative Agent or the First Lien Claimholders for adequate protection or (ii) any objection by the First Lien Administrative Agent or the First Lien Claimholders to any motion, relief, action or proceeding based on the
First Lien Administrative Agent or the First Lien Claimholders claiming a lack of adequate protection. In any Insolvency or Liquidation Proceeding, the Second Lien Administrative Agent, on behalf of itself and the Second Lien Claimholders, may seek
adequate protection in respect of the Second Lien Obligations, subject to the provisions of this Agreement, only if (A) the First Lien Claimholders (or any subset thereof) are granted adequate protection in the form of additional collateral
including replacement liens on post-petition collateral, and (B) such additional protection requested by the Second Lien Administrative Agent is in the form of a Lien on such additional collateral, which Lien, if granted, will be subordinated
to the adequate protection Liens securing the First Lien Obligations and the Liens securing any DIP Financing (and all Obligations relating thereto) on the same basis as the other Liens securing the Second Lien Obligations are so subordinated to the
Liens securing the First Lien Obligations under this Agreement and the Liens securing any such DIP Financing. In the event the Second Lien Administrative Agent, on behalf of itself or any of the Second Lien Claimholders, seeks or requests adequate
protection in respect of Second Lien Obligations and such adequate protection is granted in the form of additional collateral, then the Second Lien Administrative Agent, on behalf of itself and the Second Lien Claimholders, agrees that as a
condition to the Second Lien Administrative Agent’s receipt of such Lien, the First Lien Administrative Agent also shall be granted a Lien on such additional collateral as security for the First Lien Obligations and for any DIP Financing and
that any Lien on such additional collateral securing the Second Lien Obligations shall be subordinated to the Liens on such collateral securing the First Lien Obligations and any DIP Financing (and all Obligations relating thereto) and to any other
Liens granted to the First Lien Claimholders as adequate protection on the same basis as the other Liens securing the Second Lien Obligations are so subordinated to the Liens securing the First Lien Obligations under this Agreement and the Liens
securing any DIP Financing. Each of the Second Lien Lenders agrees, pursuant to Section 1129(a)(9) of the Bankruptcy Code, that such junior superpriority claims (including any claim arising under 11 U.S.C. §507(b)) may be paid under any
plan of reorganization in any combination of cash, debt, equity or other property having a value on the effective date of such plan equal to the allowed amount of such claims. Each of the Second Lien Lenders agrees that, upon the request of the
First Lien Administrative Agent, they shall waive a right to distributions of proceeds of Avoidance Actions in respect of any claim granted to the Second Lien Lenders in connection with the DIP Financing or cash collateral usage or arising as a
result of the Second Lien Lenders’ rights under 11 U.S.C. §507(b). Each of the Second Lien Lenders agrees that except as expressly set forth in this Section, none of them shall seek or accept adequate protection without the prior written
consent of the First Lien Administrative Agent. 
 (b) Similarly, if the First Lien Claimholders (or any subject
thereof) are granted adequate protection in the form of a superpriority claim, then the Second Lien Administrative Agent, on behalf of itself or any of the Second Lien Claimholders, may seek or request a superpriority claim, which superpriority
claim will be junior in all respects to the superpriority claim granted to the First Lien Administrative Agent and the First Lien Claimholders, and, in the event that the Second Lien Administrative Agent, on behalf of itself or any of the Second
Lien Claimholders, seeks or requests adequate protection in respect of Second Lien Obligations and such adequate protection is granted in the form of a superpriority claim, then the Second Lien Administrative Agent, on behalf of itself and the

 CHARl\1175377v2 
 30 

  

 

 

  
 Second Lien
Claimholders, agrees that the First Lien Administrative Agent and the providers of any DIP Financing also shall be granted a superpriority claim, which superpriority claim will be senior in all respects to the superpriority claim granted to the
Second Lien Administrative Agent and the Second Lien Claimholders. 
 6.5 No Waiver. Nothing contained herein
shall prohibit or in any way limit the First Lien Administrative Agent or any First Lien Claimholder from objecting in any Insolvency or Liquidation Proceeding or otherwise to any action taken by the Second Lien Administrative Agent or any of the
Second Lien Claimholders, including the seeking by the Second Lien Administrative Agent or any Second Lien Claimholders of adequate protection or the asserting by the Second Lien Administrative Agent or any Second Lien Claimholders of any of its
rights and remedies under the Second Lien Loan Documents or otherwise; provided, however, that this Section 6.5 shall not limit the rights of the Second Lien Claimholders under the proviso to clauses (i) and (ii) of
Section 3.1(a)(ii) or under Section 5.4. Section 6.4 or Section 6.9. 
 6.6 Avoidance Issues.
If any First Lien Claimholder is required in any Insolvency or Liquidation Proceeding, or otherwise, to turn over or otherwise pay to the estate of Company or any other Grantor any amount in respect of a First Lien Obligation (a
“Recovery”), then such First Lien Claimholders shall be entitled to a reinstatement of First Lien Obligations with respect to all such recovered amounts. If this Agreement shall have been terminated prior to such Recovery, this Agreement
shall be reinstated in full force and effect, and such prior termination shall not diminish, release, discharge, impair or otherwise affect the obligations of the parties hereto from such date of reinstatement. Collateral or proceeds thereof
received by the Second Lien Administrative Agent or any Second Lien Claimholder after a Discharge of First Lien Obligations and prior to the reinstatement of such First Lien Obligations shall be delivered to the First Lien Administrative Agent upon
such reinstatement in accordance with Section 4.2. 
 6.7 Separate Grants of Security and Separate
Classification. Each of the Grantors, the First Lien Claimholders and the Second Lien Claimholders acknowledges and agrees that (i) the grants of Liens pursuant to the First Lien Collateral Documents and the Second Lien Collateral Documents
constitute two separate and distinct grants of Liens and (ii) because of, among other things, their differing rights in the Collateral, the Second Lien Obligations are fundamentally different from the First Lien Obligations and must be
separately classified in any plan of reorganization proposed or adopted in an Insolvency or Liquidation Proceeding. To further effectuate the intent of the parties as provided in the immediately preceding sentence, if it is held that the claims of
the First Lien Claimholders and Second Lien Claimholders in respect of the Collateral constitute only one secured claim (rather than separate classes of senior and junior secured claims), then the First Lien Claimholders shall be entitled to
receive, in addition to amounts distributed to them from, or in respect of, the Collateral in respect of principal, pre- petition interest and other claims, all amounts owing in respect of post-petition interest, fees, costs and other charges,
irrespective of whether a claim for such amounts is allowed or allowable in such Insolvency or Liquidation Proceeding, until the occurrence of the Discharge of First Lien Obligations, before any distribution from, or in respect of, any Collateral is
made in respect of the claims held by the Second Lien Claimholders), with the Second Lien Claimholders hereby acknowledging and agreeing to turn over to the First Lien Claimholders amounts otherwise received or receivable by them to the extent
necessary to effectuate the intent of this sentence, even if such turnover has the effect of reducing the claim or recovery of the Second Lien Claimholders. 
 6.8 Reorganization Securities. If, in any Insolvency or Liquidation Proceeding, debt obligations of the reorganized debtor secured by Liens upon any property of the reorganized debtor are
distributed pursuant to a plan of reorganization or similar dispositive restructuring plan, both on account of First Lien Obligations and on account of Second Lien Obligations, then, to the extent the debt 

CHARl\1175377v2 
 31 

  

 

 

  
 obligations
distributed on account of the First Lien Obligations and on account of the Second Lien Obligations are secured by Liens upon the same property, the provisions of this Agreement will survive the distribution of such debt obligations pursuant to such
plan and will apply with like effect to the Liens securing such debt obligations. 
  

	 6.9
	 Post-Petition Claims. 

Neither the Second Lien Administrative Agent nor any other Second Lien Claimholder shall oppose or seek to challenge any
claim by the First Lien Administrative Agent or any First Lien Claimholder for allowance in any Insolvency or Liquidation Proceeding of First Lien Obligations consisting of post-petition interest, fees, costs, charges or expenses to the extent of
the value of the lien of the First Lien Administrative Agent held for the benefit of the First Lien Claimholders, without regard to the existence of the Lien of the Second Lien Administrative Agent on behalf of the Second Lien Claimholders on the
Collateral. 
 6.10 Waiver. The Second Lien Administrative Agent, for itself and on behalf of the Second Lien
Claimholders, waives any claim it or they may hereafter have against the First Lien Administrative Agent or any First Lien Claimholder arising out of the election of the First Lien Administrative Agent or any First Lien Claimholder of the
application of Section 1111 (b)(2) of the Bankruptcy Code, or out of any cash collateral or financing arrangement in accordance with Section 6.1 hereof or out of any grant of a security interest in connection with the Collateral in any
Insolvency or Liquidation Proceeding. 
 6.11 Expense Claims. Neither Second Lien Administrative Agent nor any
Second Lien Claimholder will (i) contest the payment of fees, expenses or other amounts to the First Lien Administrative Agent or any First Lien Claimholder under Section 506(b) of the Bankruptcy Code or otherwise to the extent provided
for in the First Lien Credit Agreement or (ii) assert or enforce, at any time prior to the Discharge of First Lien Obligations, any claim under Section 506(c) of the Bankruptcy Code senior to or on parity with the First Lien Obligations
for costs or expenses of preserving or disposing of any Collateral. 
 6.12 Effectiveness in Insolvency or
Liquidation Proceedings. This Agreement, which the parties hereto expressly acknowledge is a “subordination agreement” under Section 510(a) of the Bankruptcy Code, shall be effective before, during and after the commencement of an
Insolvency or Liquidation Proceeding. All references in this Agreement to any Grantor shall include such Person as a debtor-in-possession and any receiver or trustee for such Person in any Insolvency or Liquidation Proceeding. 

SECTION 7 Reliance; Waivers; Etc. 
 7.1 Non-Reliance 
 (a) The consent by the First
Lien Claimholders to the execution and delivery of the Second Lien Loan Documents and the grant to the Second Lien Administrative Agent on behalf of the Second Lien Claimholders of a Lien on the Collateral and all loans and other extensions of
credit made or deemed made on and after the date hereof by the First Lien Claimholders to the Grantors shall be deemed to have been given and made in reliance upon this Agreement. The Second Lien Administrative Agent, on behalf of itself and the
Second Lien Claimholders, acknowledges that it and the Second Lien Claimholders have, independently and without reliance on the First Lien Administrative Agent or any First Lien Claimholder, and based on documents and information deemed by them
appropriate, made their own credit analysis and decision to enter into the Second Lien Credit Agreement, the other Second Lien Loan Documents, this 
 CHARl\1175377v2 
 32 

  

 

 

  
 Agreement and
the transactions contemplated hereby and thereby and they will continue to make their own credit decision in taking or not taking any action under the Second Lien Credit Agreement, the other Second Lien Loan Documents or this Agreement. 

(b) The consent by the Second Lien Claimholders to the execution and delivery of the First Lien Loan Documents and the
grant to the First Lien Administrative Agent on behalf of the First Lien Claimholders of a Lien on the Collateral and all loans and other extensions of credit made or deemed made on and after the date hereof by the Second Lien Claimholders to the
Grantors shall be deemed to have been given and made in reliance upon this Agreement. The First Lien Administrative Agent, on behalf of itself and the First Lien Claimholders, acknowledges that it and the First Lien Claimholders have, independently
and without reliance on the Second Lien Administrative Agent or any Second Lien Claimholder, and based on documents and information deemed by them appropriate, made their own credit analysis and decision to enter into the First Lien Credit
Agreement, the other First Lien Loan Documents, this Agreement and the transactions contemplated hereby and thereby and they will continue to make their own credit decision in taking or not taking any action under the First Lien Credit Agreement,
the other First Lien Loan Documents or this Agreement. 
 7.2 No Warranties or Liability. The First Lien
Administrative Agent, on behalf of itself and the First Lien Claimholders, acknowledges and agrees that each of the Second Lien Administrative Agent and the Second Lien Claimholders have made no express or implied representation or warranty,
including with respect to the execution, validity, legality, completeness, collectibility or enforceability of any of the Second Lien Loan Documents, the ownership of any Collateral or the perfection or priority of any Liens thereon. The Second Lien
Claimholders will be entitled to manage and supervise their respective loans and extensions of credit under the Second Lien Loan Documents in accordance with law and as they may otherwise, in their sole discretion, deem appropriate. The Second Lien
Administrative Agent, on behalf of itself and the Second Lien Obligations, acknowledges and agrees that the First Lien Administrative Agent and the First Lien Claimholders have made no express or implied representation or warranty, including with
respect to the execution, validity, legality, completeness, collectibility or enforceability of any of the First Lien Loan Documents, the ownership of any Collateral or the perfection or priority of any Liens thereon. The First Lien Claimholders
will be entitled to manage and supervise their respective loans and extensions of credit under their respective First Lien Loan Documents in accordance with law and as they may otherwise, in their sole discretion, deem appropriate. The Second Lien
Administrative Agent and the Second Lien Claimholders shall have no duty to the First Lien Administrative Agent or any of the First Lien Claimholders, and the First Lien Administrative Agent and the First Lien Claimholders shall have no duty to the
Second Lien Administrative Agent or any of the Second Lien Claimholders, to act or refrain from acting in a manner which allows, or results in, the occurrence or continuance of an event of default or default under any agreements with Company or any
other Grantor (including the First Lien Loan Documents and the Second Lien Loan Documents), regardless of any knowledge thereof which they may have or be charged with. 
 7.3 No Waiver of Lien Priorities. 
 (a) No right of
the First Lien Claimholders, the Control Agent, the First Lien Administrative Agent or any of them to enforce any provision of this Agreement, any First Lien Loan Document shall at any time in any way be prejudiced or impaired by any act or failure
to act on the part of the Company or any other Grantor or by any act or failure to act by the Control Agent, any First Lien Claimholder or the First Lien Administrative Agent, or by any noncompliance by any Person with the terms, provisions and
covenants of this Agreement, any of the First Lien Loan Documents or any of the Second Lien Loan Documents, regardless of any 
 CHARl\1175377v2 
 33 

  

 

 

  
 knowledge
thereof which the Control Agent, any First Lien Claimholder, any First Lien Administrative Agent, or any of them, may have or be otherwise charged with. 
 (b) Without in any way limiting the generality of the foregoing paragraph (but subject to the rights of the Company and the other Grantors under the First Lien Loan Documents and subject
to the provisions of Section 5.3(bT). the First Lien Claimholders, the First Lien Administrative Agent and any of them may, at any time and from time to time in accordance with the First Lien Loan Documents or applicable law, without the
consent of, or notice to, the Second Lien Administrative Agent or any Second Lien Claimholders, without incurring any liabilities to the Second Lien Administrative Agent or any Second Lien Claimholders and without impairing or releasing the Lien
priorities and other benefits provided in this Agreement (even if any right of subrogation or other right or remedy of the Second Lien Administrative Agent or any Second Lien Claimholders is affected, impaired or extinguished thereby) do any one or
more of the following: 
 (i) make loans and advances to any Grantor or issue, guaranty or obtain letters of
credit for account of any Grantor or otherwise extend credit to any Grantor, in any amount and on any terms, whether pursuant to a commitment or as a discretionary advance and whether or not any default or event of default or failure of condition is
then continuing (subject, in each case, to the limits set forth in the definition of “First Lien Obligations” and Section 5.3); 
 (ii) change the manner, place or terms of payment or change or extend the time of payment of, or amend, renew, exchange, increase or alter, the terms of any of the First Lien Obligations
or any Lien on any First Lien Collateral or guaranty thereof or any liability of Company or any other Grantor, or any liability incurred directly or indirectly in respect thereof (including any increase in or extension of the First Lien Obligations,
without any restriction as to the amount, tenor or terms of any such increase or extension, subject to the limits set forth in the definition of “First Lien Obligations”) or, subject to the provisions of this Agreement, otherwise amend,
renew, exchange, extend, modify or supplement in any manner any Liens held by the First Lien Administrative Agent or any of the First Lien Claimholders, the First Lien Obligations or any of the First Lien Loan Documents; provided, however, the
foregoing shall not prohibit the Second Lien Administrative Agent and Second Lien Claimholders from enforcing, consistent with the other terms of this Agreement, any right arising under the Second Lien Credit Agreement as a result of any
Grantor’s violation of the terms thereof. 
 (iii) subject to the provisions of this Agreement, sell,
exchange, release, surrender, realize upon, enforce or otherwise deal with in any manner and in any order any part of the Collateral or any liability of Company or any other Grantor to the First Lien Claimholders or the First Lien Administrative
Agent, or any liability incurred directly or indirectly in respect thereof; 
 (iv) settle or compromise any
First Lien Obligation or any other liability of Company or any other Grantor or any security therefor or any liability incurred directly or indirectly in respect thereof and apply any sums by whomsoever paid and however realized to any liability
(including the First Lien Obligations) in any manner or order; 
 (v) exercise or delay in or refrain from
exercising any right or remedy against Company or any security or any other Grantor or any other Person, elect any remedy and otherwise deal freely with Company, any other Grantor or any First Lien 

CHARl\1175377v2 
 34 

  

 

 

  
 Collateral and
any security and any guarantor or any liability of Company or any other Grantor to the First Lien Claimholders or any liability incurred directly or indirectly in respect thereof; 

(vi) take or fail to take any Lien securing the First Lien Obligations or any other collateral security for any First Lien
Obligations or take or fail to take any action which may be necessary or appropriate to ensure that any Lien securing First Lien Obligations or any other Lien upon any property is duly enforceable or perfected or entitled to priority as against any
other Lien or to ensure that any proceeds of any property subject to any Lien are applied to the payment of any First Lien Obligation or any Obligation secured thereby; or 
 (vii) otherwise release, discharge or permit the lapse of any or all Liens securing the First Lien Obligations or any other Liens upon any property at any time securing any First Lien
Obligations. 
 (c) The Second Lien Administrative Agent, on behalf of itself and the Second Lien Claimholders,
also agrees that the Control Agent, the First Lien Claimholders and the First Lien Administrative Agent shall have no liability to the Second Lien Administrative Agent or any Second Lien Claimholders, and the Second Lien Administrative Agent, on
behalf of itself and the Second Lien Claimholders, hereby waives all claims against the Control Agent, any First Lien Claimholder or the First Lien Administrative Agent, arising out of any and all actions which the Control Agent, the First Lien
Claimholders or the First Lien Administrative Agent may take or permit or omit to take with respect to: (i) the First Lien Loan Documents, (ii) the collection of the First Lien Obligations or (iii) the foreclosure upon, or sale,
liquidation or other disposition of, any Collateral (including, without limitation, the Control Collateral, as applicable). The Second Lien Administrative Agent, on behalf of itself and the Second Lien Claimholders, agrees that the First Lien
Claimholders and the First Lien Administrative Agent have no duty to them in respect of the maintenance or preservation of the Collateral, the First Lien Obligations or otherwise. 

(d) Subject to Section 5.4, the Second Lien Administrative Agent, on behalf of itself and the Second Lien
Claimholders, agrees not to assert and hereby waives, to the fullest extent permitted by law, any right to demand, request, plead or otherwise assert or otherwise claim the benefit of, any marshalling, appraisal, valuation or other similar right
that may otherwise be available under applicable law with respect to the Collateral or any other similar rights a junior secured creditor may have under applicable law. 
 7.4 Obligations Unconditional. All rights, interests, agreements and obligations of the First Lien Administrative Agent and the First Lien Claimholders and the Second Lien Administrative
Agent and the Second Lien Claimholders, respectively, hereunder shall remain in full force and effect irrespective of: 
 (a) any lack of validity or enforceability of any First Lien Loan Documents or any Second Lien Loan Documents or any setting aside or avoidance of any Lien; 

(b) except as otherwise set forth in the Agreement, any change in the time, manner or place of payment of, or in any other
terms of, all or any of the First Lien Obligations or Second Lien Obligations, or any amendment or waiver or other modification, including any increase in the amount thereof, whether by course of conduct or otherwise, of the terms of any First Lien
Loan Document or any Second Lien Loan Document; 
 CHARl\1175377v2 

35 

  

 

 

  
 (c) any
exchange of any security interest in any Collateral or any other collateral, or any amendment, waiver or other modification, whether in writing or by course of conduct or otherwise, of all or any of the First Lien Obligations or Second Lien
Obligations or any guarantee thereof; 
 (d) the commencement of any Insolvency or Liquidation Proceeding in
respect of Company or any other Grantor; or 
 (e) any other circumstances which otherwise might constitute a
defense available to, or a discharge of, the Company or any other Grantor in respect of the First Lien Obligations or of the Second Lien Administrative Agent or any Second Lien Claimholder in respect of this Agreement. 

7.5 Certain Notices. 
 (a) Promptly upon Discharge of First Lien Obligations, the First Lien Administrative Agent shall deliver written notice confirming same to the Second Lien Administrative Agent; provided
that the failure to give any such notice shall not result in any liability of the First Lien Administrative Agent or the First Lien Claimholders hereunder or in the modification, alteration, impairment, or waiver of the rights of any party
hereunder. 
 (b) Promptly upon (or as soon as practicable following) the commencement by the First Lien
Administrative Agent of any Enforcement Action with respect to any Collateral (including by way of a public or private sale of Collateral), the First Lien Administrative Agent shall notify the Second Lien Administrative Agent of such action;
provided that the failure to give any such notice shall not result in any liability of the First Lien Administrative Agent or the First Lien Claimholders hereunder or in the modification, alteration, impairment, or waiver of the rights of any party
hereunder. 
 SECTION 8 Miscellaneous. 
 8.1 Conflicts. As between the First Lien Administrative Agent, the First Lien Claimholders, the Second Lien Administrative Agent and the Second Lien Claimholders, in the event of any
conflict between the provisions of this Agreement and the provisions of the First Lien Loan Documents or the Second Lien Loan Documents, the provisions of this Agreement shall govern and control. The parties hereto acknowledge that the terms of this
Agreement are not intended to negate any specific rights granted to Company in the First Lien Loan Documents and the Second Lien Loan Documents. 
 8.2 Effectiveness; Continuing Nature of this Agreement: Severability. This Agreement shall become effective when executed and delivered by the parties hereto. This is a continuing
agreement of lien subordination and the First Lien Claimholders may continue, at any time and without notice to the Second Lien Administrative Agent or any Second Lien Claimholder subject to the Second Lien Loan Documents, to extend credit and other
financial accommodations and lend monies to or for the benefit of Company or any Grantor constituting First Lien Obligations in reliance hereof. The Second Lien Administrative Agent, on behalf of itself and the Second Lien Claimholders, and First
Lien Administrative Agent, on behalf of itself and the First Lien Claimholders, each hereby waives any right it may have under applicable law to revoke this Agreement or any of the provisions of this Agreement. The terms of this Agreement shall
survive, and shall continue in full force and effect, in any Insolvency or Liquidation Proceeding. Any provision of this Agreement which is prohibited or unenforceable in any jurisdiction shall not invalidate the remaining provisions hereof, and any
such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any 
 CHARl\1175377v2 
 36 

  

 

 

  
 other
jurisdiction. All references to Company or any other Grantor shall include Company or such Grantor as debtor and debtor-in-possession and any receiver or trustee for Company or any other Grantor (as the case may be) in any Insolvency or Liquidation
Proceeding. This Agreement shall terminate and be of no further force and effect, (i) with respect to the Second Lien Administrative Agent, the Second Lien Claimholders and the Second Lien Obligations, upon the later of (1) the date upon
which the obligations under the Second Lien Credit Agreement terminate and payment has been made in full in cash of all other Second Lien Obligations outstanding on such date and (2) if there are other Second Lien Obligations outstanding on
such date, the date upon which such Second Lien Obligations terminate and (ii) with respect to the First Lien Administrative Agent, the First Lien Claimholders and the First Lien Obligations, the date of Discharge of First Lien Obligations,
subject to the rights of the First Lien Claimholders under Section 5.6 and Section 6.5. 
 8.3
Amendments; Waivers. No amendment, modification or waiver of any of the provisions of this Agreement by the Second Lien Administrative Agent or the First Lien Administrative Agent shall be deemed to be made unless the same shall be in writing signed
on behalf of each party hereto or its authorized agent and each waiver, if any, shall be a waiver only with respect to the specific instance involved and shall in no way impair the rights of the parties making such waiver or the obligations of the
other parties to such party in any other respect or at any other time. Notwithstanding the foregoing, Company shall not have any right to consent to or approve any amendment, modification or waiver of any provision of this Agreement except to the
extent its rights are decreased or its obligations are increased thereby. 
 8.4 Information Concerning Financial
Condition of Company and its Subsidiaries. 
 (a) The First Lien Administrative Agent and the First Lien
Claimholders, on the one hand, and the Second Lien Claimholders and the Second Lien Administrative Agent, on the other hand, shall each be responsible for keeping themselves informed of (a) the financial condition of Company and its
Subsidiaries and all endorsers and/or guarantors of the First Lien Obligations or the Second Lien Obligations and (b) all other circumstances bearing upon the risk of nonpayment of the First Lien Obligations or the Second Lien Obligations. The
First Lien Administrative Agent and the First Lien Claimholders shall have no duty to advise the Second Lien Administrative Agent or any Second Lien Claimholder of information known to it or them regarding such condition or any such circumstances or
otherwise. Similarly, the Second Lien Administrative Agent and the Second Lien Claimholders shall have no duty to advise the First Lien Administrative Agent or any First Lien Claimholder of information known to it or them regarding such condition or
any such circumstances or otherwise. In the event that the First Lien Administrative Agent or any First Lien Claimholder, in its or their sole discretion, undertakes at any time or from time to time to provide any such information to the Second Lien
Administrative Agent or any Second Lien Claimholder, or the Second Lien Administrative Agent or any Second Lien Claimholder, in its or their sole discretion, undertakes any time or from time to time to provide any such information to the First Lien
Administrative Agent or any First Lien Claimholder, it or they shall be under no obligation (w) to make, and it shall not make, any express or implied representation or warranty, including with respect to the accuracy, completeness,
truthfulness or validity of any such information so provided, (x) to provide any additional information or to provide any such information on any subsequent occasion, (y) to undertake any investigation or (z) to disclose any
information which, pursuant to accepted or reasonable commercial finance practices, such party wishes to maintain confidential or is otherwise required to maintain confidential. 

(b) The Grantors agree that any information provided to the First Lien Administrative Agent, the Second Lien
Administrative Agent, the Control Agent, any First Lien 
 CHARl\1175377v2 

37 

  

 

 

  
 Claimholder or
any Second Lien Claimholder may be shared by such Person with any First Lien Claimholder, any Second Lien Claimholder, the Control Agent, the First Lien Administrative Agent or the Second Lien Administrative Agent; provided that such information
shall otherwise be subject to the respective confidentiality provisions in the First Lien Credit Agreement and the Second Lien Credit Agreement, as applicable. 
 8.5 Subrogation. Subject to the Discharge of First Lien Obligations, with respect to the value of any payments or distributions in cash, property or other assets that the Second Lien
Claimholders or Second Lien Administrative Agent pay over to the First Lien Administrative Agent or any of the other First Lien Claimholders under the terms of this Agreement, the Second Lien Claimholders and the Second Lien Administrative Agent
shall be subrogated to the rights of the First Lien Administrative Agent and such other First Lien Claimholders; provided that, the Second Lien Administrative Agent, on behalf of itself and the Second Lien Claimholders, hereby agrees not to enforce
all such rights of subrogation it may acquire as a result of any payment hereunder until the Discharge of First Lien Obligations has occurred. Each of the Grantors acknowledges and agrees that the value of any payments or distributions in cash,
property or other assets received by the Second Lien Administrative Agent or any Second Lien Claimholder that are paid over to the First Lien Administrative Agent or any First Lien Claimholder pursuant to this Agreement shall not reduce any of the
Second Lien Obligations but shall instead, to the extent applied to repay the First Lien Obligations, be deemed to be a payment by the Grantors on account of the First Lien Obligations. 

8.6 Application of Payments. All payments received by the First Lien Administrative Agent or the First Lien Claimholders
may be applied, reversed and reapplied, in whole or in part, to such part of the First Lien Obligations provided for in the First Lien Loan Documents. The Second Lien Administrative Agent, on behalf of itself and the Second Lien Claimholders,
assents to (a) subject to Section 5.3, any extension or postponement of the time of payment of the First Lien Obligations or any part thereof and to any other indulgence with respect thereto and (b) subject to Section 2 hereof,
(i) any substitution, exchange or release of any security which may at any time secure any part of the First Lien Obligations and (ii) the addition or release of any other Person primarily or secondarily liable therefor. 

8.7 SUBMISSION TO JURISDICTION: WAIVER OF JURY TRIAL. 

(a) ALL JUDICIAL PROCEEDINGS BROUGHT AGAINST ANY PARTY ARISING OUT OF OR RELATING HERETO MAY BE BROUGHT IN ANY STATE OR
FEDERAL COURT OF COMPETENT JURISDICTION IN THE STATE, COUNTY AND CITY OF NEW YORK TO THE EXTENT PERMITTED BY APPLICABLE LAW. BY EXECUTING AND DELIVERING THIS AGREEMENT, EACH PARTY, FOR ITSELF AND IN CONNECTION WITH ITS PROPERTIES, IRREVOCABLY, TO
THE EXTENT PERMITTED BY APPLICABLE LAW (i) ACCEPTS GENERALLY AND UNCONDITIONALLY THE NON-EXCLUSIVE JURISDICTION AND VENUE OF SUCH COURTS; (ii) WAIVES ANY DEFENSE OF FORUM NON CONVENIENS; (iii) AGREES THAT SERVICE OF ALL PROCESS IN ANY
SUCH PROCEEDING IN ANY SUCH COURT MAY BE MADE BY REGISTERED OR CERTIFD2D MAIL, RETURN RECEIPT REQUESTED, TO THE APPLICABLE PARTY AT ITS ADDRESS PROVIDED IN ACCORDANCE WITH SECTION 8.8: AND (iv) AGREES THAT SERVICE AS PROVTOED IN CLAUSE
(c) ABOVE IS SUFFICIENT TO CONFER PERSONAL JURISDICTION OVER THE APPLICABLE PARTY IN ANY SUCH PROCEEDING IN ANY SUCH COURT, AND OTHERWISE CONSTITUTES EFFECTIVE AND BINDING SERVICE IN EVERY RESPECT. 

CHARl\1175377v2 
 38 

  

 

 

  
 (b) EACH OF THE
PARTIES HERETO HEREBY AGREES TO WAIVE ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING HEREUNDER. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND
THAT RELATE TO THE SUBJECT MATTER HEREOF, INCLUDING CONTRACT CLAIMS, TORT CLAIMS, BREACH OF DUTY CLAIMS AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. EACH PARTY HERETO ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL INDUCEMENT TO ENTER INTO A BUSINESS
RELATIONSHIP, THAT EACH HAS ALREADY RELIED ON THIS WAIVER IN ENTERING INTO THIS AGREEMENT, AND THAT EACH WILL CONTINUE TO RELY ON THIS WAIVER IN ITS RELATED FUTURE DEALINGS. EACH PARTY HERETO FURTHER WARRANTS AND REPRESENTS THAT IT HAS REVIEWED THIS
WAIVER WITH ITS LEGAL COUNSEL AND THAT IT KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL. THIS WAIVER IS IRREVOCABLE, MEANING THAT IT MAY NOT BE MODIFIED EITHER ORALLY OR IN WRITING (OTHER THAN BY A
MUTUAL WRITTEN WAIVER SPECIFICALLY REFERRING TO THIS SECTION 8.7(b) AND EXECUTED BY EACH OF THE PARTIES HERETO), AND THIS WAIVER SHALL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS OR MODIFICATIONS HERETO. IN THE EVENT OF LITIGATION,
THIS AGREEMENT MAY BE FILED AS A WRITTEN CONSENT TO A TRIAL BY THE COURT. 
 8.8 Notices. All notices to the
Control Agent, the Second Lien Claimholders and the First Lien Claimholders permitted or required under this Agreement shall also be sent to the Second Lien Administrative Agent and the First Lien Administrative Agent, respectively. Unless otherwise
specifically provided herein, any notice or other communication herein required or permitted to be given shall be in writing and may be personally served, electronically mailed or sent by courier service or U.S. mail and shall be deemed to have been
given when delivered in person or by courier service, upon receipt of electronic mail or four Business Days after deposit in the U.S. mail (registered or certified, with postage prepaid and properly addressed). For the purposes hereof, the addresses
of the parties hereto shall be as set forth below each party’s name on the signature pages hereto, or, as to each party, at such other address as may be designated by such party in a written notice to all of the other parties. 

8.9 Further Assurances. The First Lien Administrative Agent, on behalf of itself and the First Lien Claimholders under the
First Lien Loan Documents, and the Second Lien Administrative Agent, on behalf of itself and the Second Lien Claimholders under the Second Lien Loan Documents, and Company, agrees that each of them shall take such further action and shall execute
and deliver such additional documents and instruments (in recordable form, if requested) as the First Lien Administrative Agent or the Second Lien Administrative Agent may reasonably request to effectuate the terms of and the lien priorities
contemplated by this Agreement. 
 8.10 APPLICABLE LAW. THIS AGREEMENT SHALL BE GOVERNED BY, AND SHALL BE
CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 
 8.11 Binding on Successors and
Assigns. This Agreement shall be binding upon the each of the parties hereto, the First Lien Claimholders, the Second Lien Claimholders, the Control Agent and each of their respective successors and assigns. 

CHARl\1175377v2 
 39 

  

 

 

  
 8.12 Specific
Performance. Each of the First Lien Administrative Agent and the Second Lien Administrative Agent may demand specific performance of this Agreement. The First Lien Administrative Agent, on behalf of itself and the First Lien Claimholders under its
First Lien Loan Documents, and the Second Lien Administrative Agent, on behalf of itself and the Second Lien Claimholders, hereby irrevocably waives any defense based on the adequacy of a remedy at law and any other defense which might be asserted
to bar the remedy of specific performance in any action which may be brought by any First Lien Administrative Agent or the Second Lien Administrative Agent, as the case may be. 
 8.13 Headings. Section headings in this Agreement are included herein for convenience of reference only and shall not constitute a part of this Agreement for any other purpose or be given
any substantive effect. 
 8.14 Counterparts. This Agreement may be executed in counterparts (and by different
parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page of this Agreement or any document
or instrument delivered in connection herewith by telecopy or other electronic means shall be effective as delivery of a manually executed counterpart of this Agreement or such other document or instrument, as applicable. 

8.15 Authorization. By its signature, each Person executing this Agreement on behalf of a party hereto represents and
warrants to the other parties hereto that it is duly authorized to execute this Agreement. 
 8.16 No Third Party
Beneficiaries. This Agreement and the rights and benefits hereof shall inure to the benefit of each of the parties hereto and its respective successors and assigns and shall inure to the benefit of each of the First Lien Administrative Agent, the
First Lien Claimholders, the Second Lien Administrative Agent, the Second Lien Claimholders, the Control Agent, the Company and each Guarantor. No other Person shall have or be entitled to assert rights or benefits hereunder. 

8.17 Provisions Solely to Define Relative Rights. The provisions of this Agreement are and are intended solely for the
purpose of defining the relative rights of the First Lien Claimholders on the one hand and the Second Lien Claimholders on the other hand. Nothing in this Agreement is intended to or shall impair the rights of Company or any other Grantor, or the
obligations of Company or any other Grantor, which are absolute and unconditional, to pay the First Lien Obligations and the Second Lien Obligations as and when the same shall become due and payable in accordance with their terms. 

8.18 Grantors; Additional Grantors. It is understood and agreed that the Company and each other Grantor on the date of
this Agreement shall constitute the original Grantors party hereto. The parties hereto agree that each Person which becomes a Grantor at any time (and any security granted by any such Person) shall be subject to the provisions hereof as fully as if
same constituted a Guarantor party hereto and had complied with the requirements of the immediately preceding sentence. 
 [REMAINDER OF THIS PAGE LEFT BLANK INTENTIONALLY] 

CHARl\1175377v2 
 40 

  

 

 

  
 IN WITNESS
WHEREOF, each of the parties hereto has caused a counterpart of this Agreement to be duly executed and delivered as of the date first above written. 
 BORROWER: AMN HEALTHCARE, INC., 
 a Nevada
corporation 
 By: 
 Name:_ Title: 
 PARENT: AMN HEALTHCARE SERVICES,
INC., 
 a Delaware corporation 

By: 
 Name:_ Title: 
 CHARl\1175377vl 

41 

  

 

 

  
 SUBSIDIARY
GUARANTORS: 
 AMN SERVICES, INC., 
 a North Carolina corporation 
 By: 

Name: 
 Title: 
 O’GRADY-PEYTON INTERNATIONAL (USA),
INC., 
 a Massachusetts corporation 
 By:_ 
 Name:_ Title: 

INTERNATIONAL HEALTHCARE RECRUITERS, INC., a Delaware corporation 

By: 
 Name: 
 Title: 

AMN STAFFING SERVICES, INC., 
 a Delaware corporation 
 By: 

Name: 
 Title: 
 THE MHA GROUP, INC., 

a Texas corporation 
 By: 
 Name: 

Title: 
 MERRITT, HAWKINS & ASSOCIATES, 
 a
California corporation 
 By: 
 Name: 
 Title: 

CHARl\1175377v2 
 42 

  

 

 

  
 AMN HEALTHCARE
ALLIED, INC., 
 a Texas corporation 
 By: 
 Name: 

Title: 
 RN DEMAND, INC., 
 a Texas corporation 

By: 
 Name: 
 Title: 

[TARGET ENTITIES], 
 By:_ 
 Name:_ Title: 

CHARl\1175377v2 
 43 

  

 

 

  
 STAFF CARE,
INC., 
 a Delaware corporation 
 By: 
 Name: 

Title: 
 MHA ALLIED CONSULTING, INC., 
 a Texas corporation

 By: 
 Name: 
 Title: 

AMN ALLIED SERVICES, LLC, 
 a Delaware limited liability company 
 By:

 Name: 
 Title: 
 LIFEWORK, INC., 

a Colorado corporation 
 By: 
 Name: 

Title: 
 PHARMACY CHOICE, INC., 
 a Colorado corporation

 By: 
 Name: 
 Title: 

RX PRO HEALTH, INC., 
 a Colorado corporation 
 By: 

Name: 
 Title: 
 CHARl\1175377v2 

44 

  

 

 

  
 FIRST LIEN

 ADMINISTRATIVE AGENT: BANK OF AMERICA, N. A., 

in its capacity as First Lien Administrative Agent 

By: 
 Name: Title: 
 SECOND LIEN 

ADMINISTRATIVE AGENT: BANK OF AMERICA, N. A., 

in its capacity as Second Lien Administrative Agent 

By: 
 Name: Title: 
 CONTROL AGENT: BANK OF AMERICA, N.
A., 
 in its capacity as Control Agent 
 By: 
 Name: Title: 

CHARl\1175377v2 
 45

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00180-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00180-of-00352.parquet"}]]